Literature: A-K ; L-Z ; subject area
Compiled by: Julian Thorpe
Literature A - K
(These journals include: Neurology, Neurobiology of Disease, Journal of Neurochemistry, Alzheimer's Disease Review)
|
|
Go to: A ; B ; C ; D ; E ; F ; G ; H ; I ; J ; K ; Literature L-Z
Abdul, HM, Wenk, GL, Gramling, M, Hauss-Wegrzyniak, B, Butterfield, DA (2004) APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. NEUROSCIENCE LETTERS 368: 148-150
Abe, K and Saito, H (2000) Amyloid beta neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons. NEUROSCIENCE LETTERS 292: 1-4
Abe, Y, Kouyama, K, Tomita, T, Tomita, Y, Ban, N, Nawa,
M, Matsuoka, M, Niikura, T, Aiso, S, Kita, Y, Iwatsubo, T, Nishimoto, I (2003) Analysis of neurons created from wild-type and Alzheimer's mutation
knock-in embryonic stem cells by a highly efficient differentiation protocol.
JOURNAL OF NEUROSCIENCE 23: 8513-8525
Abraha, A, Ghoshal, N, Gamblin, TC, Cryns, V, Berry, RW, Kuret, J and Binder, LI (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. JOURNAL OF CELL SCIENCE 113: 3737-3745
Abraham, C. R.; Selkoe, D. J.; Potter, H. (1988) Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
Abraham, R, Hamshere, M, Myers, A, Kwon, J, Spurlock, G, Thomas, H, Turic, D, Marshall, H, De-Vrieze, FW, Compton, D, Hoogendoom, B, Liolitsa, D, Lovestone, S, Hardy, J, Goate, A, O'Donovan, M, Williams, J, Owen, MJ, Jones, L (2001) Insulin degrading enzyme is not associated with late-onset Alzheimer's disease. AMERICAN JOURNAL OF HUMAN GENETICS 69: 2236
Abraham, R, Myers, A, Wavrant-DeVrieze, F, Hamshere, ML, Thomas, HV, Marshall, H, Compton, D, Spurlock, G, Turic, D, Hoogendoorn, B, Kwon, KM, Petersen, RC, Tangalos, E, Norton, J, Morris, JC, Bullock, R, Liolitsa, S, Lovestone, S, Hardy, J, Goate, A, O'Donovan, M, Williams, J, Owen, MJ, Jones, L (2001) Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. HUMAN GENETICS 109: 646-652
Abrahamsen,
H, Gao, TY, Jennings, P, Newton, A (2005)
Pin1 regulates the activation-induced downregulation of PKC
beta II. FASEB JOURNAL 19: A272
Abramova, NA, Cassarino, DS, Khan, SM, Painter, TW, Bennett, JP (2002) Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. JOURNAL OF NEUROSCIENCE RESEARCH 67: 494-500
Acharya,
A, Xu, XJ, Husain-Ponnampalam, RD, Hoffmann-Benning, S, Kuo, MH (2005) Production
of constitutively acetylated recombinant p53 from yeast and Escherichia coli by
tethered catalysis. PROTEIN EXPRESSION AND PURIFICATION
41: 417-425
Ackerley, S, Thornhill, P, Grierson, AJ, Brownlees, J,
Anderton, BH, Leigh, PN, Shaw, CE, Miller, CCJ (2003)
Neurofilament heavy chain side arm phosphorylation regulates axonal transport of
neurofilaments. JOURNAL OF CELL BIOLOGY 161: 489-495
Adamec, E, Chang, HT, Stopa, EG, Hedreen, JC, Vonsattel, JP (2001) Tau protein expression in frontotemporal dementias. NEUROSCIENCE LETTERS 315: 21-24
Adamec, E, Murrell, JR, Takao, M, Hobbs, W, Nixon, RA, Ghetti, B, Vonsattel, JP (2002) P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein. JOURNAL OF THE NEUROLOGICAL SCIENCES 200: 85-93
Adlard, PA, Vickers, JC (2002) Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease. ACTA NEUROPATHOLOGICA 103: 377-383
Agius, LM (2003)
beta-amyloidosis as an index of activity of the Alzheimer process rather than as
a primary mechanism of neuronal injury in organic dementia. MEDICAL HYPOTHESES
60: 880-885
Agorogiannis,
EI, Agorogiannis, GI, Papadimitriou, A, Hadjigeorgiou, GM (2004)
Protein misfolding in neurodegenerative diseases. NEUROPATHOLOGY AND APPLIED
NEUROBIOLOGY 30: 215-224
Aguzzi, A, Haass, C (2003)
Games played by rogue proteins in prion disorders and
Ahlijanian MK; Barrezueta NX; Williams RD; Jakowski A; Kowsz KP; McCarthy S; Coskran T; Carlo A; Seymour PA; Burkhardt JE;Nelson RB; McNeish JD (2000). Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97: 2910-2915
Ahmed, ARH, Ho, PKY and Jones, RW (2000) Increased markers of oxidative stress in patients with Alzheimer's disease. ALZHEIMERS REPORTS 3: 269-273
Ait-Ghezala, G, Abdullah, L, Crescentini, R, Crawford, F, Town, T, Singh, S, Richards, D, Duara, R, Mullan, M (2002) Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample. NEUROSCIENCE LETTERS 325: 87-90
Akiyama H, Shin R-W, Uchida C, Kitamtoto T, Uchida T (2005) Pin1 promotes production of Alzheimer's amyloid b from b-cleaved amyloid precursor protein. Biochemical and Biophysical Research Communications 336: 521-529
Aksenov, MY, Aksenova, MV, Butterfield, DA, Geddes, JW and Markesbery, WR (2001) Protein oxidation in the brain in Alzheimer's disease. NEUROSCIENCE 103: 373-383
Albers, DS and Augood, SJ (2001) New insights into progressive supranuclear palsy. TRENDS IN NEUROSCIENCES 24: 347-352
Albers, DS, Beal, MF (2002) Mitochondrial dysfunction in progressive supranuclear palsy. NEUROCHEMISTRY INTERNATIONAL 40: 559-564
Albers, DS, Swerdlow, RH, Manfredi, G, Gajewski, C, Yang, LC, Parker, WD, Beal, MF (2001) Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. EXPERIMENTAL NEUROLOGY 168: 196-198
Albert A, Lavoie S, Vincent M (1999) A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Science 112: 2493-2500
Albert, AL, Lavoie, SB, Vincent, M (2004) Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3. BMC CELL BIOLOGY 5: 10-22
Aletta_Jm, Shelanski_Ml, Greene_La. (1989) Phosphorylation Of The Peripherin 58-Kda Neuronal Intermediate Filament Protein - Regulation By Nerve Growth-Factor And Other Agents. JOURNAL OF BIOLOGICAL CHEMISTRY, Vol.264, No.8, pp.4619- 4627
Aliev, G, Smith, MA, Seyidova, D, Neal, ML, Lamb, BT, Nunomura, A, Gasimov, EK, Vinters, HV, Perry, G, LaManna, JC, Friedland, RP (2002) The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. BRAIN PATHOLOGY 12: 21-35
Allen, B, Ingram, E, Takao, M,
Smith, MJ, Jakes, R, Virdee, K, Yoshida, H, Holzer, M, Craxton, M, Emson, PC,
Atzori, C, Migheli, A, Crowther, RA, Ghetti, B, Spillantini, MG, Goedert, M
(2002) Abundant tau filaments and nonapoptotic
neurodegeneration in transgenic mice expressing human P301S tau protein
Allen, JW, Eldadah, BA, Huang, XL, Knoblach, SM and Faden, AI (2001) Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. JOURNAL OF NEUROSCIENCE RESEARCH 65: 45-53
Allsop, D, Twyman, LJ, Davies, Y, Moore, S, York, A, Swanson, L, Soutar, I (2001) Modulation of beta-amyloid production and fibrillization. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 1-14
Almeida, OP, Hulse, GK, Lawrence, D, Flicker, L (2002) Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. ADDICTION 97: 15-28
Alonso, AD, Zaidi, T, Novak, M, Grundke-Iqbal, I and Iqbal, K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 6923-6928
Alvarez, A, Munoz, JP and Maccioni, RB (2001) A cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of cdk5 activity in hippocampal neurons. EXPERIMENTAL CELL RESEARCH 264: 266-274
Alvarez, A, Toro, R, Caceres, A and Maccioni, RB (2000) Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS LETTERS 459: 421-426
Alvarez, G, Munoz-Montano, JR, Satrustegui, J, Avila, J, Bogonez, E, Diaz-Nido, J (2002) Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. BIPOLAR DISORDERS 4: 153-165
An,
WL, Bjorkdahl, C, Liu, R, Cowburn, RF, Winblad, B, Pei, JJ (2005) Mechanism
of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3
beta in SH-SY5Y neuroblastoma cells. JOURNAL OF NEUROCHEMISTRY 92: 1104-1115
An, WL, Cowburn, RF,
Li, L, Braak, H, Alafuzoff, I, Iqbal, K, Grundke-Iqbal, IG, Winblad, B, Pei, JJ
(2003)
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to
neurofibrillary pathology in Alzheimer's disease. AMERICAN JOURNAL OF PATHOLOGY
163: 591-607
Anandatheerthavarada, HK, Biswas, G, Robin, MA,
Avadhani, NG (2003) Mitochondrial targeting and a novel transmembrane
arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function
in neuronal cells. JOURNAL OF CELL BIOLOGY 161: 41-54
Anderson, AJ, Stoltzner, S, Lai, F, Su, J and Nixon, RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. NEUROBIOLOGY OF AGING 21: 511-524
Anderson, AJ, Su, JH and Cotman, CW (1996) DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. JOURNAL OF NEUROSCIENCE 16: 1710-1719
Anderson, I, Adinolfi, C, Doctrow, S, Huffman, K, Joy, KA, Malfroy, B, Soden, P, Rupniak, HT, Barnes, JC (2001) Oxidative signalling and inflammatory pathways in Alzheimer's disease. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 141-149
Anderson, SJ, Barker, PE, Hadfield, MG (2002) Cytonectin expression in Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 230-236
Andersson, K, Olofsson, A, Nielsen, EH, Svehag, SE, Lundgren, E (2002)
Only amyloidogenic intermediates of transthyretin induce apoptosis.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 294: 309-314
Anderton, BH, Betts, J, Blackstock, WP, Brion, JP, Chapman, S, Connell, J, Dayanandan, R, Gallo, JM, Gibb, G, Hanger, DP, Hutton, M, Kardalinou, E, Leroy, K, Lovestone, S, Mack, T, Reynolds, CH, Van Slegtenhorst, M (2001) Sites of phosphorylation in tau and factors affecting their regulation. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 73-80
Anderton, BH, Dayanandan, R, Killick, R and Lovestone, S (2000) Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease? MOLECULAR MEDICINE TODAY 6: 54-59
Andorfer,
C, Acker, CM, Kress, Y, Hof, PR, Duff, K, Davies, P (2005)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human
tau isoforms. JOURNAL OF NEUROSCIENCE 25: 5446-5454
Andorfer, CA and Davies, P (2000) PKA phosphorylations on tau: Developmental studies in the mouse. DEVELOPMENTAL NEUROSCIENCE 22: 303-309
Andorfer, C, Kress, Y, Espinoza, M, de Silva, R,
Tucker, KL, Barde, YA, Duff, K, Davies, P (2003)
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau
isoforms. JOURNAL OF NEUROCHEMISTRY 86: 582-590
Andreasen,
N, Blennow, K (2005)
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
CLINICAL NEUROLOGY AND NEUROSURGERY 107: 165-173
Angelastro_JM, Ho_CL, Frappier_T, Liem_RKH, Greene_LA. (1998) Peripherin is tyrosine-phosphorylated at its carboxyl-terminal tyrosine. JOURNAL OF NEUROCHEMISTRY,Vol.70, No.2, pp.540-549
Angelo, M, Plattner, F, Irvine, EE, Giese, KP (2003)
Improved reversal learning and altered fear conditioning in transgenic mice with
regionally restricted p25 expression. EUROPEAN JOURNAL OF NEUROSCIENCE 18:
423-431
Annaert, W, Cupers, P, Saftig, P, De Strooper, B (2000) Presenilin function in APP processing. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 158-164
Apelt, J, Mehlhorn, G, Hollborn, M and Schliebs, R (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic TG2576 mice with Alzheimer pathology. EUROPEAN JOURNAL OF NEUROSCIENCE 12: 211
Apelt, J and Schliebs, R (2001) beta-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. BRAIN RESEARCH 894: 21-30
Arai, H, Ishiguro, K, Ohno, H, Moriyama, M, Itoh, N,
Okamura, N, Matsui, T, Morikawa, Y, Horikawa, E, Kohno, H, Sasaki, H, Imahori, K
(2000) CSF phosphorylated tau protein and mild cognitive impairment: a
prospective study. EXPERIMENTAL NEUROLOGY 166: 201-203
Arai, T, Ikeda, K, Akiyama, H, Tsuchiya, K, Yagishita, S, Takamatsu, J (2001) Intracellular processing of aggregated tan differs between corticobasal degeneration and progressive supranuclear palsy. NEUROREPORT 12: 935-938
Arai, T, Ikeda, K, Akiyama, H, Shikamoto, Y, Tsuchiya, K, Yagishita, S, Beach, T, Rogers, J, Schwab, C, McGeer, PL (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. ACTA NEUROPATHOLOGICA 101: 167-173
Arai, T, Ikeda, K, Akiyama, H, Tsuchiya, K, Iritani, S, Ishiguro, K, Yagishita, S, Oda, T, Odawara, T, Iseki, E (2003) Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. ACTA NEUROPATHOLOGICA 105: 489-498
Arai, T, Nonaka, T, Hasegawa, M, Akiyama, H, Yoshida,
M, Hashizume, Y, Tsuchiya, K, Oda, T, Ikeda, K (2003)
Neuronal and glial inclusions in frontotemporal dementia with or without motor
neuron disease are immunopositive for p62. NEUROSCIENCE LETTERS 342: 41-44
Arai, Y, Yamazaki, M, Mori, O, Muramatsu, H, Asano, G and Katayama, Y (2001) alpha-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. BRAIN RESEARCH 888: 287-296
Araki, W, Yuasa, K, Takeda, S, Shirotani, K, Takahashi, K, Tabira, T (2000) Overexpression of presenilin-2 enhances apoptotic death of cultured cortical neurons. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 241-244
Araki, W, Yuasa, K, Takeda, S, Takeda, K, Shirotani, K, Takahashi, K, Tabira, T (2001) Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons. JOURNAL OF NEUROCHEMISTRY 79: 1161-1168
Arango, D, Cruts, M, Torres, O, Backhovens, H, Serrano, ML, Villareal, E, Montanes, P, Matallana, D, Cano, C, Van Broeckhoven, C, Jacquier, M (2001) Systematic genetic study of Alzheimer disease in Latin America: Mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. AMERICAN JOURNAL OF MEDICAL GENETICS 103: 138-143
Ardley, HC, Scott, GB, Rose, SA, Tan, NGS, Markham, AF,
Robinson, PA (2003) Inhibition of proteasomal activity causes
inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
MOLECULAR BIOLOGY OF THE CELL 14: 4541-4556
Arendash, GW, Gordon, MN, Diamond, DM, Austin, LA, Hatcher, JM, Jantzen, P, Dicarlo, G, Wilcock, D, Morgan, D (2001) Behavioral assessment of Alzheimer's transgenic mice following long-term A beta vaccination: Task specificity and correlations between A beta deposition and spatial memory. DNA AND CELL BIOLOGY 20: 737-744
Arendash, GW, King, DL, Gordon, MN, Morgan, D, Hatcher, JM, Hope, CE and Diamond, DM (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. BRAIN RESEARCH 891: 42-53
Arendt, T (2000) Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. NEUROBIOLOGY OF AGING 21: 783-796
Arendt, T (2001) Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. NEUROSCIENCE 102: 723-765
Arendt,
T (2002) Dysregulation of neuronal differentiation and cell
cycle control in Alzheimer's disease
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 62:
77-85
Arendt,
T (2003)
Synaptic plasticity and cell cycle activation in neurons are alternative
effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease
or the yin and yang of neuroplasticity. PROGRESS IN NEUROBIOLOGY 71: 83-248
Arendt,
T (2004)
Neurodegeneration and plasticity. INTERNATIONAL JOURNAL OF DEVELOPMENTAL
NEUROSCIENCE 22: 507-514
Arendt, T, Holzer, M and Bruckner, MK (1998) Neuronal expression of cell-cycle-markers in Alzheimer's disease. EUROPEAN JOURNAL OF NEUROSCIENCE 10: 3217
Arendt_T, Holzer_M, Fruth_R, Bruckner_MK, Gartner_U. (1998) Phosphorylation of tau, A beta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. NEUROBIOLOGY OF AGING, Vol.19, No.1, pp.3-13
Arendt, T, Holzer, M and Gartner, U (1998) Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION 105: 949-960
Arendt, T, Holzer, M, Gartner, U and Bruckner, MK (1998) Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION SU54: 147-158
Arendt, T, Holzer, M, Stobe, A, Gartner, U, Luth, HJ, Bruckner, MK, Ueberham, U (2000) Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 249-255
Arendt, T, Holzer, M, Stobe, A, Ueberham, U, Gartner, U and Bruckner, MK (2000) Cell cycle regulatory factors in Alzheimer's disease. BRAIN PATHOLOGY 10: 796
Arendt,
T, Stieler, J, Strijkstra, AM, Hut, RA, Rudiger, J, Van der Zee, EA, Harkany, T,
Holzer, M, Hartig, W (2003)
Reversible paired helical filament-like phosphorylation of tau is an adaptive
process associated with neuronal plasticity in hibernating animals. JOURNAL OF
NEUROSCIENCE 23: 6972-6981
Arevalo-Rodriguez, M, Cardenas, ME, Wu, XY, Hanes, SD and Heitman, J (2000) Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO JOURNAL 19: 3739-3749
Arima K; Izumiyama Y; Nakamura M; Nakayama H; Kimura M; Ando S; Ikeda K; Takahashi K. (1998) Argyrophilic tau-positive twisted and non-twisted tubules in astrocytic processes in brains of Alzheimer-type dementia: an electron microscopical study. Acta Neuropathol (Berl), 95:1, 28-39
Arima_K, Nakamura_M, Sunohara_N, Nishio_T, Ogawa_M, Hirai_S, Kawai_M, Ikeda_K. (1999) Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy brains. ACTA NEUROPATHOLOGICA, 1999, Vol.97, No.6, pp.565-576
Armogida M, Petit A, Vincent B, ScarzelloS, Alves da Costa C, Checler F (2001) Endogenous b-amyloid production in presenilin-deficient embryonic mouse fibroblasts. NATURE CELL BIOLOGY 3: 1030-1033
Armstrong, RA (2000) Diffuse beta-amyloid (A beta) deposits and neurons: in situ secretion or diffusion of A beta? ALZHEIMERS REPORTS 3: 289-294
Armstrong, RA (2003) Quantifying
the pathology of neurodegenerative disorders: quantitative measurements,
sampling strategies and data analysis. HISTOPATHOLOGY 42: 521-529
Armstrong_RA, Cairns_NJ, Lantos_PL (1998) Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies. ALZHEIMERS REPORTS 1: 159-163
Armstrong_RA, Cairns_NJ, Lantos_PL (1999) Laminar distribution of Pick bodies, Pick cells and Alzheimer disease pathology in the frontal and temporal cortex in Pick's disease. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 25: 266-271
Armstrong, RA, Cairns, NJ and Lantos, PL (2001a) What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? NEUROPATHOLOGY 21: 1-12
Armstrong, RA, Cairns, NJ and Lantos, PL (2001b) Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease. NEUROPATHOLOGY 21: 19-24
Armstrong,
RA, Lantos, PL, Cairns, NJ (2005) Overlap
between neurodegenerative disorders. NEUROPATHOLOGY 25: 111-124
Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. and Hyman, B.T. (1992) Neurofibrillary tangles but not senile plaques parrallel duration and severity of Alzheimer's disease. Neurology 42: 631-639
Atamna,
H (2004)
Heme, iron, and the mitochondrial decay of ageing. AGEING RESEARCH REVIEWS 3:
303-318
Atchison,
FW, Capel, B, Means, AR (2003)
Pin1 regulates the timing of mammalian primordial germ cell proliferation.
DEVELOPMENT 130: 3579-3586
Atchison, FW, Means, AR (2003) Spermatogonial depletion in adult Pin1-deficient mice. BIOLOGY OF REPRODUCTION 69: 1989-1997
Atchison,
FW, Means, AR (2004) A
role for Pin1 in mammalian germ cell development and spermatogenesis. FRONTIERS
IN BIOSCIENCE 9: 3248-3256
Athan, ES, Williamson, J, Ciappa, A, Santana, V, Romas, SN, Lee, JH, Rondon, H, Lantigua, RA, Medrano, M, Torres, M, Arawaka, S, Rogaeva, E, Song, YQ, Sato, C, Kawarai, T, Fafel, KC, Boss, MA, Seltzer, WK, Stern, Y, St George-Hyslop, P, Tycko, B, Mayeux, R (2001) A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 286: 2257-2263
Athlan_ES, Sacher_MG, Mushynski_WE. (1997) Associations between intermediate filament proteins expressed in cultured dorsal root ganglion neurons. JOURNAL OF NEUROSCIENCE RESEARCH, 1997, Vol.47, No.3, pp.300-310
Atzori, C, Ghetti, B, Piva, R, Srinivasan, AN, Zolo, P, Delisle, MB, Mirra, SS, Migheli, A (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 1190-1197
Augustinack, JC, Sanders, JL, Tsai, LH, Hyman, BT (2002) Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 557-564
Augustinack, JC, Schneider, A, Mandelkow, EM, Hyman, BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. ACTA NEUROPATHOLOGICA 103: 26-35
Avila, J, Lim, F, Moreno, F, Belmonte, C, Cuello, AC (2002) Tau function and dysfunction in neurons - Its role in neurodegenerative disorders. MOLECULAR NEUROBIOLOGY 25: 213-231
Avila,
J, Lucas, JL, Perez, M, Hernandez, F (2004)
Role of tau protein in both physiological and pathological conditions.
PHYSIOLOGICAL REVIEWS 84: 361-384
Avila,
J, Perez, M, Lim, F, Gomez-Ramos, A, Hernandez, F, Lucas, JJ (2004) Tau
in neurodegenerative diseases: Tau phosphorylation and assembly. NEUROTOXICITY
RESEARCH 6: 477-482
Ayala,
G, Wang, DG, Wulf, G, Frolov, A, Li, R, Sowadski, J, Wheeler, TM, Lu, KP, Bao, L
(2003)
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
CANCER RESEARCH 63: 6244-6251
| B |
Back to Top
Baekelandt, V, Moechars, D, Laenen, I, Lorent, K and Van Leuven, F (1999) Disturbance of the glutamatergic system in mice transgenic for the amyloid precursor protein. ALZHEIMERS REPORTS 2: 359-368
Bajo, M, Yoo, BC, Cairns, N, Gratzer, M, Lubec, G (2001) Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease. AMINO ACIDS 21: 293-301
Baki, L, Marambaud, P, Efthimiopoulos, S, Georgakopoulos, A, Wen, P, Cui, W, Shioi, J, Koo, E, Ozawa, M, Friedrich, VL and Robakis, NK (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 2381-2386
Baloyannis,
SJ (2005)
Morphological and morphometric alterations of Cajal-Retzius cells in early cases
of Alzheimer's disease: A Golgi and electron microscope study. INTERNATIONAL
JOURNAL OF NEUROSCIENCE 115: 965-980
Baloyannis, SJ, Costa, V, Koutsouraki, E and Psaroulis, D (1997) The blood capillaries of the cerebellum in Alzheimer's disease: A Golgi and electron microscopy study. BRAIN PATHOLOGY 7: 1203
Baloyannis, SJ, Manolidis, SL and Manolidis, LS (2000) Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease - A Golgi and electron microscope study. ACTA OTO-LARYNGOLOGICA 120: 247-250
Bamberger, ME, Harris, ME, McDonald, DR, Husemann, J,
Landreth, GE (2003) A cell surface receptor complex for fibrillar beta-amyloid
mediates microglial activation. JOURNAL OF NEUROSCIENCE 23: 2665-2674
Bamberger, ME, Landreth, GE (2002) Inflammation, apoptosis, and Alzheimer's disease. NEUROSCIENTIST 8: 276-283
Bao,
L, Kimzey, A, Sauter, G, Sowadski, JM, Lu, KP, Wang, DG (2004)
Prevalent overexpression of prolyl isomerase Pin1 in human cancers. AMERICAN
JOURNAL OF PATHOLOGY 164: 1727-1737
Barbato,
C, Canu, N, Zambrano, N, Serafino, A, Minopoli, G, Ciotti, MT, Amadoro, G,
Russo, T, Calissano, P (2005) Interaction
of Tau with Fe65 links tau to APP. NEUROBIOLOGY OF DISEASE 18: 399-408
Barbiero,
L, Benussi, L, Ghidoni, R, Alberici, A, Russo, C, Schettini, G, Pagano, SF,
Parati, EA, Mazzoli, F, Nicosia, F, Signorini, S, Feudatari, E, Binetti, G
(2003)
BACE-2 is overexpressed in Down's syndrome. EXPERIMENTAL NEUROLOGY 182: 335-345
Bard, F, Cannon, C, Barbour, R, Burke, RL, Games, D, Grajeda, H, Guido, T, Hu, K, Huang, JP, Johnson-Wood, K, Khan, K, Kholodenko, D, Lee, M, Lieberburg, I, Motter, R, Nguyen, M, Soriano, F, Vasquez, N, Weiss, K, Welch, B, Seubert, P, Schenk, D and Yednock, T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. NATURE MEDICINE 6: 916-919
Barghorn, S, Davies, P, Mandelkow, E (2004) Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. BIOCHEMISTRY 43: 1694-1703
Barghorn,
S, Mandelkow, E (2002)
Barghorn, S, Zheng-Fischhofer, Q, Ackmann, M, Biernat, J, von Bergen,
M, Mandelkow, EM and Mandelkow, E (2000) Structure, microtubule
interactions, and paired helical filament aggregation by tau
mutants of frontotemporal dementias. BIOCHEMISTRY 39: 11714-11721
Barger, SW and Basile, AS (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. JOURNAL OF NEUROCHEMISTRY 76: 846-854
Barghorn,
S, Mandelkow, E (2002)
Barghorn, S, Zheng-Fischhofer, Q, Ackmann, M, Biernat, J, von Bergen, M, Mandelkow, EM and Mandelkow, E (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. BIOCHEMISTRY 39: 11714-11721
Barik,
S (2004)
Development of gene-specific double-stranded RNA drugs. ANNALS OF MEDICINE 36:
540-551
Barrow, PA, Empson, RM, Gladwell, SJ, Anderson, CM, Killick, R, Yu, X, Jefferys, JGR and Duff, K (2000) Functional phenotype in transgenic mice expressing mutant human presenilin-1. NEUROBIOLOGY OF DISEASE 7: 119-126
Bartzokis,
G, Sultzer, D, Lu, PH, Neuchterlein, KH, Mintz, J, Cummings, JL (2004) Heterogeneous
age-related breakdown of white matter structural integrity: implications for
cortical "disconnection" in aging and Alzheimer's diesase.
NEUROBIOLOGY OF AGING 25: 843-851
Basu, A, Haldar, S (2002) Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway. INTERNATIONAL JOURNAL OF ONCOLOGY 21: 597-601
Basu,
A, Das, M, Qanungo, S, Fan, CJ, DuBois, G, Haldar, S (2002)
Proteasomal degradation of human peptidyl prolyl
isomerase Pin1-pointing phospho Bcl2 toward dephosphorylation. NEOPLASIA 4: 218-227
Bayer, E, Goettsch, S, Mueller, JW, Griewel, B,
Guiberman, E, Mayr, LM, Bayer, P (2003)
Structural analysis of the mitotic regulator hPin1 in solution - Insights into
domain architecture and substrate binding. JOURNAL OF BIOLOGICAL CHEMISTRY 278:
26183-26193
Bayer,
E, Thutewohl, M, Christner, C, Tradler, T, Osterkamp, F, Waldmann, H, Bayer, P
(2005)
Identification of hPin1 inhibitors that induce apoptosis in a mammalian Ras
transformed cell line. CHEMICAL COMMUNICATIONS 4: 516-518
Bayer, TA, Wirths, O, Majtenyi, K, Hartmann, T, Multhaup, G, Beyreuther, K and Czech, C (2001) Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. BRAIN PATHOLOGY 11: 1-11
Beal, MF (2002) Oxidatively modified proteins in aging and disease. FREE RADICAL BIOLOGY AND MEDICINE 32: 797-803
Becker EB, Bonni A (2006) Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery. Neuron: 655-662
Bedford MT, Sarbassova D, Xu J, Leder P, Yaffe MB (2000) A novel Pro-Arg motif recognized by WW domains. Journal of Biological Chemistry 275: 10359- 10369
Beher, D, Wrigley, JDJ, Nadin, A, Evin, G, Masters, CL, Harrison, T, Castro, JL, Shearman, MS (2001) Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma-secretase inhibitor - Implications for presenilin biology. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 45394-45402
Beher, D, Wrigley, JDJ, Owens, AP, Shearman, MS (2002) Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. JOURNAL OF NEUROCHEMISTRY 82: 563-575
Bendiske, J, Bahr, BA (2003)
Lysosomal activation is a compensatory response against protein accumulation and
associated synaptopathogenesis - An approach for slowing Alzheimer disease?
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 62: 451-463
Bendiske, J, Caba, E, Brown, QB, Bahr, BA (2002) Intracellular deposition, microtubule destabilization, and transport failure: An "early" pathogenic cascade leading to synaptic decline. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 640-650
Benjannet, S, Elagoz, A, Wickham, L, Mamarbachi, M, Munzer, JS, Basak, A, Lazure, C, Cromlish, JA, Sisodia, S, Checler, F, Chretien, M and Seidah, NG (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding - The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 10879-10887
Bennecib, M, Gong, CX, Grundke-Iqbal, I and Iqbal, K (2000) Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS LETTERS 485: 87-93
Bennecib, M, Gong, CX, Grundke-Iqbal, I and Iqbal, K (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS LETTERS 490: 15-22
Bennecib, M, Gong, CX, Wegiel, J, Lee, MH, Grundke-Iqbal, I and Iqbal, K (2000) Inhibition of protein phosphatases and regulation of tau phosphorylation in rat brain. ALZHEIMERS REPORTS 3: 295-304
Bennett, BD, Denis, P, Haniu, M, Teplow, DB, Kahn, S, Louis, JC, Citron, M and Vassar, R (2000) A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta-secretase. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 37712-37717
Bennett, DA, Schneider, JA, Wilson, RS, Bienias, JL, Arnold, SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. ARCHIVES OF NEUROLOGY 61: 378-384
Bennett GS, Quintana R. (1997) Identification of Ser-Pro and Thr-Pro phosphorylation sites in chicken neurofilament-M tail domain. J Neurochem, 1997 Feb, 68:2, 534-43
Benson_DL, Mandell_JW, Shaw_G, Banker_G. (1996) Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons. JOURNAL OF NEUROCYTOLOGY 25: 181-196
Benveniste, EN, Nguyen, VT, O'Keefe, GM (2001) Immunological aspects of microglia: relevance to Alzheimer's disease. NEUROCHEMISTRY INTERNATIONAL 39: 381-391
Berezovska, O, Jack, C, Deng, A, Gastineau, N, Rebeck, GW and Hyman, BT (2001) Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 30018-30023
Berger,
M, Stahl, N, Del Sal, G, Haupt, Y (2005) Mutations
in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA
damage. MOLECULAR AND CELLULAR BIOLOGY 25: 5380-5388
Bernado,
P, Fernandes, MX, Jacobs, DM, Fiebig, K, de la Torre, JG, Pons, M (2004)
Interpretation of NMR relaxation properties of Pin1, a two-domain protein, based
on Brownian dynamic simulations. JOURNAL OF BIOMOLECULAR NMR 29: 21-35
Bernis, C, Vigneron, S, Burgess, A, Labbe, J-C), Fesquet, D, Castro, A, Lorca, T (2007) Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF beta trcp. EMBO REPORTS 8 (1): 91-98
Bernstein_HG, Kirschke_H, Wiederanders_B, Pollak_KH, Zipress_A, Rinne_A. (1996) The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease - A review. MOLECULAR AND CHEMICAL NEUROPATHOLOGY 27: 225-247
Berriman, J, Serpell, LC, Oberg, KA, Fink, AL, Goedert,
M, Crowther, RA (2003) Tau filaments from human brain and from in vitro
assembly of recombinant protein show cross-beta structure. PROCEEDINGS OF THE
NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100: 9034-9038
Berry, RW, Abraha, A, Lagalwar, S, LaPointe, N, Gamblin,
TC, Cryns, VL, Binder, LI (2003)
Inhibition of tau polymerization by its carboxy-terminal caspase cleavage
fragment. BIOCHEMISTRY 42: 8325-8331
Berry,
RW, Sweet, AP, Clark, FA, Lagalwar, S, Lapin, BR, Wang, T, Topgi, S,
Guillozet-Bongaarts, AL, Cochran, EJ, Bigio, EH, Binder, LI (2004) Tau
epitope display in progressive supranuclear palsy and corticobasal degeneration.
JOURNAL OF NEUROCYTOLOGY 33: 287-295
Bertram, L, Blacker, D, Mullin, K, Keeney, D, Jones, J, Basu, S, Yhu, S, McInnis, MG, Go, RCP, Vekrellis, K, Selkoe, DJ, Saunders, AJ and Tanzi, RE (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. SCIENCE 290: 2302
Bertram, L, Guenette, S, Jones, J, Keeney, D, Mullin, K, Crystal, A, Basu, S, Yhu, S, Deng, A, Rebeck, GW, Hyman, BT, Go, R, McInnis, M, Blacker, D and Tanzi, R (2001) No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. ANNALS OF NEUROLOGY 49: 114-116
Bertram, L, Tanzi, RE (2001) Dancing in the dark? The status of late-onset Alzheimer's disease genetics. JOURNAL OF MOLECULAR NEUROSCIENCE 17: 127-136
Bertram,
L, Tanzi, RE (2004)
Alzheimer's disease: one disorder, too many genes? HUMAN MOLECULAR GENETICS 13:
R135-R141
Bertrand, E, Brouillet, E, Caille, I, Bouillot, C, Cole, GM, Prochiantz, A, Allinquant, B (2001) A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. MOLECULAR AND CELLULAR NEUROSCIENCE 18: 503-511
Beyer, K, Lao, JI, Gomez, M, Riutort, N, Latorre, P, Mate, JL, Ariza, A (2001) Alzheimer's disease and the cystatin C gene polymorphism: an association study. NEUROSCIENCE LETTERS 315: 17-20
Bhat, RV, Budd, SL (2002)
Bhat,
R, Xue, YF, Berg, S, Hellberg, S, Ormo, M, Nilsson, Y, Radesater, AC, Jerning,
E, Markgren, PO, Borgegard, T, Nylof, M, Gimenez-Cassina, A, Hernandez, F,
Lucas, JJ, Diaz-Nido, J, Avila, J (2003)
Structural insights and biological effects of glycogen synthase kinase
3-specific inhibitor AR-A014418. JOURNAL OF BIOLOGICAL CHEMISTRY 278:
45937-45945
Bi, XN, Yong, AP, Zhou, J, Ribak, CE and Lynch, G (2001) Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 8832-8837
Bian, F, Nath, R, Sobocinski, G, Booher, RN, Lipinski, WJ, Callahan, MJ, Pack, A, Wang, KKW, Walker, LC (2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. JOURNAL OF COMPARATIVE NEUROLOGY 246: 257-266
Biernat, J, Wu, YZ, Timm, T,
Zheng-Fischhofer, QY, Mandelkow, E, Meijer, L, Mandelkow, EM (2002) Protein kinase MARK/PAR-1 is required for neurite
outgrowth and establishment of neuronal polarity
Bigio, EH, Lipton, AM, White, CL, Dickson, DW, Hirano,
A (2003) Frontotemporal and motor neurone degeneration with neurofilament
inclusion bodies: additional evidence for overlap between FTD and ALS.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 29: 239-253
Bigio, EH, Vono, MB, Satumtira, S, Adamson, J, Sontag, E, Hynan, LS, White, CL, Baker, M and Hutton, M (2001) Cortical synapse loss in progressive supranuclear palsy. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 403-410
Bimonte-Nelson, HA, Hunter, CL, Nelson, ME, Granholm,
ACE (2003) Frontal cortex BDNF levels correlate with working
memory in an animal model of Down syndrome. BEHAVIOURAL BRAIN RESEARCH
139: 47-57
Binder,
LI, Guillozet-Bongaarts, AL, Garcia-Sierra, F, Berry, RW (2005) Tau,
tangles, and Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS
OF DISEASE 1739: 216-223
Binetti, G, Nicosia, F, Benussi, L, Ghidoni, R,
Feudatari, E, Barbiero, L, Signorini, S, Villa, A, Mattioli, F, Zanetti, O,
Alberici, A (2003) Prevalence of TAU mutations in an Italian clinical
series of familial frontotemporal patients. NEUROSCIENCE LETTERS 338: 85-87
Birchall, J. D.; Chappell, J. S. (1988) Aluminum, chemical physiology, and Alzheimer's disease. Lancet II: 1008-1010
Bird, T, Knopman, D, VanSwieten, J, Rosso, S, Feldman,
H, Tanabe, H, Graff-Raford, N, Geschwind, D, Verpillat, P, Hutton, M (2003)
Epidemiology and genetics of frontotemporal dementia/Pick's disease. ANNALS OF
NEUROLOGY 54: S29-S31
Birdi, S, Rajput, AH, Fenton, M,
Donat, JR, Rozdilsky, B, Robinson, C, Macaulay, R, George, D (2002) Progressive supranuclear palsy diagnosis and
confounding features: Report on 16 autopsied cases
Birmingham, K, Frantz, S (2002) Set back to Alzheimer vaccine studies. NATURE MEDICINE 8: 199-200
Bishop,
GM, Robinson, SR (2002)
Bishop, GM, Robinson, SR (2003)
Deposits of fibrillar A beta do not cause neuronal loss or ferritin expression
in adult rat brain. JOURNAL OF NEURAL TRANSMISSION 110: 381-400
Bjorkdahl,
C, Sjogren, MJ, Winblad, B, Pei, JJ (2005)
Zinc induces neurofilament phosphorylation independent of p70 S6 kinase in N2a
cells. NEUROREPORT 16: 591-595
Blanchard,
BJ, Chen, A, Rozeboom, LM, Stafford, KA, Weigele, P, Ingram, VM
(2004) Efficient reversal of Alzheimer's disease fibril formation and
elimination of neurotoxicity by a small molecule. PROCEEDINGS OF THE NATIONAL
ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101: 14326-14332
Blanquet, PR (2000) Casein kinase 2 as a potentially important enzyme in the nervous system. PROGRESS IN NEUROBIOLOGY 60: 211-246
Blasko, I, Veerhuis, R, Stampfer-Kountchev, M, Saurwein-Teissl, M, Eikelenboom, P and Grubeck-Loebenstein, B (2000) Costimulatory effects of interferon-gamma and interleukin-1 beta or tumor necrosis factor alpha on the synthesis of a beta 1-40 and a beta 1-42 by human astrocytes. NEUROBIOLOGY OF DISEASE 7: 682-689
Blasko,
I, Stampfer-Kountchev, M, Robatscher, P, Verrhuis, R, Eikelenboom, P,
Grubeck-Loebenstein, B (2004) How
chronic inflammation can affect the brain and support the development of
Alzheimer's disease in old age: the role of microglia and astrocytes. AGING CELL
3: 169-176
Blasko, I, Wagner, M, Whitaker, N, Grubeck-Loebenstein, B and Jansen-Durr, P (2000) The amyloid beta peptide A beta (25-35) induces apoptosis independent of p53. FEBS LETTERS 470: 221-225
Blass, JP (2000) The mitochondrial spiral - An adequate cause of dementia in the Alzheimer's syndrome. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. ALZHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES 924: 170-183
Bloom,
GS, Ren, K, Glabe, CG (2005) Cultured
cell and transgenic mouse models for tau pathology linked to beta-amyloid.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 116-124
Boccardi,
M, Sabattoli, F, Testa, C, Beltramello, A, Soininen, H, Frisoni, GB (2004)
APOE and modulation of Alzheimer's and frontotemporal dementia. NEUROSCIENCE
LETTERS 356: 167-170
Boeve, B, Dickson, D, Duffy, J, Bartleson, J, Trenerry,
M, Petersen, R (2003) Progressive nonfluent aphasia and subsequent
aphasic dementia associated with atypical progressive supranuclear palsy
pathology. EUROPEAN NEUROLOGY 49: 72-78
Bogoyevitch,
MA, Boehm, I, Oakley, A, Ketteman, AJ, Barr, RK (2004)
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic
potential. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 1697: 89-101
Boldyrev,
A, Koudinov, A, Berezov, T, Carpenter, DO (2004)
Amyloid-beta induced cell death is independent of free radicals. JOURNAL OF
ALZHEIMERS DISEASE 6: 633-638
Bondolfi, L, Calhoun, M, Ermini, F, Kuhn, HG, Wiederhold, KH, Walker, L, Staufenbiel, M, Jucker, M (2002) Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. JOURNAL OF NEUROSCIENCE 22: 515-522
Bonini, NM, Fortini, ME (2003)
Human neurodegenerative disease modeling using Drosophila. ANNUAL REVIEW OF
NEUROSCIENCE 26: 627-656
Borchelt, DR, Lee, MK, Gonzales, V, Slunt, HH, Ratovitski, T, Jenkins, NA, Copeland, NG, Price, DL, Sisodia, SS (2002) Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. NEUROBIOLOGY OF AGING 23: 171-177
Borchelt, DR, Thinakaran, G, Eckman, CB, Lee, MK, Davenport, F, Ratovitsky, T, Prada, C-M, Kim, G, Seekins, S, Yager, D et al. (1996) Familial Alzheimer's Disease-Linked Presenilin 1 Variants Elevate A Beta 1-42/1-40 Ratio In Vitro and In Vivo. NEURON 17: 1005-1013
Borghi, R, Giliberto, L, Assini, A, Delacourte, A, Perry, G, Smith, MA, Strocchi, P, Zaccheo, D, Tabaton, M (200?) Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy. NEUROLOGY 58: 589-592
Borghi,
R, Piccini, A, Delacourte, A, Strocchi, P, Zaccheo, D, Tabaton, M (2004) Protein
levels of glycogen synthase 3 kinase are normal in progressive supranuclear
palsy. NEUROSCIENCE LETTERS 366: 67-70
Borgne, A and Meijer, L (2000) The search for and potential therapeutic applications of chemical inhibitors of cyclin-dependent kinases. M S-MEDECINE SCIENCES 15: 496-503
Bornebroek,
M, Breteler, MMB (2004)
Epidemiology of non-AD dementias. CLINICAL NEUROSCIENCE RESEARCH 3: 349-361
Bornemann, KD and Staufenbiel, M (2000) Transgenic mouse models of Alzheimer's disease. MOLECULAR AND CELLULAR GERONTOLOGY 908: 260-266
Bornemann, KD, Wiederhold, KH, Pauli, C, Ermini, F, Stalder, M, Schnell, L, Sommer, B, Jucker, M and Staufenbiel, M (2001) A beta-Induce inflammatory processes in microglia cells of APP23 transgenic mice. AMERICAN JOURNAL OF PATHOLOGY 158: 63-73
Borroni,
B, DiLuca, M, Cattabeni, F, Padovani, A (2004) Advance
on the diagnostic potential of biological markers in the early detection of
Alzheimer Disease. NEUROSCIENCE RESEARCH COMMUNICATIONS 35: 232-245
Bouma, B, Kroon-Batenburg, LMJ, Wu, YP, Brunjes, B,
Posthuma, G, Kranenburg, O, de Groot, PG, Voest, EE, Gebbink, MFBG (2003)
Glycation induces formation of amyloid cross-beta structure in albumin. JOURNAL
OF BIOLOGICAL CHEMISTRY 278: 41810-41819
Bouras,
C, Riederer, BM, Kovari, E, Hof, PR, Giannakopoulos, P (2005)
Humoral immunity in brain aging and Alzheimer's disease. BRAIN RESEARCH REVIEWS
48: 477-487
Boutajangout,
A, Authelet, M, Blanchard, V, Touchet, N, Tremp, G, Pradier, L, Brion, JP (2004)
Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type
human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
NEUROBIOLOGY OF DISEASE 15: 47-60
Boutajangout,
A, Boom, A, Leroy, K, Brion, JP (2004) Expression
of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in
Alzheimer's disease. FEBS LETTERS 576: 183-189
Boutajangout, A, Leroy, K, Touchet, N, Authelet, M, Blanchard, V, Tremp, G, Pradier, L, Brion, JP (2002) Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. NEUROSCIENCE LETTERS 318: 29-33
Bozyczko-Coyne, D, O'Kane, TM, Wu, ZL, Dobrzanski, P, Murthy, S, Vaught, JL and Scott, RW (2001) CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with A beta-induced cortical neuron apoptosis. JOURNAL OF NEUROCHEMISTRY 77: 849-863
Braak, H. and Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82: 239-259
Braak, E., Braak, H. and Mandelkow, E-M (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.. Acta Neuropathol. 87: 554-567
Braak, H, Del Tredici, K, Schultz, C, Braak, E (2000) Vulnerability of select neuronal types to Alzheimer's disease. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES 924: 53-61
Brandt, R (2001) Cytoskeletal mechanisms of neuronal degeneration. CELL AND TISSUE RESEARCH 305: 255-265
Brandt,
R, Hundelt, M, Shahani, N (2005)
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 331-354
Bree,
RT, Neary, C, Samali, A, Lowndes, NF (2004)
The switch from survival responses to apoptosis after chromosomal breaks. DNA
REPAIR 3: 989-995
Breen KC, Robinson PA, Wion D, Anderton BH. (1989) Partial sequence of the rat heavy neurofilament polypeptide (NF-H). Identification of putative phosphorylation sites. Published erratum appears in FEBS Lett 1989 Feb 27;244(2):509
Bregman, DB, Pestell, RG and Kidd, VJ (2000) Cell cycle regulation and RNA polymerase II. FRONTIERS IN BIOSCIENCE 5: D224-D257
Brion JP. (1998) Neurofibrillary tangles and Alzheimer's disease. Eur Neurol, 1998 Oct, 40:3, 130-40
Brion, JP, Anderton, BH, Authelet, M, Dayanadan, R, Leroy, K, Lovestone, S, Octave, JN, Pradier, L, Touchet, N, Tremp, G (2001) Neurofibrillary tangles and tau phosphorylation. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 81-88
Broe, GA, Grayson, DA, Creasey, HM, Waite, LM, Casey, BJ, Bennett, HP, Brooks, WS and Halliday, GM (2000) Anti-inflammatory drugs protect against Alzheimer disease at low doses. ARCHIVES OF NEUROLOGY 57: 1586-1591
Broe, M, Hodges, JR, Schofield, E, Shepherd, CE, Kril,
JJ, Halliday, GM (2003) Staging disease severity in pathologically
confirmed cases of frontotemporal dementia. NEUROLOGY 60: 1005-1011
Broe,
M, Shepherd, CE, Mann, DMA, Milward, EA, Gai, WP, Thiel, E, Halliday, GM (2005)
Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.
NEUROTOXICITY RESEARCH 7: 69-76
Broe, M, Shepherd, CE, Milward, EA and Halliday, GM (2001) Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies. ACTA NEUROPATHOLOGICA 101: 616-624
Brondani,
V, Schefer, Q, Hamy, F, Klimkait, T (2005) The
peptidyl-prolyl isomerase Pin1 regulates phospho-Ser(77) retinoic acid receptor
alpha stability. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 328: 6-13
Bronfman, FC, Tesseur, I, Hofker, MH, Havekens, LM and Van Leuven, F (2000) No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice. NEUROSCIENCE 97: 411-418
Brooks,
CL, Gu, W (2003)
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53
regulation. CURRENT OPINION IN CELL BIOLOGY 15: 164-171
Brookes, AJ (2001) Issues and assays for single nucleotide polymorphism analysis in complex disease. CHEMICO-BIOLOGICAL INTERACTIONS 133:71-74
Brown, AM, Sheu, RKF, Mohs, R, Haroutunian, V and Blass, JP (2001) Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (antDNA). JOURNAL OF MOLECULAR NEUROSCIENCE 16: 41-48
Brown,
MR, Bondada, V, Keller, JN, Thorpe, J, Geddes, JW (2005)
Proteasome or calpain inhibition does not alter cellular tau levels in
neuroblastoma cells or primary neurons. JOURNAL OF ALZHEIMERS DISEASE 7: 15-24
Brown, VM, Ossadtchi, A, Khan, AH, Cherry, SR, Leahy, RM, Smith, AJ (2002) High-throughput imaging of brain gene expression. GENOME RESEARCH 12: 244-254
Brownlees, J, Ackerley, S, Grierson,
AJ, Jacobsen, NJO, Shea, K, Anderton, BH, Leigh, PN, Shaw, CE, Miller, CCJ
(2002) Charcot-Marie-Tooth disease neurofilament mutations
disrupt neurofilament assembly and axonal transport
Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, Leigh PN, Shaw CE, Miller CC (2000) Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113: 401-7
Broytman,
O, Malter, JS (2004)
Anti-A beta: The good, the bad, and the unforeseen. JOURNAL OF NEUROSCIENCE
RESEARCH 75: 301-306
Bruce-Keller, AJ, Keeling, JL, Keller, JN, Huang, FF, Camondola, S and Mattson, MP (2000) Antiinflammatory effects of estrogen on microglial activation. ENDOCRINOLOGY 141:3646-3656
Bruscolini,
P, Cecconi, F (2005)
Analysis of PIN1WW domain through a simple statistical mechanics model.
BIOPHYSICAL CHEMISTRY 115: 153-158
Bu, BT, Klunemann, H, Suzuki, K,
Li, J, Bird, T, Jin, LW, Vincent, I (2002) Niemann-Pick disease type C yields possible clue for
why cerebellar neurons do not form neurofibrillary tangles
Bucciantini, M, Giannoni, E, Chiti, F, Baroni, F, Formigli, L, Zurdo, JS, Taddei, N, Ramponi, G, Dobson, CM, Stefani, M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. NATURE 416: 507-511
Buchet, R and Pikula, S (2000) Alzheimer's disease: Its origin at the membrane, evidence and questions. ACTA BIOCHIMICA POLONICA 47: 725-733
Buchman_VL. (1998) Synucleins:Keys to the mechanisms of neurodegenerative diseases? MOLECULAR BIOLOGY, 1998, Vol.32, No.4, pp.485-490
Buee, L, Bussiere, T, Buee-Scherrer, V, Delacourte, A and Hof, PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. BRAIN RESEARCH REVIEWS 33: 95-130
Buee, L, Delacourte, A (2002) Alzheimer's disease: just another tauopathy? MEDECINE SCIENCES 18: 727-736
Buee-Scherrer, V, Goedert, M (2002) Phosphorylation of micro tubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS LETTERS 515: 151-154
Buerger, K, Teipel, SJ, Zinkowski, R, Blennow, K, Arai,
H, Engel, R, Hofmann-Kiefer, K, McCulloch, C, Ptok, U, Heun, R, Andreasen, N,
DeBernardis, J, Kerkman, D, Moeller, HJ, Davies, P, Hampel, H (2002) CSF tau protein phosphorylated at threonine 231 correlates with
cognitive decline in MCI subjects. NEUROLOGY 59: 627-629
Buerger, K, Zinkowski, R, Teipel, SJ, Arai, H,
DeBernardis, J, Kerkman, D, McCulloch, C, Padberg, F, Faltraco, F, Goernitz, A,
Tapiola, T, Rapoport, SI, Pirttila, T, Moller, HJ, Hampel, H (2003) Differentiation of geriatric major depression from
Alzheimer's disease with CSF tau protein phosphorylated at threonine 231
Buerger, K, Zinkowski, R, Teipel, SJ, Tapiola, T, Arai, H, Blennow, K,
Andreasen, N, Hofmann-Kiefer, K, DeBernardis, J, Kerkman, D, McCulloch,
C, Kohnken, R, Padberg, F, Pirttila, T, Schapiro, MB, Rapoport, SI, Moller,
HJ, Davies, P, Hampel, H (2002) Differential diagnosis of Alzheimer disease
with cerebrospinal fluid levels of tau protein phosphorylated at threonine
231. ARCHIVES OF NEUROLOGY 59: 1267-1272
Bulavin,
DV, Fornace, AJ (2004) p38
MAP kinase's emerging role as a tumor suppressor. ADVANCES IN CANCER RESEARCH
92: 95-118
Bulavin,
DV, Kovalsky, O, Hollander, MC, Fornace, AJ (2003)
Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated
protein kinase activation by disruption of gadd45a. MOLECULAR AND CELLULAR
BIOLOGY 23: 3859-3871
Burn,
DJ, Lee, AJ (2002)
Burns, M, Gaynor, K, Olm, V, Mercken, M, LaFrancois, J,
Wang, LL, Mathews, PM, Noble, W, Matsuoka, Y, Duff, K (2003) Presenilin
redistribution associated with aberrant cholesterol transport enhances beta-amyloid
production in vivo. JOURNAL OF NEUROSCIENCE 23: 5645-5649
Busciglio, J, Pelsman, A, Wong, C, Pigino, G, Yuan, ML, Mori, H, Yankner,
BA (2002) Altered metabolism of the amyloid beta precursor
protein is associated with mitochondrial dysfunction in Down's
syndrome. NEURON 33: 677-688
BUSH_ML, MIYASHIRO_JS, INGRAM_VM. (1995) ACTIVATION OF A NEUROFILAMENT KINASE, A TAU KINASE, AND A TAU PHOSPHATASE BY DECREASED ATP LEVELS IN NERVE GROWTH FACTOR-DIFFERENTIATED PC-12 CELLS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, Vol.92, No.6, pp.1861-1865
Bussiere, T, Giannakopoulos, P, Bouras, C, Perl, DP,
Morrison, JH, Hof, PR (2003) Progressive degeneration of nonphosphorylated
neurofilament protein-enriched pyramidal neurons predicts cognitive impairment
in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9.
JOURNAL OF COMPARATIVE NEUROLOGY 463: 281-302
Bussiere, T, Gold, G, Kovari, E, Giannakopoulos, P,
Bouras, C, Perl, DP, Morrison, JH, Hof, PR (2003)
Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex
area 9 in aging and Alzheimer's disease. NEUROSCIENCE 117: 577-592
Busser, J, Geldmacher, DS and Herrup, K (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. JOURNAL OF NEUROSCIENCE 18: 2801-2807
Butterfield, DA (2004) Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. BRAIN RESEARCH 1000: 1-7
Butterfield,
DA, Boyd-Kimball, D (2004) Proteomics
analysis in Alzheimer's disease: New insights into mechanisms of
neurodegeneration. HUMAN BRAIN PROTEOME 61: 161-188
Butterfield,
DA, Boyd-Kimball, D, Castegna, A (2003)
Proteomics in Alzheimer's disease: insights into potential mechanisms of
neurodegeneration. JOURNAL OF NEUROCHEMISTRY 86: 1313-1327
Butterfield, DA, Castegna, A (2003)
Proteomic analysis of oxildatively modified proteins in Alzheimer's disease
brain: Insights into neurodegeneration. CELLULAR AND MOLECULAR BIOLOGY 49:
747-751
Butterfield, DA, Drake, J, Pocernich, C, Castegna, A (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. TRENDS IN MOLECULAR MEDICINE 7: 548-554
Butterfield DA, Poon HF, Clair DSt, Keller JN, Pierce WM, Klein JB, Markesbery WR (In Press) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiology of Disease
Buttini_M, Orth_M, Bellosta_S, Akeefe_H, Pitas_RE, WyssCoray_T, Mucke_L, Mahley_RW. (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe(-/-) mice: Isoform-specific effects on neurodegeneration. JOURNAL OF NEUROSCIENCE, 1999, Vol.19, No.12, pp.4867-4880
Byrne, E (2002) Does mitochondrial respiratory chain dysfunction have a
role in common neurodegenerative disorders?
| C |
Caban-Holt,
A, Mattingly, M, Cooper, G, Schmitt, FA (2005)
Neurodegenerative memory disorders: A potential role of environmental toxins.
NEUROLOGIC CLINICS 23: 485-522
Cagnin, A, Brooks, DJ, Kennedy, AM, Gunn, RN, Myers, R, Turkheimer, FE, Jones, T and Banati, RB (2001) In-vivo measurement of activated microglia in dementia. LANCET 358: 461-467
Cairns, NJ (2001) Molecular neuropathology of transgenic mouse models of Down syndrome. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 61: 289-301
Cairns, NJ, Armstrong, RA (2003) Clustering of neuronal inclusions in "dementia with neurofilament inclusions" ACTA NEUROPATHOLOGICA 106: 125-128
Cairns,
NJ, Brannstrom, T, Khan, MN, Rossor, MN, Lantos, PL (2003)
Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative
inclusions. EXPERIMENTAL NEUROLOGY 181: 319-326
Cairns_NJ, Chadwick_A, Luthert_PJ, Lantos_PL (1992) Astrocytosis, beta-a4-protein deposition and paired helical filament formation in alzheimers-disease . JOURNAL OF THE NEUROLOGICAL SCIENCES 112: 68-75
Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee V.M.-Y, Trojanowski, JQ (2004) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63: 1376-1384
CAIRNS NJ, JAROS E, PERRY R, BIGIO E, THORPE JR, MOSAHEB S, ZHANG B, LEE V M-Y, TROJANOWSKI JQ (2003) Phosphorylated neurofilaments form abnormal aggregates in Dementia with Neurofilament Inclusions. Program No. 875.4. Society for Neuroscience 33rd Annual Meeting, New Orleans, November 8 - 12, 2003
Cairns NJ, Lee V M-Y, Trojanowski JQ (2004) The cytoskeleton in neurodegenerative diseases (review article). Journal of Pathology 204: 438-449
Cairns
NJ, Uryu K, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H,
Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee V M-Y, Trojanowski JQ (2004) a-Internexin is a major component
of the pathological inclusions of neuronal intermediate filament inclusion
disease (NIFID) and a minor component of other neurodegenerative diseases. Acta
Neuropathologica
Cairns,
NJ, Zhukareva, V, Uryu, K, Zhang, B, Bigio, E, Mackenzie, IRA, Gearing, M,
Duyckaerts, C, Yokoo, H, Nakazato, Y, Jaros, E, Perry, RH, Lee, VMY, Trojanowski,
JQ (2004)
alpha-internexin is present in the pathological inclusions of neuronal
intermediate filament inclusion disease. AMERICAN JOURNAL OF PATHOLOGY 164:
2153-2161
Calabrese, V, Scapagnini, G, Stella, AMG, Bates, TE and Clark, JB (2001) Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity. NEUROCHEMICAL RESEARCH 26: 739-764
Callahan, MJ, Lipinski, WJ, Bian, F, Durham, RA, Pack, A and Walker, LC (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. AMERICAN JOURNAL OF PATHOLOGY 158: 1173-1177
Campaner S, Kaldis P, Izraeli S, Kirsch IR (2005) Sil phosphorylation in a Pin1 binding domain affects the duration of the spindle checkpoint. Molecular and Cellular Biology 25: 6660-6672
Campbell, A (2001) beta-amyloid: friend or foe. MEDICAL HYPOTHESES 56: 388-391
Campbell, A (2002) The potential role of aluminium in Alzheimer's disease. NEPHROLOGY DIALYSIS TRANSPLANTATION 17: 17-20
Campbell, A, Hamai, D and Bondy, SC (2001) Differential toxicity of aluminum salts in human cell lines of neural origin: Implications for neurodegeneration. NEUROTOXICOLOGY 22: 63-71
Campbell HD, Webb GC, Fountain S, Young IG (1997) The human PIN1 peptidyl-prolyl cis/trans isomerase gene maps to human chromosome 19p13 and the closely related PIN1L gene to 1p31. Genomics 44: 157-162
Campdelacreu, J, Ezquerra, M, Munoz, E, Oliva, R,
Tolosa, E (2003) Mutational study of the nuclear factor kappa B
inducing kinase gene in patients with progressive supranuclear palsy.
NEUROSCIENCE LETTERS 340: 158-160
Cantuti-Castelvetri, I, Keller-McGandy, CE, Albers, DS, Beal, MF, Vonsattel,
JP, Standaert, DG, Augood, SJ (2002) Expression and activity of
antioxidants in the brain in progressive supranuclear palsy. BRAIN
RESEARCH 930: 170-181
Capsoni, S, Ugolini, G, Comparini, A, Ruberti, F, Berardi, N, Cattaneo, A (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sc. USA 97: 6826-6831
Cardoso, SM, Santos, S, Swerdlow, RH, Oliveira, CR (2002) Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB JOURNAL 15: U356-U389
Cardoso, SM, Swerdlow, RH, Oliveira, CR (2002) Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. BRAIN RESEARCH 931: 117-125
Carey_SM, Foy_C, Passmore_AP, Wisdom_GB. alpha 1-proteinase inhibitor and alpha 1-chymotrypsin inhibitor in Alzheimer's disease
Caricasole, A, Copani, A, Caraci, F, Aronica, E, Rozemuller, AJ, Caruso, A, Storto, M, Gaviraghi, G, Terstappen, GC, Nicoletti, F (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. JOURNAL OF NEUROSCIENCE 24: 6021-6027
Caricasole, A, Copani, A, Caruso, A, Caraci, F,
Iacovelli, L, Sortino, MA, Terstappen, GC, Nicoletti, F (2003)
The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic
strategies in Alzheimer's disease?. TRENDS IN PHARMACOLOGICAL SCIENCES 24:
233-238
Carney, JM (2000) Oxidative stress leading to loss of critical proteases in Alzheimer's disease - An alternative view of the etiology of AD. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES 924: 160-163
Carrell, R. W. (1988) Alzheimer's disease: enter a protease inhibitor. Nature 331: 478-479
Carrieri, G, Bonafe, M, De Luca, M, Rose, G, Varcasia, O, Bruni, A, Maletta, R, Nacmias, B, Sorbi, S, Corsonello, F, Feraco, E, Andreev, KF, Yashin, AI, Franceschi, C and De Benedictis, G (2001) Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. HUMAN GENETICS 108: 194-198
Carrilho,
PEM, Barbosa, ER (2002)
Progressive
supranuclear palsy in a sample of Brazilian population - Clinical features of 16
patients. ARQUIVOS DE NEURO-PSIQUIATRIA 60: 917-922
Carro, E, Trejo, JL, Gomez-Isla, T,
LeRoith, D, Torres-Aleman, I (2002) Serum insulin-like growth factor I regulates brain
amyloid-levels
Carson KA; Geula C; Mesulam MM. (1991) Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res, 1991 Feb, 540:1-2, 204-8
Carter, DB, Dunn, E, McKinley, DD, Stratman, NC, Boyle, TP, Kuiper, SL, Oostveen, JA, Weaver, RJ, Boller, JA, Gurney, ME (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. ANNALS OF NEUROLOGY 50: 468-475
Casanova, MF, Hill, WD, Pourdihimi, B (2001) Senile plaques exert no mass lesion effect on surrounding neurons. JOURNAL OF NEUROSCIENCE METHODS 110: 125-133
Cash, AD, Aliev, G, Siedlak, SL, Nunomura, A, Fujioka,
H, Zhu, XW, Raina, AK, Vinters, HV, Tabaton, M, Johnson, AB, Paula-Barbosa, M,
Avila, J, Jones, PK, Castellani, RJ, Smith, MA, Perry, G (2003)
Microtubule reduction in Alzheimer's disease and aging is independent of tau
filament formation. AMERICAN JOURNAL OF PATHOLOGY 162: 1623-1627
Castegna, A, Thongboonkerd, V, Klein, JB, Lynn, B,
Markesbery, WR, Butterfield, DA (2003)
Proteomic identification of nitrated proteins in Alzheimer's disease brain.
JOURNAL OF NEUROCHEMISTRY 85: 1394-1401
Castellani, R, Hirai, K, Aliev, G,
Drew, KL, Nunomura, A, Takeda, A, Cash, AD, Obrenovich, ME, Perry, G, Smith, MA
(2002) Role of mitochondrial dysfunction in Alzheimer's
disease
Castellani,
RJ, Honda, K, Zhu, XW, Cash, AD, Nunomura, A, Perry, G, Smith, MA (2004)
Contribution of redox-active iron and copper to oxidative damage in Alzheimer
disease. AGEING RESEARCH REVIEWS 3: 319-326
Castora, FJ, Hamblet, NS and Conyers, B (2000) Mutation in cytochrome c oxidase subunit III in Alzheimer's brains. AMERICAN JOURNAL OF HUMAN GENETICS 67: 1880
Castro, A and Martinez, A (2000) Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders. EXPERT OPINION ON THERAPEUTIC PATENTS 10: 1519-1527
Cataldo, AM, Petanceska, S, Peterhoff, CM, Terio, NB,
Epstein, CJ, Villar, A, Carlson, EJ, Staufenbiel, M, Nixon, RA (2003)
App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a
segmental trisomy 16 mouse model of Down syndrome. JOURNAL OF NEUROSCIENCE 23:
6788-6792
Cataldo,
AM, Petanceska, S, Terio, NB, Peterhoff, CM, Durham, R, Mercken, M, Mehta, PD,
Buxbaum, J, Haroutunian, V, Nixon, RA (2004) A
beta localization in abnormal endosomes: association with earliest A beta
elevations in AD and Down syndrome. NEUROBIOLOGY OF AGING 25: 1263-1272
Cataldo, AM, Peterhoff, CM, Troncosco, JC, Gomez-Isla, T, Hyman, BT and Nixon, RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations. American Journal Of Pathology 157: 277-286
Caughey, B, Lansbury, PT (2003)
Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible
protein aggregates from the innocent bystanders. ANNUAL REVIEW OF NEUROSCIENCE
26: 267-298
Cedazo-Minguez, A, Cowburn, RF (2001) Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 5: 254-266
Cedazo-Minguez, A, Huttinger, M and Cowburn, RF (2001) beta-VLDL protects against A beta(I-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells. NEUROREPORT 12: 201-206
Cedazo-Minguez,
A, Popescu, BO, Blanco-Millan, JM, Akterin, S, Pei, JJ, Winblad, B, Cowburn, RF
(2003)
Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase
kinase-3 beta. JOURNAL OF NEUROCHEMISTRY 87: 1152-1164
Chalmers, K, Wilcock, GK, Love, S (2003)
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by
favouring cerebrovascular over parenchymal accumulation of A beta protein.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 29: 231-238
Chan, HYE and Bonini, NM (2000) Drosophila models of human neurodegenerative disease. CELL DEATH AND DIFFERENTIATION 7: 1075-1080
Chaney, MO, Baudry, J, Esh, C, Childress, J, Luehrs,
DC, Kokjohn, TA, Roher, AE (2003) A beta, aging, and Alzheimer's disease: A tale,
models, and hypotheses. NEUROLOGICAL RESEARCH 25: 581-589
Chang, A, Cheang, S, Espanel, X and Sudol, M (2000) Rsp5 WW domains interact directly with the carboxyl-terminal domain of RNA polymerase II. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 20562-20571
Chang,
HT, Cortez, S, Vonsattel, JP, Stopa, EG, Schelper, RL (2004)
Familial frontotemporal dementia: a report of three cases of severe cerebral
atrophy with rare inclusions that are negative for tau and synuclein, but
positive for ubiquitin. ACTA NEUROPATHOLOGICA 108: 10-16
Chang, NS, Doherty, J, Ensign, A, Lewis, J, Heath, J,
Schultz, L, Chen, ST, Oppermann, U (2003)
Molecular mechanisms underlying WOX1 activation during apoptotic and stress
responses. BIOCHEMICAL PHARMACOLOGY 66: 1347-1354
Chang, RCC, Suen, KC, Ma, CH,
Elyaman, W, Ng, HK, Hugon, J (2002) Involvement of double-stranded RNA-dependent protein
kinase and phosphorylation of eukaryotic initiation factor-2 alpha in neuronal
degeneration
Chang, RCC, Wong, AKY, Ng, HK,
Hugon, J (2002) Phosphorylation of eukaryotic
initiation factor-2 alpha (eIF2 alpha) is associated with neuronal degeneration
in Alzheimer's disease. NEUROREPORT 13: 2429-2432
Chao, SH, Greenleaf, AL and Price, DH (2001) Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. NUCLEIC ACIDS RESEARCH 29: 767-773
Chapman PF, Falinska AM, Knevett SG, Ramsay MF (2001) Genes, models and Alzheimer’s disease. Trends Genet 17: 254-261
Chauhan, NB, Siegel, GJ (2002) Reversal of amyloid beta toxicity
in Alzheimer's disease model Tg2576 by intraventricular antiamyloid
beta antibody. JOURNAL OF NEUROSCIENCE RESEARCH 69: 10-23
Checler, F, da Costa, CA, Ancolio, K, Chevallier, N, Lopez-Perez, E and Marambaud, P (2000) Role of the proteasome in Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1502: 133-138
Chen,
F, David, D, Ferrari, A, Gotz, J (2004)
Posttranslational modifications of tau - Role in human tauopathies and modeling
in transgenic animals. CURRENT DRUG TARGETS 5: 503-515
Chen, FS, Yang, DS, Petanceska, S, Yang, A, Tandon, A, Yu, G, Rozmahel, R, Ghiso, J, Nishimura, M, Zhang, DM, Kawara, T, Levesque, G, Mills, J, Levesque, L, Song, YQ, Rogaeva, E, Westaway, D, Mount, H, Gandy, S, St George-Hyslop, P and Fraser, PE (2000) Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 36794-36802
Chen, GQ, Chen, KS, Knox, J, Inglis, J, Bernard, A, Martin, SJ, Justice, A, McConlogue, L, Games, D, Freedman, SB and Morris, RGM (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease . NATURE 408: 975-979
Chen J, Li L, Zhang YY, Yang HR, Wei YH, Zhang L, Liu XH, Yu L (2006) Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients. Biochemical and Biophysical Research Communications 341: 1059-1065
Chen_KS, Masliah_E, Grajeda_H, Guido_T, Huang_JP, Khan_K, Motter_R, Soriano_F, Games_D. (1998) Neurodegenerative Alzheimer-like pathology in PDAPP 717V->F transgenic mice. PROGRESS IN BRAIN RESEARCH, 1998, Vol.117, pp.327-334
Chen, M and Fernandez, HL (2001) Alzheimer movement re-examined 25 years later: Is it a "disease" or a senile condition in medical nature? FRONTIERS IN BIOSCIENCE 6: E30-E40
Chen, M and Fernandez, HL (2001) Where do Alzheimer's plaques and tangles come from? Aging-induced protein degradation inefficiency. FRONTIERS IN BIOSCIENCE 6: E1-E11
Chen, Q, Yoshida, H, Schubert, D, Maher, P, Mallory, M, Masliah, E (2001) Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation. AMERICAN JOURNAL OF PATHOLOGY 159: 1597-1602
Chen, YH, He, RQ, Liu, Y, Liu, Y and Xue, ZG (2000) Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase. BIOCHEMICAL JOURNAL 351: 233-240
Chen, YZ (2004) APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin. APOPTOSIS 9: 415-422
Chen, YZ, Liu, WY, McPhie, DL, Hassinger, L, Neve, RL
(2003) APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is
increased in Alzheimer's disease brain. JOURNAL OF CELL BIOLOGY 163: 27-33
Chen, YZ, McPhie, DL, Hirschberg, J and Neve, RL (2000) The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 8929-8935
Chen XH, Meaney DF, Xu BN, Nonaka M, Mcintosh TK, Wolf JA, Saatman KE, Smith DH. (1999) Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 58: 588-596
Chen,
YZ (2004)
APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin.
APOPTOSIS 9: 415-422
Cheng, LY, Wang, JZ, Gong, CX, Pei, JJ, Zaidi, T, Grundke-Iqbal, I and Iqbal, K (2001) Multiple forms of phosphatase from human brain: Isolation and partial characterization of affi-gel blue nonbinding phosphatase activities. NEUROCHEMICAL RESEARCH 26: 425-438
Cheon, MS, Bajo, M, Gulesserian, T, Cairns, N and Lubec, G (2001) Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease. ELECTROPHORESIS 22: 445-448
Chetelat,
G, Desgranges, B, de la Sayette, V, Viader, F, Eustache, F (2004)
At the boundary between normal aging and AD. REVUE NEUROLOGIQUE 160: S55-S63
Cheung,
ZH, Ip, NY (2004)
Cdk5: mediator of neuronal death and survival. NEUROSCIENCE LETTERS 361: 47-51
Chin, JY, Knowles, RB, Schneider, A, Drewes, G, Mandelkow, EM and Hyman, BT (2000) Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: A fluorescence resonance energy transfer study. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 59: 966-971
Ching YP, Qi Z and Wang JH (2000) Cloning of three novel neuronal Cdk5 activator binding proteins. Gene 242: 285-94
Chinnery, PF, Taylor, GA, Howell, N, Brown, DT, Parsons, TJ and Turnbull, DM (2001) Point mutations of the mtDNA control region in normal and neurodegenerative human brains. AMERICAN JOURNAL OF HUMAN GENETICS 68: 529-532
Chirichigno,
JW, Manfredi, G, Beal, MF, Albers, DS (2002)
Chirita,
CN, Congdon, EE, Yin, HS, Kuret, J (2005)
Triggers of full-length tau aggregation: A role for partially folded
interrnediates. BIOCHEMISTRY 44: 5862-5872
Chirita,
CN, Kuret, J (2004)
Evidence for an intermediate in tau filament formation. BIOCHEMISTRY 43:
1704-1714
Chirita, CN, Necula, M, Kuret, J (2003)
Anionic micelles and vesicles induce tau fibrillization in vitro. JOURNAL OF
BIOLOGICAL CHEMISTRY 278: 25644-25650
Chishti, MA, Yang, DS, Janus, C, Phinney, AL, Horne, P, Pearson, J, Strome, R, Zuker, N, Loukides, J, French, J, Turner, S, Lozza, G, Grilli, M, Kunicki, S,, Morissette, C, Paquette, J, Gervais, F, Bergeron, C, Fraser, PE, Carlson, GA, St George-Hyslop, P and Westaway, D (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 21562-21570
Chiti, F, Stefani, M, Taddei, N, Ramponi, G, Dobson, CM
(2003) Rationalization of the effects of mutations on peptide
and protein aggregation rates. NATURE 424: 805-808
Cho, HS, Hyman, BT, Greenberg, SM and Rebeck, GW (2001) Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in A beta aggregation. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 342-349
Chohan,
MO, Haque, N, Alonso, A, El-Akkad, E, Grundke-Iqbal, I, Grover, A, Iqbal, K
(2005)
Hyperphosphorylation-induced self assembly of murine tau: a comparison with
human tau. JOURNAL OF NEURAL TRANSMISSION 112: 1035-1047
Choi, YT, Jung, CH, Lee, SR, Bae, JH, Baek, WK, Suh, MH, Park, J, Park, CW, Suh, SI (2002) The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. LIFE SCIENCES 70: 603-614
Chow, TW, Miller, BL, Boone, K, Mishkin, F, Cummings, JL (2002)
Frontotemporal dementia classification and neuropsychiatry. NEUROLOGIST
8: 263-269
Christen Y. (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr, 2000 Feb, 71:2, 621S-629S
Christie, RH, Bacskai, BJ, Zipfel, WR, Williams, RM, Kajdasz, ST, Webb, WW and Hyman, BT (2001) Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. JOURNAL OF NEUROSCIENCE 21: 858-864
Christie_G, Markwell_RE, Gray_CW, Smith_L, Godfrey_F, Mansfield_F, Wadsworth_H, King_R, McLaughlin_M, Cooper_DG, Ward_RV, Howlett_DR, Hartmann_T, Lichtenthaler_SF, Beyreuther_K, Underwood_J, Gribble_SK, Cappai_R, Masters_CL, Tamaoka_A, Gardner_RL, Rivett_AJ, Karran_EH, Allsop_D. (1999) Alzheimer's disease: Correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome JOURNAL OF NEUROCHEMISTRY, 1999, Vol.73, No.1, pp.195-204
Chung, CW, Song, YH, Kim, IK, Yoon, WJ, Ryu, BR, Jo, DG, Woo, HN, Kwon, YK, Kim, HH, Gwag, BJ, Mook-Jung, IH and Jung, YK (2001) Proapoptotic effects of Tau cleavage product generated by caspase-3. NEUROBIOLOGY OF DISEASE 8: 162-172
Chung, HM, Struhl, G (2001) Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. NATURE CELL BIOLOGY 3: 1129-1132
Chung, HY, Brazil, MI, Irizarry, MC, Hyman, BT and Maxfield, FR (2001) Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice. NEUROREPORT 12:1151-1154
Chung, YH, Shin, CM, Kim, MJ, Lee, BK, Park, KH and Cha, CI (2000) Immunocytochemical study on the distribution of p53 in the hippocampus and cerebellum of the aged rat. BRAIN RESEARCH 885: 137-141
Chyung, JH, Selkoe, DJ (2003)
Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid
beta-protein at the cell surface. JOURNAL OF BIOLOGICAL CHEMISTRY 278:
51035-51043
Ciechanover, A, Brundin, P (2003)
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the
chicken, sometimes the egg. NEURON 40: 427-446
Citron, M (2000) Secretases as targets for the treatment of Alzheimer's disease. MOLECULAR MEDICINE TODAY 6: 392-397
Citron, BA, SantaCruz, KS, Davies, PJA and Festoff, BW (2001) Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 3295-3301
Civita, M, Fiorucci, A, Mie, R (2002) Identification of anomalous
aluminium contents in surface and ground water in the Alba
territory (NW Italy). GEOSTANDARDS NEWSLETTER-THE JOURNAL OF
GEOSTANDARDS AND GEOANALYSIS 25: 431-439
Clare, PM, Poorman, RA, Kelley, LC, Watenpaugh, KD, Bannow, CA, Leach, KL (2001) The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 48292-48299
Clark, LN, Levy, G, Tang, MX, Mejia-Santana, H, Ciappa,
A, Tycko, B, Cote, LJ, Louis, ED, Mayeux, R, Marder, K (2003)
The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer
disease and Parkinson's disease cohorts. NEUROSCIENCE LETTERS 347: 17-20
Clarke, RP (2000) Does longer-term memory storage never become overloaded, and would such overload cause Alzheimer's disease and other dementia? MEDICAL HYPOTHESES 55: 419-428
Cleveland DW, Monteiro MJ, Wong PC, Gill SR, Gearhart JD and Hoffman PN (1995) Involvement of neurofilaments in the radial growth of axons. J Cell Sci 15: 85-95
Cobb, M.H., Hepler, J.E., Zhen, E., Ebert, D., Cheng, M., Dang, A. and Robbins, D. (1995) Regulation and Structure of the MAP Kinases ERK1 and ERK2. pp. 78-87 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.
Cohen, FE, Kelly, JW (2003)
Therapeutic approaches to protein-misfolding diseases. NATURE 426: 905-909
Cohen, M. L.; Golde, T. E.; Usiak, M. F.; Younkin, L. H.; Younkin, S. G.(1988)In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. Proc. Nat. Acad. Sci. 85: 1227-1231
Colangelo, V, Schurr, J, Ball, MJ, Pelaez, RP, Bazan,
NG, Lukiw, WJ (2002) Gene expression profiling of 12633 genes in Alzheimer
hippocampal CA1: Transcription and neurotrophic factor down-regulation and
up-regulation of apoptotic and pro-inflammatory signaling
Cole,
AR, Knebel, A, Morrice, NA, Robertson, LA, Irving, AJ, Connolly, CN, Sutherland,
C (2004) GSK-3
phosphorylation of the Alzheimer epitope within collapsin response mediator
proteins regulates axon elongation in primary neurons. JOURNAL OF BIOLOGICAL
CHEMISTRY 279: 50176-50180
Coleman,
P, Federoff, H, Kurlan, R (2004)
A focus on the synapse for neuroprotection in Alzheimer disease and other
dementias. NEUROLOGY 63: 1155-1162
Coleman,
P, Kurlan, R, Crook, R, Werner, J, Hardy, J (2004)
New presenilin Alzheimer's disease case confirms the helical alignment of
pathogenic mutations in transmembrane domain 5. NEUROSCIENCE LETTERS 364:
139-140
Colosimo, C, Osaki, Y, Vanacore, N, Lees, AJ (2003)
Lack of association between progressive supranuclear palsy and arterial
hypertension: A clinicopathological study. MOVEMENT DISORDERS 18: 694-697
Colurso, GJ, Nilson, JE, Vervoort, LG (2003)
Quantitative assessment of DNA fragmentation and beta-amyloid deposition in
insular cortex and midfrontal gyrus from patients with Alzheimer's disease. LIFE
SCIENCES 73: 1795-1803
Combarros, O, Garcia-Roman, M, Fontalba, A,
Fernandez-Luna, JL, Llorca, J, Infante, J, Berciano, J (2003) Interaction
of the H63D mutation in the hemochromatosis gene with the apolipoprotein E
epsilon 4 allele modulates age at onset of Alzheimer's disease.
DEMENTIA AND GERIATRIC
COGNITIVE DISORDERS 15: 151-154
Combs, CK, Karlo, JC, Kao, SC and Landreth, GE (2001) beta-Amyloid stimulation of microglia and monocytes results in TNF alpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. JOURNAL OF NEUROSCIENCE 21: 1179-1188
Connell, JW, Gibb, GM, Betts, JC, Blackstock, WP, Gallo, JM, Lovestone, S, Hutton, M, Anderton, BH (2001) Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3 beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS LETTERS 493: 40-44
Connell,
JW, Rodriguez-Martin, T, Gibb, GM, Kahn, NM, Grierson, AJ, Hanger, DP, Revesz,
T, Lantos, PL, Anderton, BH, Gallo, JM (2005) Quantitative
analysis of tau isoform transcripts in sporadic tauopathies. MOLECULAR BRAIN
RESEARCH 137: 104-109
Conrad, C, Vianna, C, Freeman, M, Davies, P (2002) A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99: 7751-7756
Cook, R. H.; Ward, B. E.; Austin, J. H. Studies in aging of the brain: IV. (1979) Familial Alzheimer disease: relation to transmissible dementia, aneuploidy, and microtubular defects. Neurology 29: 1402-1412
Copani, A, Condorelli, F, Caruso, A, Vancheri, C, Sala, A, Stella, AMG, Canonico, PL, Nicoletti, F and Sortino, MA (1999) Mitotic signaling by beta-amyloid causes neuronal death. FASEB JOURNAL 13: 2225-2234
Copani, A, Melchiorri, D, Caricasole, A, Martini, F, Sale, P, Carnevale, R, Gradini, R, Sortino, MA, Lenti, L, De Maria, R, Nicoletti, F (2002) beta-amyloid-induced synthesis of the ganglioside Gd3 is a requisite for cell cycle reactivation and apoptosis in neurons. JOURNAL OF NEUROSCIENCE 22: 3963-3968
Copani, A, Sortino, MA, Nicoletti, F, Stella, AMG (2002) Alzheimer's disease research enters a "new cycle": How significant? NEUROCHEMICAL RESEARCH 27: 173-176
Coraci, IS, Husemann, J, Berman, JW, Hulette, C, Dufour, JH, Campanella, GK, Luster, AD, Silverstein, SC, El Khoury, JB (2002) CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. AMERICAN JOURNAL OF PATHOLOGY 160: 101-112
CORBO_M, HAYS_AP. (1992) Peripherin And Neurofilament Protein Coexist In Spinal Spheroids Of Motor-Neuron Disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, Vol.51, No.5, pp.531-537
Cordato, NJ, Halliday, GM, McCann, H, Davies, L, Williamson, P, Fulham, M, Morris, JGL (2001) Corticobasal syndrome with tau pathology. MOVEMENT DISORDERS 16: 656-667
Cordato, NJ, Pantelis, C, Halliday, GM, Velakoulis, D, Wood, SJ, Stuart, GW, Currie, J, Soo, M, Olivieri, G, Broe, GA, Morris, JGL (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. BRAIN 125: 789-800
Corder, EH, Woodbury, MA, Volkmann, I, Madsen, DK, Bogdanovic, N and Winblad, B (2000) Density profiles of Alzheimer disease regional brain pathology for the Huddinge brain bank: pattern recognition emulates and expands upon Braak staging. EXPERIMENTAL GERONTOLOGY 35: 951-864
Cordey,
M, Gundimeda, U, Gopalakrishna, R, Pike, CJ (2003) Estrogen activates protein kinase C in neurons: role in
neuroprotection. JOURNAL OF NEUROCHEMISTRY 84: 1340-1348
Costa, RM, Honjo, T, Silva, AJ (2003)
Learning and memory deficits in Notch mutant mice. CURRENT BIOLOGY 13: 1348-1354
Cotman, CW, Anderson, AJ (2000) The brain's microenvironment, early functional loss, and the conversion to Alzheimer's disease. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES 924: 112-116
Cotman,
CW, Poon, WW, Rissman, RA, Blurton-Jones, M (2005)
The role of caspase cleavage of tau in Alzheimer disease neuropathology. JOURNAL
OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 64: 104-112
Cottingham, MG, Hollinshead, MS.
Vaux, DJT (2002) Amyloid fibril formation by a synthetic peptide from a
region of human acetylcholinesterase that is homologous to the Alzheimer's
amyloid-beta peptide
Counts, SE, Lah, JJ and Levey, AI (2001) The regulation of presenilin-1 by nerve growth factor. JOURNAL OF NEUROCHEMISTRY 76: 679-689
Crawford, F, Freeman, M, Schinka, J, Abdullah, L, Duara, R and Mullan, M (2000) The cystatin C gene as a novel genetic risk factor for late onset Alzheimer's disease. EUROPEAN JOURNAL OF NEUROSCIENCE 12: 112
Creemers, JWM, Dominguez, DI, Plets, E, Serneels, L, Taylor, NA, Multhaup, G, Craessaerts, K, Annaert, W and De Strooper, D (2001) Processing of beta-secretase by furin and other members of the proprotein convertase family. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 4211-4217
Crenshaw DG, Yang J, Means AR, Kornbluth S (1998) The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 17:1315-1327
Crowther, RA and Goedert, M (2000) Abnormal tau-containing filaments in neurodegenerative diseases. JOURNAL OF STRUCTURAL BIOLOGY 130: 271-279
Cruts, M, Dermaut, B, Rademakers, R, Roks, G, Van den Broeck, M, Munteanu, G, van Duijn, CM, Van Broeckhoven, CV (2001) Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. NEUROSCIENCE LETTERS 313: 105-107
Cruz,
JC, Tsai, LH (2004)
Cdk5 deregulation in the pathogenesis of Alzheimer's disease. TRENDS IN
MOLECULAR MEDICINE 10: 452-458
Crystal, AS, Morais, VA, Pierson, TC, Pijak, DS,
Carlin, D, Lee, VMY, Doms, RW (2003)
Membrane topology of gamma-secretase component PEN-2. JOURNAL OF BIOLOGICAL
CHEMISTRY 278: 20117-20123
Csokova,
N, Skrabana, R, Liebig, HD, Mederlyova, A, Kontsek, P, Novak, M (2004)
Rapid purification of truncated tau proteins: model approach to purification of
functionally active fragments of disordered proteins, implication for
neurodegenerative diseases. PROTEIN EXPRESSION AND PURIFICATION 35: 366-372
Cuello,
AC (2005) Intracellular
and extracellular A beta, a tale of two neuropathologies. BRAIN PATHOLOGY 15:
66--71
Culmsee, C, Zhu, XX, Yu, QS, Chan, SL, Camandola, S, Guo, ZH, Greig, NH and Mattson, MP (2001) A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. JOURNAL OF NEUROCHEMISTRY 77: 220-228
Cummings, CJ, Sun, YL, Opal, P, Antalffy, B, Mestril, R, Orr, HT, Dillmann, WH and Zoghbi, HY (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. HUMAN MOLECULAR GENETICS 10: 1511-1518
Cupers, P, Orlans, I, Craessaerts, K, Annaert, W and De Strooper, B (2001) The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. JOURNAL OF NEUROCHEMISTRY 78: 1168-1178
Curcio, SAM, Kawarai, T, Paterson, AD, Maletta, RG, Puccio, G, Perri,
M, Di Natale, M, Palermo, S, Foncin, JF, Hyslop, PHS, Bruni, AC (2002)
A large Calabrian kindred segregating frontotemporal dementia. JOURNAL
OF NEUROLOGY 249: 911-922
Czech C; Tremp G; Pradier L. (2000) Presenilins and Alzheimer's
disease: biological functions and pathogenic mechanisms.
Prog Neurobiol, 2000 Mar, 60:4, 363-84
| D |
Dabir,
DV, Trojanowski, JQ, Richter-Landsberg, C, Lee, VMY, Forman, MS (2004)
Expression of the small heat-shock protein alpha B-crystallin in tauopathies
with glial pathology. AMERICAN JOURNAL OF PATHOLOGY 164: 155-166
da Costa, CA (2003)
Recent advances on alpha-synuclein cell biology: Functions and dysfunctions.
CURRENT MOLECULAR MEDICINE 3: 17-24
da Costa, CA, Mattson, MP, Ancolio, K, Checler, F
(2003) The C-terminal fragment of presenilin 2 triggers p53-mediated
staurosporine-induced apoptosis, a function independent of the presenilinase-derived
N-terminal counterpart. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 12064-12069
da Costa, CA, Paitel, E, Mattson, MP, Amson, R, Telerman, A, Ancolio, K, Checler, F (2002) Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99: 4043-4048
Dai,
JP, Buijs, RM, Kamphorst, W, Swaab, DF (2002)
Daly, NL, Hoffmann, R, Otvos, L and Craik, DJ (2000) Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. BIOCHEMISTRY 39: 9039-9046
D'Andrea,
MR, Cole, GM, Ard, MD (2004)
The microglial phagocytic role with specific plaque types in the Alzheimer
disease brain. NEUROBIOLOGY OF AGING 25: 675-683
D'Andrea, MR, Nagele, RG, Gumula, NA, Reiser, PA, Polkovitch, DA, Hertzog,
BM, Andrade-Gordon, P (2002) Lipofuscin and A beta 42 exhibit
distinct distribution patterns in normal and Alzheimer's disease
brains. NEUROSCIENCE LETTERS 323: 45-49
D'Andrea, MR, Nagele, RG, Wang, HY, Peterson, PA and Lee, DHS (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. HISTOPATHOLOGY 38:120-134
D'Andrea, MR, Nagele, RG, Wang, HY,
Lee, DHS (2002) Consistent immunohistochemical detection of
intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease
entorhinal cortex
Daniel, PT (2000) Dissecting the pathways to death. LEUKEMIA 14: 2035-2044
Das, P, Howard, V, Loosbrock, N, Dickson, D, Murphy,
MP, Golde, TE (2003) Amyloid-beta immunization effectively reduces amyloid
deposition in FcR gamma(-/-) knock-out mice. JOURNAL OF NEUROSCIENCE 23:
8532-8538
Das, P, Murphy, MP, Younkin, LH, Younkin, SG, Golde, TE (2001) Reduced effectiveness of A beta 1-42 immunization in APP transgenic mice with significant amyloid deposition. NEUROBIOLOGY OF AGING 22: 721-727
Datta, K, Sinha, S and Chattopadhyay, P (2000) Reactive oxygen species in health and disease. NATIONAL MEDICAL JOURNAL OF INDIA 13: 304-310
David, DC, Layfield, R, Serpell, L, Narain, Y, Goedert, M, Spillantini, MG (2002) Proteasomal degradation of tau protein. JOURNAL OF NEUROCHEMISTRY 83: 176-185
Davydov, V, Hansen, LA, Shackelford, DA (2003)
Is DNA repair compromised in Alzheimer's disease? NEUROBIOLOGY OF AGING 24:
953-968
Davidsson, P, Brinkmalm, A, Karlsson, G, Persson, R,
Lindbjer, M, Puchades, M, Folkesson, S, Paulson, L, Dahl, A, Rymo, L, Silberring,
J, Ekman, R, Blennow, K (2003)
Clinical mass spectrometry in neuroscience. Proteomics and peptidomics. CELLULAR
AND MOLECULAR BIOLOGY 49: 681-688
Davidsson, P, Sjogren, M, Andreasen, N, Lindbjer, M,
Nilsson, CL, Westman-Brinkmalm, A, Blennow, K (2002)
Studies of the pathophysiological mechanisms in frontotemporal dementia by
proteome analysis of CSF proteins. MOLECULAR BRAIN RESEARCH 109: 128-133
Davies_BJ, Pickard_BS, Steel_R, Morris_RGM, Lathe_R. (1998) Serine proteases in rodent hippocampus JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, Vol.273, No.36, pp.23004-23011
Davies, P (2000) A very incomplete comprehensive theory of Alzheimer's disease. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES 924: 8-16
Davies
P, DeBernardis J, Espinoza M, Stahl, M and Vianna C (2000)
DAVIS_DR, BRION_JP, COUCK_AM, GALLO_JM, HANGER_DP, LADHANI_K, LEWIS_C, MILLER_CCJ, RUPNIAK_T, SMITH_C, ANDERTON_BH. (1995) THE PHOSPHORYLATION STATE OF THE MICROTUBULE-ASSOCIATED PROTEIN TAU AS AFFECTED BY GLUTAMATE, COLCHICINE AND BETA-AMYLOID IN PRIMARY RAT CORTICAL NEURONAL CULTURES. BIOCHEMICAL JOURNAL, 1995, Vol.309, No.Pt3, pp.941-949
Daw, EW, Bird, TD, Nemens, EJ, Nochlin, D, Schellenberg, GD and Wijsman, EM (2000) ApoE and other loci affect age of Alzheimer's disease onset in families with PS2 mutation. AMERICAN JOURNAL OF HUMAN GENETICS 67: 192
Dayanandan, R, Ljungberg, MC, Pearce, J, Anderton, BH and Lovestone, S (2000) Monitoring the intracellular fate of apolipoprotein E: Implications for Alzheimer's disease. EUROPEAN JOURNAL OF NEUROSCIENCE 12: 348
Deb, S, Zhang, JW, Gottschall, PE (2003)
beta-amyloid induces the production of active, matrix-degrading proteases in
cultured rat astrocytes. BRAIN RESEARCH 970: 205-213
de Brito-Marques, PR, de Mello, RV, Montenegro, L (2001) Classic
Pick's disease type with ubiquitin-positive and tau-negative inclusions
- Case report. ARQUIVOS DE NEURO-PSIQUIATRIA 59: 128-133
De Ceballos, ML, Brera, B and Fernandez-Tome, MP (2001) beta-Amyloid-induced cytotoxicity, peroxide generation and blockade of glutamate uptake in cultured astrocytes. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 39: 317-318
Deechongkit, S, Kelly, JW (2002) The effect of backbone cyclization on the thermodynamics of beta-sheet unfolding: Stability optimization of the PINWW domain. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 124: 4980-4986
De
Ferrari, GV, Chacon, MA, Barria, MI, Garrido, JL, Godoy, JA, Olivares, G, Reyes,
AE, Alvarez, A, Bronfman, M, Inestrosa, NC (2003)
Activation of Wnt signaling and behavioral impairments
rescues neurodegeneration induced by beta-amyloid fibrils.
MOLECULAR PSYCHIATRY 8: 195-208
Dehmelt,
L, Halpain, S (2005) The
MAP2/Tau family of microtubule-associated proteins.
GENOME BIOLOGY 6: 195-204
De Jonghe, C, Esselens, C, Kumar-Singh, S, Craessaerts, K, Serneels, S, Checler, F, Annaert, W, Van Broeckhoven, C and De Strooper, B (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect A beta secretion and APP C-terminal fragment stability. HUMAN MOLECULAR GENETICS 10: 1665-1671
Delacourte, A, Sergeant, N, Champain, D, Wattez, A, Maurage, CA, Lebert, F, Pasquier, F, David, JP (2002) Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. NEUROLOGY 59: 398-407
Delacourte, A, Sergeant, N, Wattez,
A, Maurage, CA, Lebert, F, Pasquier, F, David, JP (2002) Tau aggregation in the hippocampal formation: an ageing
or a pathological process?
De la Monte_SM. (1999) Molecular abnormalities of the brain in Down Syndrome: relevance to Alzheimer's neurodegeneration. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, No.57, pp.1-19
de
la Monte, SM, Chen, GJ, Rivera, E, Wands, JR (2003)
Neuronal thread protein regulation and interaction with microtubule-associated
proteins in SH-Sy5y neuronal cells. CELLULAR AND MOLECULAR LIFE SCIENCES 60:
2679-2691
De la Monte, SM, Neely, TR, Cannon, J and Wands, JR (2000) Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. CELLULAR AND MOLECULAR LIFE SCIENCES 57: 1471-1481
De la Monte, SM and Wands, JR (2001) Alzheimer-Associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 195-207
De la Torre, JC and Stefano, GB (2000) Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. BRAIN RESEARCH REVIEWS 34: 119-136
Delobel, P, Flament, S, Hamdane, M, Delacourte, A, Vilain, JP, Buee, L (2002) Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3 beta and PKA kinase activities. FEBS LETTERS 516: 151-155
Delobel, P, Flament, S, Hamdane, M, Jakes, R, Rousseau, A, Delacourte, A, Vilain, JP, Goedert, M, Buee, L (2002) Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 9199-9205
Delobel, P, Flament, S, Hamdane, M,
Mailliot, C, Sambo, AV, Begard, S, Sergeant, N, Delacourte, A, Vilain, JP, Buee,
L (2002) Abnormal Tau phosphorylation of the Alzheimer-type also
occurs during mitosis
Delobel,
P, Leroy, O, Hamdane, M, Sambo, AV, Delacourte, A, Buee, L (2005) Proteasome
inhibition and Tau proteolysis: an unexpected regulation. FEBS LETTERS 579: 1-5
del Rio, MJ and Velez-Pardo, C (2001) Apoptosis in neurodegenerative diseases: Facts and controversies. REVISTA DE NEUROLOGIA 32: 851-860
Del Rio, MJ, Velez-Pardo, C (2002) Monoamine neurotoxins-induced
apoptosis in lymphocytes by a common oxidative stress mechanism:
involvement of hydrogen peroxide (H2O2), caspase-3, and nuclear
factor kappa-B (NF-kappa B), p53, c-Jun transcription factors.
BIOCHEMICAL PHARMACOLOGY 63: 677-688
DeMattos, RB, Bales, KR, Cummins, DJ, Dodart, JC, Paul, SM and Holtzman, DM (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 8850-8855
DeMattos, RB, Bales, KR, Cummins, DJ, Paul, SM, Holtzman, DM (2002)
Brain to plasma amyloid-beta efflux: a measure of brain
amyloid burden in a mouse model of Alzheimer's disease. SCIENCE
295: 2264-2267
Demeester, N, Baier, G, Enzinger, C, Goethals, M, Vandekerckhove, J, Rosseneu, M and Labeur, C (2001) Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes. MOLECULAR MEMBRANE BIOLOGY 17: 219-228
de
Mendonca, A, Ribeiro, F, Guerreiro, M, Garcia, C (2004) Frontotemporal
Mild Cognitive Impairment. JOURNAL OF ALZHEIMERS DISEASE 6: 1-9
Deng, A, Irizarry, MC, Nitsch, RM, Growdon, JH and Rebeck, GW (2001) Elevation of cystatin C in susceptible neurons in Alzheimer's disease. AMERICAN JOURNAL OF PATHOLOGY 159: 1061-1068
De Nicola F, Bruno T, Iezzi S, Di Padova M, Floridi A, Passananti C, Del Sal G, Fanciulli M. (2007) The prolyl isomerase Pin1 affects CHE-1 stability in response to apoptotic DNA damage. J. Biol. Chem.
Depboylu, C, Du, YS, Muller, U, Kurz, A, Zimmer, R,
Riemenschneider, M, Gasser, T, Oertelf, WH, Klockgether, T, Dodel, RC (2003)
Lack of association of interleukin-10 promoter region polymorphisms with
Alzheimer's disease. NEUROSCIENCE LETTERS 342: 132-134
Desai, PP, Hendrie, HC, Evans, RM, Murrell, JR, DeKosky, ST, Kamboh, MI (2001) Genetic variation in apolipoprotein D affects the risk of Alzheimer's disease in African Americans. AMERICAN JOURNAL OF HUMAN GENETICS 69: 1370
Desai, PP, Hendrie, HC, Evans, RM, Murrell, JR, DeKosky,
ST, Kamboh, MI (2003) Genetic variation in apolipoprotein D affects
the risk of Alzheimer disease in African-Americans. AMERICAN JOURNAL OF MEDICAL
GENETICS PART B NEUROPSYCHIATRIC GENETICS 116B: 98-101
de Silva, R, Hardy, J, Crook, J,
Khan, N, Graham, EA, Morris, CM, Wood, NW, Lees, AJ (2002) The tau locus is not significantly associated with
pathologically confirmed sporadic Parkinson's disease
de Silva, R, Lashley, T, Gibb, G, Hanger, D, Hope, A,
Reid, A, Bandopadhyay, R, Utton, M, Strand, C, Jowett, T, Khan, N, Anderton, B,
Wood, N, Holton, J, Revesz, T, Lees, A (2003)
Pathological inclusion bodies in tauopathies contain distinct complements of tau
with three or four microtubule-binding repeat domains as demonstrated by new
specific monoclonal antibodies. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 29:
288-302
de Silva, R, Weiler, M, Morris, HR, Martin, ER, Wood, NW, Lees, AJ (2001) Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. NEUROSCIENCE LETTERS 311: 145-148
De Strooper, B (2003)
Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase
complex. NEURON 38: 9-12
De Strooper, B, Annaert, W (2001) Presenilins and the intramembrane proteolysis of proteins: facts and fiction. NATURE CELL BIOLOGY 3: E221-E225
DeTure, M, Ko, LW, Easson, C, Yen,
SH (2002) tau assembly in inducible transfectants expressing
wild-type or FTDP-17 tau
Dev, KK, Hofele, K, Barbieri, S, Buchman, VL, van der
Putten, H (2003) Part II: alpha-synuclein and its molecular
pathophysiological role in neurodegenerative disease. NEUROPHARMACOLOGY 45:
14-44
Devasahayam, G, Chaturvedi, V, Hanes, SD (2002) The ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans. GENETICS 160: 37-48
Devi, G, Fotiou, A, Jyrinji, D, Tycko, B, DeArmand, S, Rogaeva, E, Song, YQ, Medieros, H, Liang, Y, Orlacchio, A, Williamson, J, St George-Hyslop, P and Mayeux, R (2000) Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease. ARCHIVES OF NEUROLOGY 57: 1454-1457
Devred, F, Douillard, S, Briand, C, Peyrot, V (2002) First tau repeat domain binding to growing and taxol-stabilized microtubules, and serine 262 residue phosphorylation. FEBS LETTERS 523: 247-251
de
Vrij, FMS, Fischer, DF, van Leeuwen, FW, Hol, EM (2004) Protein
quality control in Alzheimer's disease by the ubiquitin proteasome system.
PROGRESS IN NEUROBIOLOGY 74: 249--270
De Vrij, FMS, Sluijs, JA, Gregori, L, Fischer, DF, Hermens, WTJMC, Goldgaber, D, Verhaagen, J, Van Leeuwen, FW, Hol, EM (2001) Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB JOURNAL 15: 2680-2688
Dewachter, I, Moechars, D, van Dorpe, J, Tesseur, I, Van den Haute, C, Spittaels, K, Van Leuven, F (2001) Modelling Alzheimer's disease in multiple transgenic mice. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 203-210
Dewachter, I, Reverse, D, Caluwaerts, N, Ris, L, Kuiperi, C, Van den
Haute, C, Spittaels, K, Umans, L, Serneels, L, Thiry, E, Moechars,
D, Mercken, M, Godaux, E, Van Leuven, F (2002) Neuronal deficiency
of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal
long-term potentiation but not a cognitive defect of amyloid precursor
protein [V717I] transgenic mice. JOURNAL OF NEUROSCIENCE 22: 3445-3453
Dewachter, I, Van Dorpe, J, Smeijers, L, Gilis, M, Kuiperi, C, Laenen, I, Caluwaerts, N, Moechars, D, Checler, DR, Vanderstichele, H and Van Leuven, F (2000) Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1. JOURNAL OF NEUROSCIENCE 20: 6452-6458
Dewachter, I, van Dorpe, J, Spittaels, K, Tesseur, I, Van Den Haute, C, Moechars, D and Van Leuven, F (2000) Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice. EXPERIMENTAL GERONTOLOGY 35: 831-841
Dhavan,
R, Greer, PL, Morabito, MA, Orlando, LR, Tsai, LH (2002)
The cyclin-dependent kinase 5 activators p35 and p39
interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II
and alpha-actinin-1 in a calcium-dependent manner. JOURNAL OF NEUROSCIENCE 22: 7879-7891
Diaz-Cintra,
S, Yong, A, Aguilar, A, Bi, XN, Lynch, G, Ribak, CE (2004)
Ultrastructural analysis of hippocampal pyramidal neurons from apolipoprotein
E-deficient mice treated with a cathepsin inhibitor. JOURNAL OF NEUROCYTOLOGY
33: 37-48
Dickerson, TJ, Janda, KD (2003) Glycation
of the amyloid beta-protein by a nicotine metabolite: A fortuitous chemical
dynamic between smoking and Alzheimer's disease. PROCEEDINGS OF THE NATIONAL
ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100: 8182--8187
Dickey,
CA, Gordon, MN, Mason, JE, Wilson, NJ, Diamond, DM, Guzowski, JF, Morgan, D
(2004)
Amyloid suppresses induction of genes critical for memory consolidation in
APP+PS1 transgenic mice. JOURNAL OF NEUROCHEMISTRY 88: 434-442
Dickey, CA, Morgan, DG, Kudchodkar, S, Weiner, DB, Bai, Y, Cao, CH, Gordon, MN, Ugen, KE (2001) Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. DNA AND CELL BIOLOGY 20: 723-729
Dickson, D, Lewis, J, Corral, A, Lin, W, Davies, P, McGowan, E, Melrose, H and Hutton, M (2000) Neuropathology of a tau mutant (P301L) transgenic mouse. BRAIN PATHOLOGY 10: 507
Dickson, DW (2001) Neuropathology of Pick's disease. NEUROLOGY 56: S16-S20
Dickson,
DW, Bergeron, C, Chin, SS, Duyckaerts, C, Horoupian, D, Ikeda, K, Jellinger, K,
Lantos, PL, Lippa, CF, Mirra, SS, Tabaton, M, Vonsattel, JP, Wakabayashi, K,
Litvan, I (2002)
Dickson DW; Ruan D; Crystal H; Mark MH; Davies P; Kress Y; Yen SH. (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology, 1991 Sep, 41:9, 1402-9
Dickson,
TC, Chuckowree, JA, Chuah, MI, West, AK, Vickers, JC (2005)
alpha-internexin immunoreactivity reflects variable neuronal vulnerability in
Alzheimer's disease and supports the role of the beta-amyloid plaques in
inducing neuronal injury. NEUROBIOLOGY OF DISEASE 18: 286-295
Dickson TC, King CE, McCormack GH, Vickers JC. (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. EXPERIMENTAL NEUROLOGY 156: (1) 100-110
Dickson, TC and Vickers, JC (2001) The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. NEUROSCIENCE 105: 99-107
Dineley, KT, Westerman, M, Bui, D, Bell, K, Ashe, KH and Sweatt, JD (2001) beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha 7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. JOURNAL OF NEUROSCIENCE 21: 4125-4133
Dineley, KT, Xia, XF, Bui, D, Sweatt, JD, Zheng, H (2002) Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 22768-22780
Ding,
QX, Dimayuga, E, Markesbery, WR, Keller, JN (2004)
Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron
cultures. JOURNAL OF NEUROCHEMISTRY 91: 1211-1218
Ding, QX, Dimayuga, E, Martin, S, Bruce-Keller, AJ, Nukala, V, Cuervo, AM, Keller, JN (2003) Characterization of chronic low-level proteasome inhibition on neural homeostasis. JOURNAL OF NEUROCHEMISTRY 86: 489-497
Ding, XL, Husseman, J, Tomashevski, A, Nochlin, D, Jin, LW and Vincent, I (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. AMERICAN JOURNAL OF PATHOLOGY 157: 1983-1990
Dingwall, C (2001) Spotlight on BACE: The secretases as targets for treatment in Alzheimer disease. JOURNAL OF CLINICAL INVESTIGATION 108: 1243-1246
Dispersyn, G, Nuydens, R, Borgers, M and Geerts, H (1999) Nimodipine and flunarizine have different effects on survival and morphology of PC12 cells during nerve growth factor deprivation. EUROPEAN JOURNAL OF PHARMACOLOGY 384: 61-70
Dispersyn, G, Nuydens, R, Connors, R, Borgers, M and Geerts, H (1999) Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC12 cells. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1428: 357-371
Distl, R, Meske, V and Ohm, TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. ACTA NEUROPATHOLOGICA 101: 547-554
Ditaranto-Desimone,
K, Saito, M, Tekirian, TL, Saito, M, Berg, M, Dubowchik, G, Soreghan, B, Thomas,
S, Marks, N, Yang, AJ (2003) Neuronal endosomal/lysosomal membrane destabilization
activates caspases and induces abnormal accumulation of the lipid secondary
messenger ceramide. BRAIN RESEARCH BULLETIN 59: 523-531
Doan, A, Thinakaran, G, Borchelt, DR, Slunt, HH, Ratovitsky, T, Podlisny, M, Selkoe, DJ, Seeger, M, Gandy, SE, Price DL, Sisodia SS (1996) Protein Topology of Presenilin 1. NEURON 17: 1023-1030
Doble, BW, Woodgett, JR (2003)
GSK-3: tricks of the trade for a multi-tasking kinase. JOURNAL OF CELL SCIENCE
116: 1175-1186
Dobson, CM (2001) The structural basis of protein folding and its links with human disease. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 356: 133-145
Dobson, CM (2001) Protein folding and its links with human disease. BIOCHEMICAL SOCIETY SYMPOSIUM: FROM PROTEIN FOLDING TO NEW ENZYMES 68: 1-26
Dodart, JC, Bales, KR, Gannon, KS, Greene, SJ, DeMattos, RB, Mathis, C, DeLong, CA, Wu, S, Wu, X, Holtzman, DM, Paul, SM (2002) Immunization reverses memory deficits without reducing brain A beta burden in Alzheimer's disease model. NATURE NEUROSCIENCE 5: 452-457
Dodart, JC, Bales, KR, Paul, SM (2003) Immunotherapy for Alzheimer's disease: will vaccination work? TRENDS IN MOLECULAR MEDICINE 9: 85-87
Dodel, RC, Hampel, H, Du, YS (2003)
Immunotherapy for Alzheimer's disease. LANCET NEUROLOGY 2: 215-220
Doerfler, P, Shearman, MS and Perlmutter, RM (2001) Presenilin-dependent gamma-secretase activity modulates thymocyte development. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 9312-9317
PINning down the c-Myc oncoprotein. Nature Cell Biology 6, 288 - 289
Dorronsoro, I, Castro, A, Martinez,
A (2002) Inhibitors of glycogen synthase kinase-3: future
therapy for unmet medical needs?
Dou, F, Netzer, WJ, Tanemura, K,
Li, F, Hartl, FU, Takashima, A, Gouras, GK, Greengard, P, Xu, HX (2003) Chaperones increase association of tau protein with
microtubules
Dougherty,
MK, Muller, J, Ritt, DA, Zhou, M, Zhou, XZ, Copeland, TD, Conrads, TP, Veenstra,
TD, Lu, KP, Morrison, DK (2005) Regulation
of raf-1 by direct feedback phosphorylation. MOLECULAR CELL 17: 215-224
Dovey, HF, John, V, Anderson, JP, Chen, LZ, Andrieu, PD, Fang, LY, Freedman, SB, Folmer, B, Goldbach, E, Holsztynska, EJ, Hu, KL, Johnson-Wood, KL, Kennedy, SL, Kholedenko, D, Knops, JE, Latimer, LH, Lee, M, Liao, Z, Lieberburg, IM, Motter, RN, Mutter, LC, Nietz, J, Quinn, KP, Sacchi, KL, Seubert, PA, Shopp, GM, Thorsett, ED, Tung, JS, Wu, J, Yang, S, Yin, CT, Schenk, DB, May, PC, Altstiel, LD, Bender, MH, Boggs, LN, Britton, TC, Clemens, JC, Czilli, DL, Dieckman-McGinty, DK, Droste, JJ, Fuson, KS, Gitter, BD, Hyslop, PA, Johnstone, EM, Li, WY, Little, SP, Mabry, TE, Miller, FD, Ni, B, Nissen, JS, Porter, WJ, Potts, BD, Reel, JK, Stephenson, D, Su, Y, Shipley, LA, Whitesitt, CA, Yin, T and Audia, JE (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. JOURNAL OF NEUROCHEMISTRY 76: 173-181
Dowjat, WK, Wisniewski, H and Wisniewski, T (2001) Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. NEUROSCIENCE 103: 1-8
Dranovsky, A, Vincent, I, Gregori, L, Schwarzman, A, Colflesh, D, Enghild, J, Strittmatter, W, Davies, P and Goldgaber, D (2001) Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. NEUROBIOLOGY OF AGING 22: 517-528
Drewes,
G (2004) MARKing
tau for tangles and toxicity. TRENDS IN BIOCHEMICAL SCIENCES 29: 548-555
Drouet, B, Fifre, A, Pincon-Raymond, M, Vandekerckhove, J, Rosseneu, M, Gueant, JL, Chambaz, J and Pillot, T (2001) ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide. JOURNAL OF NEUROCHEMISTRY 76: 117-127
D'Souza, I, Schellenberg, GD (2002) Tau exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3 ' splice sites. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 26587-26599
D'Souza,
I, Schellenberg, GD (2005) Regulation
of tau isoform expression and dementia. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR
BASIS OF DISEASE 1739: 104-115
Du, Y, Dodel, R, Hampel, H, Buerger, K, Lin, S, Eastwood, B, Bales, K, Gao, F, Moeller, HJ, Oertel, W, Farlow, M and Paul, S (2001) Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. NEUROLOGY 57: 801-805
Dubois,
B, Albert, ML (2004)
Amnestic MCI or prodromal Alzheimer's disease? LANCET NEUROLOGY 3: 246-248
Duff, K (2001) Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 195-202
Duff, K and Rao, MV (2001) Progress in the modeling of neurodegenerative diseases in transgenic mice. CURRENT OPINION IN NEUROLOGY 14: 441-447
Dumanchin-Njock, C, da Costa, CA, Mercken, L, Pradier, L and Checler, F (2001) The caspase-derived C-terminal fragment of beta APP induces caspase-independent toxicity and triggers selective increase of A beta 42 in mammalian cells. JOURNAL OF NEUROCHEMISTRY 78: 1153-1161
Dumery, L, Bourdel, F, Soussan, Y, Fialkowsky, A, Viale, S, Nicolas,
P and Reboud-Ravaux, M (2001) beta-amyloid protein aggregation:
its implication in the physiopathology of Alzheimer's disease.
PATHOLOGIE BIOLOGIE 49: 72-85
| E |
Echeverria, V, Cuello, AC (2002)
Intracellular A-beta amyloid, a sign for worse things
to come?
Echeverria,
V, Ducatenzeiler, A, Dowd, E, Janne, E, Grant, SM, Szyf, M, Wandosell, F, Avila,
J, Grimm, H, Dunnett, SB, Hartmann, T, Alhonen, L, Cuello, AC (2004) Altered
mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild
spatial learning dysfunction in transgenic rats expressing the beta-amyloid
peptide intracellularly in hippocampal and cortical neurons. NEUROSCIENCE 129:
583-592
Eckert,
A, Marques, CA, Keil, U, Schussel, K, Muller, WE (2004)
Increased apoptotic cell death in sporadic and genetic Alzheimer's disease.
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS. ANNALS OF THE NEW YORK
ACADEMY OF SCIENCES 1010: 604-609
Eckert, A, Oster, M, Zerfass, R, Hennerici, M and Muller, WE (2001) Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease - Specific differences to vascular dementia. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 12: 98-105
Eckert, A, Schindowski, K, Leutner, S, Luckhaus, C, Touchet, N, Czech, C, Muller, WE (2001) Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. NEUROBIOLOGY OF DISEASE 8: 331-342
Eckert, A, Steiner, B, Marques, C, Leutz, S, Romig, H, Haass, C and Muller, WE (2001) Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. JOURNAL OF NEUROSCIENCE RESEARCH 64: 183-192
Eckerdt F, Yuan JP, Saxena K, Martin B, Kappel S, Lindenau C, Kramer A, Naumann S, Daum S, Fischer G, Dikic I, Kaufmann M, Strebhardt K (2005) Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem 280: 36575-36583
Edbauer, D, Winkler, E, Regula, JT, Pesold, B, Steiner,
H, Haass, C (2003) Reconstitution of gamma-secretase activity.
NATURE CELL BIOLOGY 5: 486-488
Edgar,
KA, Belvin, M, Parks, AL, Whittaker, K, Mahoney, MB, Nicoll, M, Park, CC,
Winter, CG, Chen, F, Lickteig, K, Ahmad, F, Esengil, H, Lorenzi, MV, Norton, A,
Rupnow, BA, Shayesteh, L, Tabios, M, Young, LM, Carroll, PM, Kopczynski, C,
Plowman, GD, Friedman, LS, Francis-Lang, HL (2005) Synthetic
lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a
novel peptidyl prolyl isomerase gene. GENETICS 170: 161-171
Eggert,
S, Paliga, K, Soba, P, Evin, G, Masters, CL, Weidemann, A, Beyreuther, K (2004)
The proteolytic processing of the amyloid precursor protein gene family members
APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages -
Modulation of APLP-1 processing by N-glycosylation. JOURNAL OF BIOLOGICAL
CHEMISTRY 279: 18146-18156
Egnaczyk, GF, Greis, KD, Stimson, ER, Maggio, JE (2001) Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits. BIOCHEMISTRY 40: 11706-11714
Ehl, C, Kolsch, H, Ptok, U, Jessen,
F, Schmitz, S, Frahnert, C, Schlosser, R, Rao, ML, Maier, W, Heun, R (2003)
Association of an interleukin-1 beta gene polymorphism
at position-511 with Alzheimer's disease
Eidenmuller, J, Fath, T, Hellwig, A, Reed, J, Sontag, E and Brandt, R (2000) Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins. BIOCHEMISTRY 39: 13166-13175
Eidenmuller, J, Fath, T, Maas, T, Pool, M, Sontag, E and Brandt, R (2001) Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. BIOCHEMICAL JOURNAL 357: 759-767
Ekinci, FJ, Ortiz, D, Shea, TB (2003)
Okadaic acid mediates tau phosphorylation via sustained activation of the
L-voltage- sensitive calcium channel. MOLECULAR BRAIN RESEARCH 117: 145-151
Ekinci, FJ and Shea, TB (1999) Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC. BRAIN RESEARCH 850: 207-216
El-Agnaf, OMA, Irvine, GB (2002) Aggregation and properties of alpha-synuclein and related proteins. SPECTROSCOPY-AN INTERNATIONAL JOURNAL 15: 141-150
Eldadah, BA and Faden, AI (2000) Caspase pathways, neuronal apoptosis, and CNS injury. JOURNAL OF NEUROTRAUMA 17: 811-829
Eldar-Finkelman, H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. TRENDS IN MOLECULAR MEDICINE 8: 126-132
El-Guendy, N, Rangnekar, VM (2003) Apoptosis by Par-4 in cancer and neurodegenerative
diseases
Eliezer,
D, Barre, P, Kobaslija, M, Chan, D, Li, XH, Heend, L (2005)
Residual structure in the repeat domain of tau: Echoes of microtubule binding
and paired helical filament formation. BIOCHEMISTRY 44: 1026-1036
El Khoury, JB, Moore, KJ, Means, TK, Leung, J, Terada,
K, Toft, M, Freeman, MW, Luster, AD (2003)
CD36 mediates the innate host response to beta-amyloid. JOURNAL OF EXPERIMENTAL
MEDICINE 197: 1657-1666
Ellisdon,
AM, Bottomley, SP (2004)
The role of protein misfolding in the pathogenesis of human diseases. IUBMB LIFE
56: 119-123
Emilien G; Maloteaux JM; Beyreuther K; Masters CL. (2000) Alzheimer disease: mouse models pave the way for therapeutic opportunities. Arch Neurol, 2000 Feb, 57:2, 176-81
Engelborghs, S, De Brabander, M, De Cree, J, D'Hooge, R, Geerts, H, Verhaegen, H and De Deyn, PP (1999) Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. NEUROCHEMISTRY INTERNATIONAL 34: 523-530
Engidawork, E, Gulesserian, T, Yoo, BC, Cairns, N and Lubec, G (2001) Alteration of Caspases and Apoptosis-Related Proteins in Brains of Patients with Alzheimer's Disease. Biochem. Biophys. Res. Comm. 281: 84-93
Engidawork, E, Lubec, G (2001) Protein expression in Down syndrome brain. AMINO ACIDS 21: 331-361
Ermak, G, Davies, KJA (2002) Gene expression in Alzheimer's disease. DRUGS OF TODAY 38: 509-516
Ermak,
G, Davies, KJA (2003)
DSCR1(Adapt78)
- A Janus gene providing stress protection but causing Alzheimer's disease? IUBMB LIFE 55: 29-31
Ermak G, Morgan T, Davies KJ (2001) Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 38787-38794
Ermolenko,
DN, Zherdev, AV, Dzantiev, BB (2004)
Antibodies as specific chaperones. BIOCHEMISTRY-MOSCOW 69: 1233-1238
ERRANTE_LD, WICHE_G, SHAW_G. (1994) DISTRIBUTION OF PLECTIN, AN INTERMEDIATE FILAMENT-ASSOCIATED PROTEIN, IN THE ADULT-RAT CENTRAL-NERVOUS-SYSTEM. JOURNAL OF NEUROSCIENCE RESEARCH, 1994, Vol.37, No.4, pp.515-528
Ertekin-Taner, N, Graff-Radford, N, Younkin, LH, Eckman, C, Baker, M, Adamson, J, Ronald, J, Blangero, J, Hutton, M and Younkin, SG (2000) Linkage of plasma A beta 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. SCIENCE 290: 2303
Esler, WP, Kimberly, WT, Ostaszewski, BL, Ye, WJ, Diehl, TS, Selkoe,
DJ, Wolfe, MS (2002) Activity-dependent isolation of the
presenilin-gamma-secretase complex reveals nicastrin and a
gamma substrate. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES
OF THE UNITED STATES OF AMERICA 99: 2720-2725
Esler, WP and Wolfe, MS (2001) Biomedicine - A portrait of Alzheimer secretases - New features and familiar faces. SCIENCE 293: 1449-1454
Esposito, G, Viglino, P, Novak, M and Cattaneo, A (2000) The solution structure of the C-terminal segment of tau protein. JOURNAL OF PEPTIDE SCIENCE 6: 550-559
Ethell,
DW, Buhler, L (2003)
Fas ligand-mediated apoptosis in degenerative disorders of the brain. JOURNAL OF
CLINICAL IMMUNOLOGY 23: 439-446
Etzkorn,
FA, Wang, XDJ, Xu, BL, Neiler, FK, Mullins, AB (2004)
Phosphoser-cis-Pro isostere inhibits Pin1 23-fold better than the trans-pro
isostere.. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 228: 1
Evans, DB, Rank, KB, Bhattacharya, K, Thomsen, DR, Gurney, ME and Sharma, SK (2000) Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tan's ability to promote microtubule assembly. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 24977-24983
Evin, G, Smith, MJ, Tziotis, A, McLean, C, Canterford, L, Sharples,
RA, Cappai, R, Weidemann, A, Beyreuther, K, Cotton, RGH, Masters,
CL, Culvenor, JG (2002) Alternative transcripts of presenilin-I
associated with frontotemporal dementia. NEUROREPORT 13: 719-723
Exley, C, Korchazhkina, OV (2001) Plasmin cleaves A beta 42 in vitro and prevents its aggregation into beta-pleated sheet structures. NEUROREPORT 12: 2967-2970
Eyer J and Peterson A (1994) Neurofilament-deficient axons and perikaryal
aggregates in viable transgenic mice expressing a neurofilament beta-galactosidase
fusion protein. Neuron 12: 389-405
| F |
Fabrega, C, Shen, V, Shuman, S, Lima, CD (2003)
Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal
domain of RNA polymerase II. MOLECULAR CELL 11: 1549-1561
Fagan, AM, Watson, M, Parsadanian, M, Bales, KR, Paul, SM, Holtzman, DM (2002) Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. NEUROBIOLOGY OF DISEASE 9: 305-318
Fahnestock,
M, Garzon, D, Holsinger, RMD, Michalski, B (2002)
Neurotrophic factors and Alzheimer's disease: are we
focusing on the wrong molecule?
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 62:
241-252
Falke, E, Nissanov, J, Mitchell, TW, Bennett, DA,
Trojanowski, JQ, Arnold, SE (2003) Subicular dendritic arborization in Alzheimer's
disease correlates with neurofibrillary tangle density. AMERICAN JOURNAL OF
PATHOLOGY 163: 1615-1621
Faltraco, F, Teipel, SJ, Blennow, K, Moller, HJ, Hampel,
H (2003) A new polymorphism in the cell division cycle 2 gene
is associated with Alzheimer's disease and frontotemporal dementia.
PHARMACOPSYCHIATRY 36: 72
Fan, QW, Yu, W, Senda, T, Yanagisawa, K and Michikawa,
M (2001) Cholesterol-dependent modulation of tau phosphorylation
in cultured neurons. JOURNAL OF NEUROCHEMISTRY 76: 391-400
Farmery, MR, Tjernberg, LO, Pursglove, SE, Bergman, A,
Winblad, B, Naslund, J (2003) Partial purification and characterization of
gamma-secretase from post-mortem human brain. JOURNAL OF BIOLOGICAL CHEMISTRY
278: 24277-24284
Farris, W, Mansourian, S, Chang, Y, Lindsley, L, Eckman,
EA, Frosch, MP, Eckman, CB, Tanzi, RE, Selkoe, DJ, Guenette, S (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein,
and the beta-amyloid precursor protein intracellular domain in vivo. PROCEEDINGS
OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100:
4162-4167
Farris,
W, Mansourian, S, Leissring, MA, Eckman, EA, Bertram, L, Eckman, CB, Tanzi, RE,
Selkoe, DJ (2004)
Partial loss-of-function mutations in insulin-degrading enzyme that induce
diabetes also impair degradation of amyloid beta-protein. AMERICAN JOURNAL OF
PATHOLOGY 164: 1425-1434
Fasman_GD (1996) Aluminum and Alzheimer's disease: Model studies. COORDINATION CHEMISTRY REVIEWS 149:.125-165
Fassbender,
K, Walter, S, Kuhl, S, Landmann, R, Ishii, K, Bertsch, T, Stalder, AK,
Muehlhauser, F, Liu, Y, Ulmer, AJ, Rivest, S, Lentschat, A, Gulbins, E, Jucker,
M, Staufenbiel, M, Brechtel, K, Walter, J, Multhaup, G, Penke, B, Adachi, Y,
Hartmann, T, Beyreuther, K (2003)
The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB
JOURNAL 17: U518-U532
Fath, T, Eidenmuller, J, Brandt, R
(2002) Tau-mediated cytotoxicity in a
pseudohyperphosphorylation model of Alzheimer's disease
Fath, T, Eidenmuller, J, Wunderlich, I, Zobeley, S, Hutter, H, Brandt, R (2001) Simulation of Alzheimer's disease-like tau hyperphosphorylation induces degeneration of neural cells and uncoordinated movements of C-elegans. MOLECULAR BIOLOGY OF THE CELL 12: 1688
Feany, MB (2000) Studying human neurodegenerative diseases in flies and worms. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 59: 847-856
Feijoo,
C, Campbell, DG, Jakes, R, Goedert, M, Cuenda, A (2005)
Evidence that phosphorylation of the microtubule-associated protein Tau by
SAPK4/p38 delta at Thr50 promotes microtubule assembly. JOURNAL OF CELL SCIENCE
118: 397-408
Feinstein,
SC, Wilson, L (2005)
Inability of tau to properly regulate neuronal microtubule dynamics: a
loss-of-function mechanism by which tau might mediate neuronal cell death.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 268-279
Feldman, H and Kertesz, A (2001) Diagnosis, classification and natural history of degenerative dementias. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 28: S17-S27
Feng Y, Hodge DR, Palmieri G, Chase DL, Longo DL, Ferris DK (1999) Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. Biochemical Journal 339: 435-442
Feng, Y and Walsh, CA (2001) Protein–Protein Interactions, Cytoskeletal Regulation And Neuronal Migration. Nature Reviews Neuroscience 2: 408 -416
Ferman, TJ, McRae, CA, Arvanitakis, Z, Tsuboi, Y, Vo,
A, Wszolek, ZK (2003) Early and pre-symptomatic neuropsychological
dysfunction in the PPND family with the N279K tau mutation. PARKINSONISM &
RELATED DISORDERS 9: 265-270
Fernandez-Vizarra,
P, Fernandez, AP, Castro-Blanco, S, Serrano, J, Bentura, ML, Martinez-Murillo,
R, Martinez, A, Rodrigo, J (2004)
Intra- and extracellular AB and PHF in clinically evaluated cases of Alzheimer's
disease. HISTOLOGY AND HISTOPATHOLOGY 19: 823-844
Ferrari, A, Hoerndli, F, Baechi, T, Nitsch, RM, Gotz, J
(2003) beta-amyloid induces paired helical filament-like tau filaments in
tissue culture. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 40162-40168
Ferreira, A., Kincaid, R.L. and Kosik, K. (1993) Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity. Mol. Biol. Cell 4: 1225-1238
Ferreira, ST and De Felice, FG (2001) Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases. FEBS LETTERS 498: 129-134
Ferrer,
I (2004)
Stress kinases involved in tau phosphorylation in Alzheimer's disease,
tauopathies and APP transgenic mice. NEUROTOXICITY RESEARCH 6: 469-475
Ferrer, I, Barrachina, M, Puig, B
(2002) Glycogen synthase kinase-3 is associated with neuronal
and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's
disease, progressive supranuclear palsy and corticobasal degeneration
Ferrer, I, Barrachina, M, Puig, B
(2002) Anti-tau phospho-specific Ser(262) antibody recognizes
a variety of abnormal hyperphosphorylated tau deposits in tauopathies including
Pick bodies and argyrophilic grains
Ferrer, I, Barrachina, M, Tolnay, M, Rey, MJ, Vidal, N,
Carmona, M, Blanco, R, Puig, B (2003)
Phosphorylated protein kinases associated with neuronal and glial tau deposits
in argyrophilic grain disease. BRAIN PATHOLOGY 13: 62-78
Ferrer, I and Blanco, R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. MOLECULAR BRAIN RESEARCH 77: 270-276
Ferrer, I, Blanco, R, Carmona, M, Puig, B (2001) Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 27: 343-351
Ferrer, I, Blanco, R, Carmona, M, Puig, B (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. JOURNAL OF NEURAL TRANSMISSION 108: 1397-1415
Ferrer, I, Blanco, R, Carmona, M, Puig, B, Barrachina, M, Gomez, C, Ambrosio, S (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. JOURNAL OF NEURAL TRANSMISSION 108: 1383-1396
Ferrer, I, Blanco, R, Carmona, M, Ribera, R, Goutan, E, Puig, B, Rey, MJ, Cardozo, A, Vinals, F and Ribalta, T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. BRAIN PATHOLOGY 11: 144-158
Ferrer, I, Pastor, P, Rey, MJ, Munoz, E, Puig, B, Pastor, E, Oliva, R,
Tolosa, E (2003) Tau phosphorylation and kinase
activation in familial tauopathy linked to deln296 mutation. NEUROPATHOLOGY
AND APPLIED NEUROBIOLOGY 29: 23-34
Festy, F, Lins, L, Peranzi, G, Octave, JN, Brasseur, R and Thomas, A (2001) Is aggregation of beta-amyloid peptides a mis-functioning of a current interaction process? BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1546: 356-364
Feuillette,
S, Blard, O, Lecourtois, M, Frebourg, T, Campion, D, Dumanchin, C (2005) Tau
is not normally degraded by the proteasome. JOURNAL OF NEUROSCIENCE RESEARCH 80:
400-405
Figlewicz DA, Rouleau GA, Krizus A, Julien JP. (1993) Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene, 1993 Oct, 132:2, 297-300
Figueroa, DJ, Morris, JA, Ma, L, Kandpal, G, Chen, E, Li, YM, Austin, CP (2002) Presenilin-dependent gamma-secretase activity modulates neurite outgrowth. NEUROBIOLOGY OF DISEASE 9: 49-60
Finelli,
A, Kelkar, A, Song, HJ, Yang, HD, Konsolaki, M (2004)
A model for studying Alzheimer's A beta 42-induced toxicity in Drosophila
melanogaster. MOLECULAR AND CELLULAR NEUROSCIENCE 26: 365-375
Fischer, DF, De Vos, RAI, Van Dijk, R, De Vrij, FMS,
Proper, EA, Sonnemans, MAF, Verhage, MC, Sluijs, JA, Hobo, B, Zouambia, M, Steur,
ENHJ, Kamphorst, W, Hol, EM, Van Leeuwen, FW (2003)
Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal
dysfunction in the brain. FASEB JOURNAL 17: 2014-2024
Flaherty, DB, Soria, JP, Tomasiewicz, HG and Wood, JG (2000) Phosphorylation of human tau protein by microtubule-associated kinases: GSK3 beta and cdk5 are key participants. JOURNAL OF NEUROSCIENCE RESEARCH 62: 463-472
Flaten, TP (2001) Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. BRAIN RESEARCH BULLETIN 55: 187-196
Fleming_LM, Weisgraber_KH, Strittmatter_WJ, Troncoso_JC, Johnson_GVW.(1996) Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. EXPERIMENTAL NEUROLOGY, 1996, Vol.138, No.2, pp.252-260
Fleminger, S, Oliver, DL, Lovestone, S, Rabe-Hesketh,
S, Giora, A (2003) Head injury as a risk factor for Alzheimer's disease:
the evidence 10 years on; a partial replication. JOURNAL OF NEUROLOGY
NEUROSURGERY AND PSYCHIATRY 74: 857-862
Flood, DG, Reaume, AG, Dorfman, KS, Lin, YG, Lang, DM, Trusko, SP, Savage, MJ, Annaert, WG, De Strooper, B, Siman, R, Scott, RW (2002) FAD mutant PS-1 gene-targeted mice: Increased A beta 42 and A beta deposition without APP overproduction. NEUROBIOLOGY OF AGING 23: 335-348
Foguel,
B, Silva, JL (2004) New
insights into the mechanisms of protein misfolding and aggregation in
amyloidogenic diseases derived from pressure studies. BIOCHEMISTRY 43:
11361-11370
Forbes, MS, Ghribi, O, Herman, MM, Savory, J (2002) Aluminum-induced dendritic pathology revisited: Cytochemical and electron microscopic studies of rabbit cortical pyramidal neurons. ANNALS OF CLINICAL AND LABORATORY SCIENCE 32: 75-86
Forloni, G, Terreni, L, Bertani, I,
Fogliarino, S, Invernizzi, R, Assini, A, Ribizzi, G, Negro, A, Calabrese, E,
Volonte, MA, Mariani, C, Franceschi, M, Tabaton, M, Bertoli, A (2002)
Protein misfolding in Alzheimer's and Parkinson's
disease: genetics and molecular mechanisms
Forman, MS, Lee, VMY and Trojanowski, JQ (2001) New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. JOURNAL OF CHEMICAL NEUROANATOMY 20: 225-244
Forman, MS, Zhukareva, V, Bergeron, C, Chin, SSM, Grossman, M, Clark,
C, Lee, VMY, Trojanowski, JQ (2002) Signature tau neuropathology
in gray and white matter of corticobasal degeneration. AMERICAN JOURNAL
OF PATHOLOGY 160: 2045-2053
Fortini, ME (2001) Notch and Presenilin: a proteolytic mechanism emerges. CURRENT OPINION IN CELL BIOLOGY 13: 627-634
Fountoulakis,
M (2004)
Application of proteomics technologies in the investigation of the brain. MASS
SPECTROMETRY REVIEWS 23: 231-258
Fountoulakis M, Hardmeier R, Höger H and Lubec G (2001) Postmortem Changes in the Level of Brain Proteins. EXPERIMENTAL NEUROLOGY 167: 86-94
Frasca,
G, Chiechio, S, Vancher, C, Nicoletti, F, Copani, A, Sortino, MA (2004)
beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells - Correlation
with the MAP kinase pathway. JOURNAL OF MOLECULAR NEUROSCIENCE 22: 231-235
Fraser, PE, Yang, DS, Yu, G, Levesque, L, Nishimura, M, Arawaka, S, Serpell, LC, Rogaeva, E and St George-Hyslop, P (2000) Presenilin structure, function and role in Alzheimer disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1502: 1-15
Fraser, PE, Yu, G, Levesque, L, Nishimura, M, Yang, DS, Mount, HTJ, Westaway, D, St George-Hyslop, PH (2001) Presenilin function: connections to Alzheimer's disease and signal transduction. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 89-100
Freeman, M (2001) Pin-pointing MAPK signalling. NATURE CELL BIOLOGY 3: E136-E137
Frenkel, D, Kariv, N and Solomon, B (2001) Generation of auto-antibodies towards Alzheimer's disease vaccination. VACCINE 19: 2615-2619
Friedhoff, P, von Bergen, M, Mandelkow, EM and Mandelkow, E (2000) Structure of tau protein and assembly into paired helical filaments. BIOCHIMICA ET BIOPHYSICA ACTA- MOLECULAR BASIS OF DISEASE 1502: 122-132
Friedland, RP, Fritsch, T, Smyth, KA, Koss, E, Lerner, AJ, Chen, CH, Petot, GJ and Debanne, SM (2001) Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 3440-3445
Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, Estivill XA (1995) A New Human Gene From The Down-Syndrome Critical Region Encodes A Proline-Rich Protein Highly Expressed In Fetal Brain And Heart. Hum Mol Genet 4: 1935-1944
Fujimori, F, Gunji, W, Kikuchi, J, Mogi, T, Ohashi, Y, Makino, T, Oyama, A, Okuhara, K, Uchida, T, Murakami, Y (2001) Crosstalk of prolyl isomerases, Pin1/Ess1, and cyclophilin A. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 289: 181-19
Fujimori F, Takahashi K, Uchida C, Uchida T (1999) Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Bioch Biophys Res Comm 265: 658-663
Fujiyama, S, Yanagida, M, Hayano, T, Miura, Y, Isobe, T, Takahashi, N (2002) Isolation and proteomic characterization of human parvulin-associating preribosomal ribonucleoprotein complexes. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 23773- 23780
Fukutani, Y, Cairns, NJ, Shiozawa, M, Sasaki, K, Sudo, S, Isaki, K and Lantos, PL (2000) Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. PSYCHIATRY AND CLINICAL NEUROSCIENCES 54: 523-529
Fukuyama, R, Izumoto, T and Fushiki, S (2001) The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia. EUROPEAN NEUROLOGY 46: 35-38
Fullerton, SM, Clark, AG, Weiss, KM, Nickerson, DA, Taylor, SL, Stengard, JH, Salomaa, V, Vartiainen, E, Perola, M, Boerwinkle, E and Sing, CF (2000) Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. AMERICAN JOURNAL OF HUMAN GENETICS 67: 881-900
Furlan,
R, Brambilla, E, Sanvito, F, Roccatagliata, L, Olivieri, S, Bergami, A, Pluchino,
S, Uccelli, A, Comi, G, Martino, G (2003) Vaccination with amyloid-beta peptide induces
autoimmune encephalomyelitis in C57/BL6 mice.
BRAIN 126: 285-291
Furuya, H, Yasuda, M, Terasawa, K, Tanaka, K, Murai, H,
Kira, J, Ohyagi, Y (2003) A novel mutation (L250V) in the presenilin 1
gene in a Japanese familial Alzheimer's disease with myoclonus and generalized
convulsion. JOURNAL OF THE NEUROLOGICAL SCIENCES: 209: 75-77
| G |
Gajdusek, D. C. (1986) On the uniform source of amyloid in plaques, tangles and vascular deposits. Neurobiol. Aging 7: 453-454
Galat,
A (2003)
Peptidylprolyl cis/trans isomerases (immunophilins): Biological diversity
targets – Functions. CURRENT TOPICS IN MEDICINAL CHEMISTRY 3: 1315-1347
Galvin_JE, Lee_VMY, Baba_M, Mann_DMA, Dickson_DW, Yamaguchi_H, Schmidt_ML, Iwatsubo_T, Trojanowski_JQ. (1997) Monoclonal antibodies to purified cortical lewy bodies recognize the mid-size neurofilament subunit. ANNALS OF NEUROLOGY,1997, Vol.42, No.4, pp.595-603
Gamblin, TC, Berry, RW, Binder, LI (2003)
Tau polymerization: Role of the amino terminus. BIOCHEMISTRY 42: 2252-2257
Gamblin, TC, King, ME, Kuret, J, Berry, RW and Binder, LI (2000) Oxidative regulation of fatty acid-induced tau polymerization. BIOCHEMISTRY 39: 14203-14210
Gamliel, A, Teicher, C, Michaelson, DM, Pradier, L, Hartmann, T, Beyreuther, K, Stein, R (2002) Increased expression of presenilin 2 inhibits protein synthesis. MOLECULAR AND CELLULAR NEUROSCIENCE 19: 111-124
Gandy S, Naslund J and Nordstedt C (2001) Alzheimer's disease: Molecular consequences of presenilin-1 mutation. Nature 411, 654 - 655
Gandy, S, Petanceska, S (2000) Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1502: 44-52
Gangalum,
RK, Schibler, MJ, Bhat, SP (2004)
Small heat shock protein alpha B-crystallin is part of cell cycle-dependent
Golgi reorganization. JOURNAL OF BIOLOGICAL CHEMISTRY 279: 43374-43377
Gao, YH, Pimplikar, SW (2001) The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 14979-14984
Garcia, FJG, Ayala, MIS, Martin, AP, Correa, EM, Alonso, CM, Ferrer, GR, Colmenero, CG, Rizos, LR, Barquero, MJR and Avila, GG (2001) The prevalence of dementia and its wain subtypes in subjects older than 65 years: the effects of occupation and education. Toledo Study. MEDICINA CLINICA 116: 401-407
Garcia, ML and Cleveland, DV (2001) Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. CURRENT OPINION IN CELL BIOLOGY 13: 41-48
Garcia-Lozano, JR, Mir, P, Alberca, R, Aguilera, I, Neciga, EG, Fernandez-Lopez, O, Cayuela, A, Nunez-Roldan, A (2002) Mitochondrial DNA A4336G mutation in Alzheimer's and Parkinson's diseases. EUROPEAN NEUROLOGY 48: 34-36
Garcia-Ospina, GP, Jimenez-Del Rio, M, Lopera, F,
Velez-Pardo, C (2003) Neuronal DNA damage correlates with a positive
detection of c-Jun nuclear factor kappa B, p53 and Par-4 transcription factors
in Alzheimer's disease. REVISTA DE NEUROLOGIA 36: 1004-1010
Garcia-Sierra, F, Wischik, CM, Harrington, CR, Luna-Munoz, J and Mena, R (2001) Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. JOURNAL OF CHEMICAL NEUROANATOMY 22: 65-77
Gartner, U, Bruckner, MK, Krug, S, Schmetsdorf, S,
Staufenbiel, M, Arendt, T (2003) Amyloid deposition in APP23 mice is associated
with the expression of cyclins in astrocytes but not in neurons. ACTA
NEUROPATHOLOGICA 106: 535-544
Gartner, U, Holzer, M and Arendt, T (1999) Elevated expression of p21(ras) is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. NEUROSCIENCE 91: 1-5
Gary, DS and Mattson, MP (2001) Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. JOURNAL OF NEUROCHEMISTRY 76: 1485-1496
Gasparini, L, Gouras, GK, Wang, R, Gross, RS, Beal, MF, Greengard, P and Xu, HX (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. JOURNAL OF NEUROSCIENCE 21: 2561-2570
Gasparini, L, Netzer, WJ, Greengard, P, Xu, HX (2002) Does insulin dysfunction play a role in Alzheimer's disease? TRENDS IN PHARMACOLOGICAL SCIENCES 23: 288-293
Gauthier, E, Fortier, I, Courchesne, F, Pepin, P, Mortimer, J and Gauvreau, D (2000) Aluminum forms in drinking water and risk of Alzheimer's disease. ENVIRONMENTAL RESEARCH 84: 232-246
Geerts, H (1998) The tau protein in the pathophysiology of Alzheimer's disease. ALZHEIMERS REPORTS 1: S7-S8
Geling, A, Steiner, H, Willem, M, Bally-Cuif, L, Haass, C (2002) A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO REPORTS 3: 688-694
Gemmill,
TR, Wu, XY, Hanes, SD (2005)
Vanishingly low levels of Ess1 prolyl-isomerase activity are sufficient for
growth in Saccharomyces cerevisiae. JOURNAL OF BIOLOGICAL CHEMISTRY 280:
15510-15517
Georgopoulou, N, McLaughlin, M, McFarlane, I, Breen, KC (2001) The role of post-translational modification in beta-amyloid precursor protein processing. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 23-36
Gerez L, Mohrmann K, van Raak M, Jongeneelen M, Zhou XZ, Lu KP and van der Sluijs P (2000) Accumulation of rab4GTP in the cytoplasm and association with the peptidyl-prolyl isomerase Pin1 during mitosis. Molecular Biology of the Cell 11: 2201-2211
Gerst, JL, Raina, AK, Pirim, I, McShea, A, Harris, PLR, Siedlak, SL,
Takeda, A, Petersen, RB and Smith, MA (2000) Altered
cell-matrix associated ADAM proteins in Alzheimer disease.
JOURNAL OF NEUROSCIENCE RESEARCH 59: 680-684
Ghanevati, M, Chu, H, Lin, S, Miller, CA (2002) Increased beta-catenin expression in Alzheimer's disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 165
Ghiso, JA, Holton, J, Miravalle, L, Calero, M, Lashley, T, Vidal, R, Houlden, H, Wood, N, Neubert, TA, Rostagno, A, Plant, G, Revesz, T, Frangione, B (2001) Systemic amyloid deposits in familial British dementia. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 43909-43914
Ghribi, O, DeWitt, DA, Forbes, MS, Herman, MM and Savory, J (2001) Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. BRAIN RESEARCH 903: 66-73
Giacobini, E (2000) Cholinesterase inhibitors stabilize Alzheimer's disease. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 321-327
Giannakopoulos, P, Herrmann, FR, Bussiere, T, Bouras,
C, Kovari, E, Perl, DP, Morrison, JH, Gold, G, Hof, PR (2003)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in
Alzheimer's disease. NEUROLOGY 60: 1495-500
Giasson_BI, Mushynski_WE. (1997) Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. JOURNAL OF NEUROSCIENCE, 1997, Vol.17, No.24, pp.9466-9472
Giasson, BI, Sampathu, DM, Wilson, CA,
Vogelsberg-Ragaglia, V, Mushynski, WE, Lee, VMY (2002)
The environmental toxin arsenite induces tau hyperphosphorylation
Gibson, GE, Haroutunian, V, Zhang, H, Park, LCH, Shi, Q, Lesser, M, Mohs, RC, Sheu, RKF and Blass, JP (2000) Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. ANNALS OF NEUROLOGY 48: 297-303
Gibson, GE, Park, LCH, Zhang, H, Sorbi, S and Calingasan, NY (1999) Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 893: 79-94
Giffard,
RG, Xu, LJ, Heng, Z, Carrico, W, Ouyang, YB, Qiao, YL, Sapolsky, R, Steinberg,
G, Hu, BR, Yenari, MA (2004) Chaperones,
protein aggregation, and brain protection from hypoxic/ischemic injury. JOURNAL
OF EXPERIMENTAL BIOLOGY 207: 3213-3220
Gil, MLG, Moran, MA, Gomez-Ramos, P (2001) Ubiquitinated granular structures and initial neurofibrillary changes in the human brain. JOURNAL OF THE NEUROLOGICAL SCIENCES 192: 27-34
Gillardon,
F, Steinlein, P, Burger, E, Hildebrandt, T, Gerner, C (2005) Phosphoproteome
and transcriptome analysis of the neuronal response to a CDK5 inhibitor.
PROTEOMICS 5: 1299-1307
Ginsberg_SD, Crino_PB, Lee_VMY, Eberwine_JH, Trojanowski_JQ. (1997) Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. ANNALS OF NEUROLOGY, 1997, Vol.41, No.2, pp.200-209
Giovanni, A, Keramaris, E, Morris, EJ, Hou, ST, O'Hare, M, Dyson, N, Robertson, GS, Slack, RS and Park, DS (2000) E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 11553-11560
Giovanni, A, Wirtz-Brugger, F, Keramaris, E, Slack, R and Park, DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F center dot DP, in B-amyloid-induced neuronal death. JOURNAL OF BIOLOGICAL CHEMISTRY 274: 19011-19016
Girardot,
N, Allinquant, B, Langui, D, Laquerriere, A, Dubois, B, Hauw, JJ, Duyckaerts, C
(2003)
Accumulation of flotillin-1 in tangle-bearing neurones of Alzheimer's disease.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 29: 451-461
Gislason, TB, Sjogren, M, Larsson, L, Skoog, I (2003)
The prevalence of frontal variant frontotemporal dementia and the frontal lobe
syndrome in a population based sample of 85 year olds. JOURNAL OF NEUROLOGY
NEUROSURGERY AND PSYCHIATRY 74: 867-871
Glabe, C (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. JOURNAL OF MOLECULAR NEUROSCIENCE 17: 137-145
Glanzer,
JG, Eberwine, JH (2003)
Mechanisms of translational control in dendrites. NEUROBIOLOGY OF AGING 24:
1105-1111
Glenner, G. G.; Wong, C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890
Goddard,
KAB, Olson, JM, Payami, H, van der Voet, M, Kuivaniemi, H, Tromp, G (2004)
Evidence of linkage and association on chromosome 20 for late-onset Alzheimer
disease. NEUROGENETICS 5: 121-128
Goedert, M, Ghetti, B, Spillantini, MG (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 74-83
Goedert,
M, Jakes, R (2005)
Mutations causing neurodegenerative tauopathies. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR
BASIS OF DISEASE 1739: 240-250
Goedert, M and Spillantini, MG (2000) Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA- MOLECULAR BASIS OF DISEASE 1502: 110-121
Goedert, M, Spillantini, MG (2001) Tau gene mutations and neurodegeneration. NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE 67: 59-71
Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau : sequences and localisation in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526
Goedert, M, Spillantini, MG, Serpell, LC, Berriman, J, Smith, MJ, Jakes, R, and Crowther, RA (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 356: 213-227
Goetz, CG (2003)
Progressive supranuclear palsy. REVUE NEUROLOGIQUE 159: S25-S29
Goetz, CG, Leurgans, S, Lang, AE, Litvan, I (2003)
Progression of gait, speech and swallowing deficits in progressive supranuclear
palsy. NEUROLOGY 60: 917-922
Gold, G, Blouin, JL, Herrmann, FR, Michon, A, Mulligan,
R, Sail, GD, Bouras, C, Giannakopoulos, P, Antonarakis, SE, A-Ntonarakis, SE
(2003) Specific BACE1 genotypes provide additional risk
for late-onset Alzheimer disease in APOE epsilon 4 carriers. AMERICAN JOURNAL OF
MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 119B: 44-47
Golde, TE, Eckman, CB (2001) Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease. DRUG DISCOVERY TODAY 6: 1049-1055
Goldstine, J, Seligson, DB, Beizai, P, Miyata, H, Vinters, HV (2002) Tissue microarrays in the study of non-neoplastic disease of the nervous system. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 653-662
Gomez-Lazaro,
M, Fernandez-Gomez, FJ, Jordan, J (2004) The
role of protein p53 in neurodegenerative processes throughout the 25 years of
its history. REVISTA DE NEUROLOGIA 39: 243-250
Gomez-Ramos,
A, Abad, X, Fanarraga, ML, Bhat, R, Zabala, JC, Avila, J (2004)
Expression of an altered form of tau in Sf9 insect cells results in the assembly
of polymers resembling Alzheimer's paired helical filaments. BRAIN RESEARCH
1007: 57-64
Gomez-Ramos, A, Smith, MA, Perry, G, Avila, J (2004) Tau phosphorylation and assembly. ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64: 33-39
Gomez-Ramos, P, Mufson, EJ, Moran, MA (2001) Apolipoprotein E immunoreactivity
in neurons and neurofibrillary degeneration of aged non-demented
and Alzheimer's disease patients. MICROSCOPY RESEARCH AND
TECHNIQUE 55: 48-58
Gompel,
M, Soulie, C, Ceballos-Picot, I, Meijer, L (2004)
Expression and activity of cyclin-dependent kinases and glycogen synthase
kinase-3 during NT2 neuronal differentiation. NEUROSIGNALS 13: 134-143
Gong, CX, Lidsky, T, Wegiel, J, Grundke-Iqbal, I and Iqbal, K (2001) Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain. BRAIN RESEARCH PROTOCOLS 6: 134-140
Gong C-X, Lidsky T, Weigel J, Zuck L, Grundke-Iqbal, I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275: 5535-5544
Gong,
CX, Liu, F, Grundke-Iqbal, I, Iqbal, K (2005) Post-translational
modifications of tau protein in Alzheimer's disease. JOURNAL OF NEURAL
TRANSMISSION 112: 813-838
Gong, CX, Liu, F, Wu, GX, Rossie, S, Wegiel, J, Li, L, Grundke-Iqbal, I, Iqbal, K (2004) Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. JOURNAL OF NEUROCHEMISTRY 88: 298-310
Gong, CX, Wang, JZ, Iqbal, K, Grundke-Iqbal, I (2003)
Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of
neurofilaments in metabolically active rat brain slices. NEUROSCIENCE LETTERS
340: 107-110
Gonzalez-Lima, F, Berndt, JD, Valla, JE, Games, D and Reiman, EM (2001) Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. NEUROREPORT 12: 2375-2379
Goodenough, S, Engert, S and Behl, C (2000) Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. NEUROSCIENCE LETTERS 296: 49-52
Gordon, MN, Holcomb, LA, Jantzen, PT, DiCarlo, G, Wilcock, D, Boyett,
KW, Connor, K, Melachrino, J, O'Callaghan, JP, Morgan, D
(2002) Time course of the development of Alzheimer-like
pathology in the doubly transgenic PS1+APP mouse. EXPERIMENTAL
NEUROLOGY 173: 183-195
Gostissa, M, Hofmann, TG, Will, H, Del Sal, G (2003)
Regulation of p53 functions: let's meet at the nuclear bodies. CURRENT OPINION
IN CELL BIOLOGY 15: 351-357
Gothel SF, Marahiel MA (1999) Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cellular and Molecular Life Sciences 55: 423-436
Gottlieb, S (2000) Head injury doubles the risk of Alzheimer's disease. BRITISH MEDICAL JOURNAL 321: 1100
GOTTRON_F, TURETSKY_D, CHOI_D. (1995) SMI-32 ANTIBODY AGAINST NONPHOSPHORYLATED NEUROFILAMENTS IDENTIFIES A SUBPOPULATION OF CULTURED CORTICAL-NEURONS HYPERSENSITIVE TO KAINATE TOXICITY. NEUROSCIENCE LETTERS, 1995, Vol.194, No.1-2, pp.1-4
Gotz, J (2001) Tau and transgenic animal models. BRAIN RESEARCH REVIEWS 35: 266-286
Gotz, J, Barmettler, R, Ferrari, A, Goedert, M, Probst, A, Nitsch,
RM (2000) In vivo analysis of wild-type and FTDP-17 tau transgenic mice.
MOLECULAR BASIS OF DEMENTIA 920: 126-133
Gotz, J, Chen, F, van Dorpe, J and Nitsch, RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A beta 42 fibrils. SCIENCE 293: 1491-1495
Gotz, J and Nitsch, RM (2001) Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice. NEUROREPORT 12: 2007-2016
Gotz, J, Schild, A (2003) Transgenic and knockout models of PP2A. PROTEIN PHOSPHATASES Methods Enzymol. 366: 390-403
Gotz,
J, Streffer, JR, David, D, Schild, A, Hoerndli, F, Pennanen, L, Kurosinski, P,
Chen, F (2004)
Transgenic animal models of Alzheimer's disease and related disorders:
Histopathology, behavior and therapy. MOLECULAR PSYCHIATRY 9: 664-683
Gou_JP, Leterrier_J. (1995) Possible involvement of ubiquitination in neurofilament degradation. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, Vol.217, No.2, pp.529-538
Goux, WJ (2002) The conformations of filamentous and soluble tau
associated with Alzheimer paired helical filaments
Grace,
EA, Rabiner, CA, Busciglio, J (2002)
Characterization of neuronal dystrophy induced by
fibrillar amyloid beta: Implications for Alzheimer's disease
NEUROSCIENCE 114: 265-273
Graham, NL, Bak, TH, Hodges, JR (2003)
Corticobasal degeneration as a cognitive disorder. MOVEMENT DISORDERS 18:
1224-1232
Granholm, ACE, Ford, KA, Hyde, LA,
Bimonte, HA, Hunter, CL, Nelson, M, Albeck, D, Sanders, LA, Mufson, EJ, Crnic,
LS (2002) Estrogen restores cognition and cholinergic phenotype
in an animal model of Down syndrome
Gray, N, Detivaud, L, Doerig, C and Meijer, L (1999) ATP-site directed inhibitors of cyclin-dependent kinases. CURRENT MEDICINAL CHEMISTRY 6: 859-875
Grazina,
M, Silva, F, Santana, I, Santiago, B, Mendes, C, Simoes, M, Oliveira, M, Cunha,
L, Oliveira, C (2004)
Frontotemporal dementia and mitochondrial DNA transitions. NEUROBIOLOGY OF
DISEASE 15: 306-311
Grbovic, OM, Mathews, PM, Jiang, Y, Schmidt, SD,
Dinakar, R, Summers-Terio, NB, Ceresa, BP, Nixon, RA, Cataldo, AM (2003) Rab5-stimulated
up-regulation of the endocytic pathway increases intracellular beta-cleaved
amyloid precursor protein carboxyl-terminal fragment levels and A beta
production. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 31261-31268
Greber-Platzer, S, Fleischmann, C, Nussbaumer, C,
Cairns, N, Lubec, G (2003) Increased RNA levels of the 25 kDa synaptosomal
associated protein in brain samples of adult patients with Down Syndrome.
NEUROSCIENCE LETTERS 336: 77-80
Green, EK, Thaker, U, McDonagh, AM, Iwatsubo, T, Lambert, JC, Chartier-Harlin,
MC, Harris, JM, Pickering-Brown, SM, Lendon, CL, Mann, DMA (2002)
A polymorphism within intron 11 of the tau gene is not increased
in frequency in patients with sporadic Alzheimer's disease, nor does
it influence the extent of tau pathology in the brain. NEUROSCIENCE
LETTERS 324: 113-116
Green, KN and Peers, C (2001) Amyloid beta peptides mediate hypoxic augmentation of Ca2+ channels. JOURNAL OF NEUROCHEMISTRY 77: 953-956
Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct t proteins by polyacrylamide gel electrophoresis. Proc Nat Acad Sci USA 87:5827-5831
Greenfield, JP, Gross, RS, Gouras, GK and Xu, HX (2000) Cellular and molecular basis of beta-amyloid precursor protein metabolism. FRONTIERS IN BIOSCIENCE 5: D72-D83
Greenfield, JP, Leung, LW, Cai, DM, Kaasik, K, Gross, RS, Rodriguez-Boulan, E, Greengard, P, Xu, HX (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 12128-12136
Greeve,
I, Kretzschmar, D, Tschape, JA, Beyn, A, Brellinger, C, Schweizer, M, Nitsch, RM,
Reifegerste, R (2004)
Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in
transgenic Drosophila. JOURNAL OF NEUROSCIENCE 24: 3899-3906
Gregersen, N, Bross, P, Andresen, BS, Pedersen, CB, Corydon, TJ and Bolund, L (2001) The role of chaperone-assisted folding and quality control in inborn errors of metabolism: Protein folding disorders. JOURNAL OF INHERITED METABOLIC DISEASE 24: 189-212
Grierson, AJ, Johnson, GVW and Miller, CCJ (2001) Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. NEUROSCIENCE LETTERS 298: 9-12
Griffin, WST, Nicoll, JAR, Grimaldi, LME, Sheng, JG and Mrak, RE (2000) The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk. EXPERIMENTAL GERONTOLOGY 35: 481-487
Griffin, B, Selassie, M and Gwebu, ET (2000) Effect of aged garlic extract on the cytotoxicity of Alzheimer beta-amyloid peptide in neuronal PC12 cells. NUTRITIONAL NEUROSCIENCE 3: 139-142
Grilli,
M, Toninelli, GF, Uberti, D, Spano, P, Memo, M (2003)
Alzheimer's disease linking neurodegeneration with neurodevelopment. FUNCTIONAL
NEUROLOGY 18: 145-148
Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. PROGRESS IN NEUROBIOLOGY 65: 391-426
Grossman, M (2002) Frontotemporal dementia: A review. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY 8: 566-583
Grote, E., Bonzelius, F., Herman, G., Ramaswami, M., van de Goor, J., Green, S. and Kelly, R.B. (1995) Endocytotic pathways in neurons. pp. 1-14 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.
Grover, A, England, E, Baker, M, Sahara, N, Adamson, J,
Granger, B, Houlden, H, Passant, U, Yen, SH, DeTure, M, Hutton, M (2003)
A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy.
EXPERIMENTAL NEUROLOGY 184: 131-140
Grundke-Iqbal, I.; Johnson, A. B.; Wisniewski, H. M.; Terry, R. D.; Iqbal, K.(1979) Evidence that Alzheimer neurofibrillary tangles originate from neurotubules. Lancet I: 578-581, 1979.
Grynspan_F, Griffin_WR, Cataldo_A, Katayama_S, Nixon_RA. (1997) Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. BRAIN RESEARCH, 1997, Vol.763, No.2, pp.145-158
Guenette, SY (2002) A role for APP in motility and transcription?
TRENDS IN PHARMACOLOGICAL SCIENCES 23: 203-205
Guenette, SY, Bertram, L, Crystal, A, Bakondi, B, Hyman, BT, Rebeck, GW, Tanzi, RE and Blacker, D (2000) Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. NEUROSCIENCE LETTERS 296: 17-20
Guillozet-Bongaarts,
AL, Garcia-Sierra, F, Reynolds, MR, Horowitz, PM, Fu, YF, Wang, TY, Cahill, ME,
Bigio, EH, Berry, RW, Binder, LI (2005) Tau
truncation during neurofibrillary tangle evolution in Alzheimer's disease.
NEUROBIOLOGY OF AGING 26: 1015-1022
Guillozet, AL, Weintraub, S, Mash, DC, Mesulam, MM
(2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive
impairment. ARCHIVES OF NEUROLOGY 60: 729-736
Guise, S, Braguer, D, Carles, G, Delacourte, A and Briand, C (2001) Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. JOURNAL OF NEUROSCIENCE RESEARCH 63: 257-267
Gunawardena, S, Goldstein, LSB (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. NEURON 32: 389-401
Guo, GW and Liang, YX (2001) Aluminum-induced apoptosis in cultured astrocytes and its effect on calcium homeostasis. BRAIN RESEARCH 888: 221-226
GuoRoss_S, Yang_E, Bondy_SC. (1998) Elevation of cerebral proteases after systemic administration of aluminum. NEUROCHEMISTRY INTERNATIONAL, 1998, Vol.33, No.3, pp.277-282
Gurd, JM, Herzberg, L, Joachim, C, Marshall, JC, Jobst, K, McShane, RH, Hindley, NJ and King, EE (2000) Dementia with Lewy bodies: A pure case. BRAIN AND COGNITION 44: 307-323
Gustafson, D, Rothenberg, E, Blennow, K, Steen, B,
Skoog, I (2003) An 18-year follow-up of overweight and risk of
Alzheimer disease. ARCHIVES OF INTERNAL MEDICINE 163: 1524-1528
Gydesen, S, Brown, JM, Brun, A,
Chakrabarti, L, Gade, A, Johannsen, P, Rossor, M, Thusgaard, T, Grove, A,
Yancopoulou, D, Spillantini, MG, Fisher, EMC, Collinge, J, Sorensen, SA (2002)
Chromosome 3 linked frontotemporal dementia (FTD-3)
| H |
Haass, C (2002) New hope for Alzheimer disease vaccine
Haass, C and Steiner, H (2001) Protofibrils, the unifying toxic molecule of neurodegenerative disorders? NATURE NEUROSCIENCE 4: 859-860
Haass, C, Steiner, H (2002)
Alzheimer disease gamma-secretase: a complex story of
GxGD-type presenilin proteases
Habeck, M (2001) Is Alzheimer's disease a form of cancer? DRUG DISCOVERY TODAY 6: 651-652
Haier,
RJ, Alkire, MT, White, NS, Uncapher, MR, Head, E, Lott, IT, Cotman, CW (2003) Temporal
cortex hypermetabolism in Down syndrome prior to the onset of dementia.
NEUROLOGY 61: 1673-1679
Halks-Miller, M, Schroeder, ML, Haroutunian, V,
Moenning, U, Rossi, M, Achim, C, Purohit, D, Mahmoudi, M, Horuk, R (2003)
CCR1 is an early and specific marker of Alzheimer's disease. ANNALS OF NEUROLOGY
54: 638-646
Hall, GF, Lee, S, Yao, J (2002)
Neurofibrillary degeneration can be arrested in an in
vivo cellular model of human tauopathy by application of a compound which
inhibits tau filament formation in vitro
Hall, GF, Lee, VMY, Lee, G and Yao, J (2001) Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. AMERICAN JOURNAL OF PATHOLOGY 158: 234-246
Halliwell, B (2002) Hypothesis: Proteasomal dysfunction - A primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES: NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL 962: 182-194
Halverson,
RA, Lewis, J, Frausto, S, Hutton, M, Muma, NA (2005)
Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
JOURNAL OF NEUROSCIENCE 25: 1226-1233
Hama, E, Shirotani, K, Masumoto, H, Sekine-Aizawa, Y, Aizawa, H, Saido, TC (2001) Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. JOURNAL OF BIOCHEMISTRY 30: 721-726
Hamdane, M, Delobel, P, Sambo, AV, Smet, C, Begard, S,
Violleau, A, Landrieu, I, Delacourte, A, Lippens, G, Flament, S, Buee, L (2003)
Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to
neuronal apoptosis? BIOCHEMICAL PHARMACOLOGY 66: 1619-1625
Hamdane, M, Sambo, AV, Delobel, P, Begard, S, Violleau,
A, Delacourte, A, Bertrand, P, Benavides, J, Buee, L (2003)
Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. JOURNAL OF
BIOLOGICAL CHEMISTRY 278: 34026-34034
Hamdane, M, Smet, C, Sambo, AV,
Leroy, A, Wieruszeski, JM, Delobel, P, Maurage, CA, Ghestem, A, Wintjens, R,
Begard, S, Sergeant, N, Delacourte, A, Horvath, D, Landrieu, I, Lippens, G, Buee,
L (2002) Pin1 - A therapeutic target in Alzheimer
neurodegeneration
Hamilton, RL (2003)
The other dementias: The neuropathology of the non-Alzheimer's disease
dementias. REVISTA DE NEUROLOGIA 37: 130-139
Hampel, H, Buerger, K, Kohnken, R, Teipel, SJ, Zinkowski, R, Moeller, HJ, Rapoport, SI and Davies, P (2001) Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. ANNALS OF NEUROLOGY 49: 545-546
Hampel,
H, Burger, K, Pruessner, JC, Zinkowski, R, DeBernardis, J, Kerkman, D,
Leinsinger, G, Evans, AC, Davies, P, Moller, HJ, Teipel, SJ (2005)
Correlation of cerebrospinal fluid levels of Tau protein phosphorylated at
threonine 231 with rates of hippocampal atrophy in Alzheimer disease. ARCHIVES
OF NEUROLOGY 62: 770-773
Hampel, H, Buerger, K, Zinkowski, R, Teipel, SJ, Goernitz, A, Andreasen, N, Sjoegren, M, DeBernardis, J, Kerkman, D, Ishiguro, K, Ohno, H, Vanmechelen, E, Vanderstichele, H, McCulloch, C, Moller, HJ, Davies, P, Blennow, K (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study. ARCHIVES OF GENERAL PSYCHIATRY 61: 95-102
Hampel,
H, Teipel, SJ (2004)
Total and phosphorylated tau proteins: Evaluation as core biomarker candidates
in frontotemporal dementia. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 17:
350-354
Hampel,
H, Teipel, SJ, Fuchsberger, T, Andreasen, N, Wiltfang, J, Otto, M, Shen, Y,
Dodel, R, Du, Y, Farlow, M, Moller, HJ, Blennow, K, Buerger, K (2004)
Value of CSF beta-amyloid(1-42) and tau as predictors of Alzheimer's disease in
patients with mild cognitive impairment. MOLECULAR
PSYCHIATRY 9: 705-710
Hanai,
S, Kanai, M, Ohashi, S, Okamoto, K, Yamada, M, Takahashi, H, Miwa, M (2004)
Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in
Drosophila melanogaster. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE
UNITED STATES OF AMERICA 101: 82-86
Hanger, DP, Gibb, GM, de Silva, R,
Boutajangout, A, Brion, JP, Revesz, T, Lees, AJ, Anderton, BH (2002) The complex relationship between soluble and insoluble
tau in tauopathies revealed by efficient dephosphorylation and specific
antibodies
Harada, T., Morooka, T., Ogawa, S. and Nishida, E. (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 . Nature Cell Biology 3: 453 - 459
Haraguchi, T, Ishizu, H, Takehisa, Y, Kawai, K, Yokota, O, Terada, S, Tsuchiya, K, Ikeda, K, Morita, K, Horike, T, Kira, S, Kuroda, S (2001) Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of leads neurotoxicity. NEUROREPORT 12: 3887-3890
Hardy, J (2003)
The relationship between amyloid and tau. JOURNAL OF MOLECULAR NEUROSCIENCE 20:
203-206
Harkany, T, Abraham, I, Timmerman, W, Laskay, G, Toth, B, Sasvari, M, Konya, C, Sebens, JB, Korf, J, Nyakas, C, Zarandi, M, Soos, K, Penke, B, Luiten, PGM (2000) beta-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. EUROPEAN JOURNAL OF NEUROSCIENCE 12:2735-2745
Harman, D (2000) Alzheimer's disease: A hypothesis on pathogenesis. JOURNAL OF THE AMERICAN AGING ASSOCIATION 23: 147-161
Haroutunian_V, Zhou_YL, Elder_G, Li_C, Lazzarini_RA. (1996) Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene .1. MOLECULAR BRAIN RESEARCH, 1996, Vol.42, No.1, pp.62-70
Harper, C. G.; Buck, D.; Gonatas, N. K.; Guilbert, B.; Avrameas, S. (1979) Skin fibroblast microtubular network in Alzheimer disease. Ann. Neurol. 6: 548-552
Harper, SJ, Wilkie, N (2003) MAPKs:
new targets for neurodegeneration. EXPERT OPINION ON THERAPEUTIC TARGETS 7:
187-200
Harris,
FM, Brecht, WJ, Xu, Q, Mahley, RW, Huang, YD (2004) Increased
tau phosphorylation in apolipoprotein E4 transgenic mice is associated with
activation of extracellular signal-regulated kinase - Modulation by zinc.
JOURNAL OF BIOLOGICAL CHEMISTRY 279: 44795-44801
Harris, K.A., Oyler, G.A., Doolittle, G.M., Vincent, I., Lehman, R.A.W., Kincaid, R.L. and Billingsley, M.L. (1993) Okadaic acid induces hyperphosphorylated forms of Tau protein in human brain slices. Ann. Neurol. 32: 635-645
Harris, PLR, Zhu, XW, Pamies, C, Rottkamp, CA, Ghanbari, HA, McShea, A, Feng, Y, Ferris, DK and Smith, MA (2000) Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. NEUROBIOLOGY OF AGING 21: 837-841
Hartig, W, Klein, C, Brauer, K, Schuppel, KF, Arendt, T, Bigl, V and Bruckner, G (2001) Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison. NEUROBIOLOGY OF AGING 22: 25-33
Hartlage-Rubsamen, M, Apelt, J and Schliebs, R (2001) Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology. NEUROSCIENCE LETTERS 302: 73-76
Hartman, RE, Wozniak, DF, Nardi, A, Olney, JW, Sartorius, L and Holtzman, DM (2001) Behavioral phenotyping of GFAP-ApoE3 and-ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. EXPERIMENTAL NEUROLOGY 170: 326-344
Hartmann D (2001) From Alzheimer's disease to skin tumors: The catenin connection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 10522-10523
Hartmann, D, Tournoy, J, Saftig, P, Annaert, W, De Strooper, B (2001) Implication of APP secretases in notch signaling. JOURNAL OF MOLECULAR NEUROSCIENCE 17: 171-181
Hartmann, T (2001) Cholesterol, A beta and Alzheimer's disease. TRENDS IN NEUROSCIENCES 24: S45-S48
Hartzler, AW, Zhu, XW, Siedlak, SL,
Castellani, RJ, Avila, J, Perry, G, Smith, MA (2002) The p38 pathway is activated in Pick disease and
progressive supranuclear palsy: a mechanistic link between mitogenic pathways,
oxidative stress, and tau
Hashemzadeh-Bonehi L, Phillips RG, Cairns NJ, Mosaheb S, Thorpe JR (2006) Pin1 protein associates with neuronal lipofuscin: potential consequences in age-related neurodegeneration. Experimental Neurology 199: 328-338
Hashiguchi, M, Saito, T, Hisanaga,
S, Hashiguchi, T (2002) Truncation of CDK5 activator p35 induces intensive
phosphorylation of Ser(202)/Thr(205) of human tau
Hashiguchi, M, Sobue, K and Paudel, HK (2000) 14-3-3 zeta is an effector of tau protein phosphorylation. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 25247-25254
Hashimoto, M, Sagara, Y, Langford, D, Everall, IP, Mallory, M, Everson, A, Digicaylioglu, M, Masliah, E (2002) Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3 beta pathway - Implications for neuroprotection. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 32985- 32991
Hashimoto, M, Yasuda, M, Tanimukai, S, Matsui, M, Hirono, N, Kazui, H, Mori, E (2001) Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. NEUROLOGY 57: 1461-1466
Hashimoto, N, Takeuchi, T, Ishihara, R, Ukai, K,
Kobayashi, H, Iwata, H, Iwai, K, Mizuno, Y, Yamaguchi, H, Shibayama, H (2003)
Glial fibrillary tangles in diffuse neurofibrillary tangles with calcification.
ACTA NEUROPATHOLOGICA 106: 150-156
Hashimoto_R, Nakamura_Y, Tsujio_I, Tanimukai_H, Kudo_T, Takeda_M. (1999) Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, Vol.53, No.5, pp.587-591
Hashimoto,
Y, Tsuji, O, Niikura, T, Yamagishi, Y, Ishizaka, M, Kawasumi, M, Chiba, T,
Kanekura, K, Yamada, M, Tsukamoto, E, Kouyama, K, Terashita, K, Aiso, S, Lin, A,
Nishimoto, I (2003)
Involvement
of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell
death. JOURNAL OF NEUROCHEMISTRY 84: 864-877
Hashimoto, Y, Jiang, H, Niikura, T, Ito, Y, Hagiwara, A, Umezawa, K, Abe, Y, Murayama, Y and Nishimoto, I (2000) Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. JOURNAL OF NEUROSCIENCE 20: 8401-8409
Hashimoto, Y, Niikura, T, Ito, Y and Nishimoto, I (2000) Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 34541-34551
Hass, S, Weidemann, A, Utermann, G and Baier, G (2001) Intracellular apolipoprotein E affects amyloid precursor protein processing and amyloid A beta production in COS-1 cells. MOLECULAR GENETICS AND GENOMICS 265: 791-800
Hata, R, Masumura, M, Akatsu, H, Li, F, Fujita, H, Nagai, Y, Yamamoto, T, Okada, H, Kosaka, K, Sakanaka, M and Sawada, T (2001) Up-regulation of calcineurin A beta mRNA in the Alzheimer's disease brain: Assessment by cDNA microarray. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 284: 310-316
Hattori, M, Hashizume, Y, Yoshida, M, Iwasaki, Y,
Hishikawa, N, Ueda, R, Ojika, K (2003)
Distribution of astrocytic plaques in the corticobasal degeneration brain and
comparison with tuft-shaped astrocytes in the progressive supranuclear palsy
brain. ACTA NEUROPATHOLOGICA 106: 143-149
Haugabook, SJ, Le, T, Yager, D, Zenk, B, Healy, BM, Eckman, EA, Prada, C, Younkin, L, Murphy, P, Pinnix, I, Onstead, L, Sambamurti, K, Golde, TE, Dickson, D, Younkin, SG and Eckman, CB (2001) Reduction of A beta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin. FASEB JOURNAL b15: 16-18
Haupt,
Y (2004)
p53 regulation - A family affair – Introduction. CELL CYCLE 3: 884-885
He, JQ, Lau, AG, Yaffe, MB, Hall, RA (2001) Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 41559-41565
He, LM, Chen, LY, Lou, XL, Qu, AL, Zhou, Z, Xu, T (2002) Evaluation of beta-amyloid peptide 25-35 on calcium homeostasis in cultured rat dorsal root ganglion neurons. BRAIN RESEARCH 939: 65-75
Head, E, Lott, IT, Cribbs, DH,
Cotman, CW, Rohn, TT (2002) beta-amyloid deposition and neurofibrillary tangle
association with caspase activation in Down syndrome
Heber, S, Herms, J, Gajic, V, Hainfellner, J, Aguzzi, A, Rulicke, T, Kretzschmar, H, von Koch, C, Sisodia, S, Tremml, P, Lipp, HP, Wolfer, DP and Muller, U (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. JOURNAL OF NEUROSCIENCE 20: 7951-7963
Hebert, LE, Scherr, PA, McCann, JJ, Beckett, LA and Evans, DA (2001) Is the risk of developing Alzheimer's disease greater for women than for men? AMERICAN JOURNAL OF EPIDEMIOLOGY 153: 132-136
Heckmann,
JM, Low, WC, de Villiers, C, Rutherfoord, S, Vorster, A, Rao, H, Morris, CM,
Ramesar, RS, Kalaria, RN (2004)
Novel presenilin 1 mutation with profound neurofibrillary pathology in an
indigenous Southern African family with early-onset Alzheimer's disease. BRAIN
127: 133-142
Heckmann, JM, Low, WC, Morris, CM, de Villiers, C,
Rutherfoord, S, Ramesar, R, Kalaria, R (2003)
Novel presenilin 1 mutation with profound neurofibrillary pathology in an
indigenous South African (Xhoas) family with early onset familial Alzheimer's
disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 74: 040
Heese,
K, Inoue, N, Nagai, Y, Sawada, T (2004)
APP, NGF & the 'Sunday-driver' in a trolley on the road. RESTORATIVE
NEUROLOGY AND NEUROSCIENCE 22: 131-136
Heese,
K, Nagai, Y, Sawada, T (2003)
Comparative
gene identification-94 - A pivotal regulator of apoptosis. NEUROSCIENCE 116:
321-324
Heininger, K (2000) A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. REVIEWS IN THE NEUROSCIENCES 11: 213-328
Heintz, N.; Zoghbi, H. (1997) Alpha-synuclein--a link between Parkinson and Alzheimer diseases? Nature Genet. 16: 325-327
Helbecque, N, Abderrhamani, A, Meylan, L, Riederer, B,
Mooser, V, Miklossy, J, Delplanque, J, Boutin, P, Nicod, P, Haefliger, JA,
Cottel, D, Amouyel, P, Froguel, P, Waeber, G (2003)
Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter
variant is associated with Alzheimer's disease. MOLECULAR PSYCHIATRY 8: 413-422
Helbecque, N, Berr, C, Cottel, D, Fromentin-David, I, Sazdovitch, V, Ricolfi, F, Ducimetiere, P, Di Menza, C and Amouyel, P (2001) VLDL receptor polymorphism, cognitive impairment, and dementia. NEUROLOGY 56: 1183-1188
Hendriksen, JVRB, Nottet, HSLM, Smits, HA (2002) Secretases as targets for drug design in Alzheimer's disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 32: 60-68
Heneka, MT and Feinstein, DL (2001) Expression and function of inducible nitric oxide synthase in neurons. JOURNAL OF NEUROIMMUNOLOGY 114: 8-18
Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, Kullertz G, Fischer G (1998) Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37: 5953-5960
Hernandez, F, Borrell, J, Guaza, C,
Avila, J, Lucas, JJ (2002) Spatial learning deficit in transgenic mice that
conditionally over-express GSK-3 beta in the brain but do not form tau filaments
Hernandez,
F, Cuadros, R, Avila, J (2004)
Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers.
NEUROSCIENCE LETTERS 357: 143-146
Hernandez,
F, Lucas, JJ, Cuadros, R, Avila, J (2003)
GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are
present in different tau isoforms. NEUROBIOLOGY OF AGING 24: 1087-1094
Hernandez,
F, Perez, M, Lucas, JJ, Mata, AM, Bhat, R, Avila, J (2004)
Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and
intranuclear distribution of SC35 - Implications for Alzheimer's disease.
JOURNAL OF BIOLOGICAL CHEMISTRY 279: 3801-3806
Herreman, A, Hartmann, D, Annaert, W, Saftig, P, Craessaerts, K, Serneels,
L, Umans, L, Schrijvers, V, Checler, F, Vanderstichele,
H, Baekelandt, V, Dressel, R, Cupers, P, Huylebroeck, D, Zwijsen,
A, Van Leuven, F and De Strooper, B (1999) Presenilin 2
deficiency causes a mild pulmonary phenotype and no changes
in amyloid precursor protein processing but enhances the embryonic
lethal phenotype of presenilin 1 deficiency. PROCEEDINGS OF THE
NATIONAL ACADEMY OF SCIENCES OF THE UNITED
STATES OF AMERICA 96: 11872-11877
Herreman, A, Van Gassen, G, Bentahir, M, Nyabi, O,
Craessaerts, K, Mueller, U, Annaert, W, De Strooper, B (2003)
gamma-Secretase activity requires the presenilin-dependent trafficking of
nicastrin through the Golgi apparatus but not its complex glycosylation. JOURNAL
OF CELL SCIENCE 116: 1127-1136
Herrmann H and Aebi U (2000) Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 12: 79-90
Herrup,
K, Neve, R, Ackerman, SL, Copani, A (2004)
Divide and die: Cell cycle events as triggers of nerve cell death. JOURNAL OF
NEUROSCIENCE 24: 9232-9239
Herrup, K, Yang, Y (2001) Pictures in molecular medicine - Contemplating Alzheimer's disease as cancer: a loss of cell-cycle control. TRENDS IN MOLECULAR MEDICINE 7: 527
Hershko,
T, Chaussepied, M, Oren, M, Ginsberg, D (2005) Novel
link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally
upregulated by E2F. CELL DEATH AND DIFFERENTIATION 12: 377-383
Heston, L. L.; White, J.(1978) Pedigrees of 30 families with Alzheimer disease: associations with defective organization of microfilaments and microtubules. Behav. Genet. 8: 315-331
Hetenyi, C, Szabo, Z, Klement, T, Datki, Z, Kortvelyesi, T, Zarandi, M, Penke, B (2002) Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 292: 931-936
Heun,
R, Bonsignore, M (2004)
No evidence for a genetic relationship between Alzheimer's disease and
longevity. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 18: 1-5
Higuchi, M, Ishihara, T, Zhang, B, Hong, M, Andreadis, A, Trojanowski, JQ, Lee, VMY (2002) Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. NEURON 35; 433-446
Higuchi, M, Lee, VMY, Trojanowski,
JQ (2002) Tau and axonopathy in neurodegenerative disorders
Higuchi, S, Yoshino, A, Matsui, T, Matsushita, S, Satoh, A, Iimura, T, Ishikawa, M, Arai, H and Shirakura, K (2000) A novel PS1 mutation (W165G) in a Japanese family with early-onset Alzheimer's disease. ALZHEIMERS REPORTS 3: 227-231
Hill, DA, Gridley, G, Cnattingius, S, Mellemkjaer, L,
Linet, M, Adami, HO, Olsen, JH, Nyren, O, Fraumeni, JF (2003)
Mortality and cancer incidence among individuals with Down syndrome. ARCHIVES OF
INTERNAL MEDICINE 163: 705-711
HILTON_DA, LOVE_S, FERGUSON_I, NEWMAN_P. (1995) MOTOR-NEURON DISEASE WITH NEUROFIBRILLARY TANGLES IN A NON-GUAMANIAN PATIENT. ACTA NEUROPATHOLOGICA, 1995, Vol.90, No.1, pp.101-106
Hirai, K, Aliev, G, Nunomura, A, Fujioka, H, Russell, RL, Atwood, CS, Johnson, AB, Kress, Y, Vinters, HV, Tabaton, M, Shimohama, S, Cash, AD, Siedlak, SL, Harris, PLR, Jones, PK, Petersen, RB, Perry, G and Smith, MA (2001) Mitochondrial abnormalities in Alzheimer's disease. JOURNAL OF NEUROSCIENCE 21: 3017-3023
Hiraoka,
S, Yao, TM, Minoura, K, Tomoo, K, Sumida, M, Taniguchi, T, Ishida, T (2004)
Conformational transition state is responsible for assembly of
microtubule-binding domain of tau protein. BIOCHEMICAL AND BIOPHYSICAL RESEARCH
COMMUNICATIONS 315: 659-663
Hirose, Y and Manley, TL (2000) RNA polymerase II and the integration of nuclear events. GENES & DEVELOPMENT 14: 1415-1429
Hisanaga,
S, Saito, T (2003)
The regulation of cyclin-dependent kinase 5 activity through the metabolism of
p35 or p39 Cdk5 activator. NEUROSIGNALS 12: 221-229
Hishikawa, N, Hashizume, Y, Ujihira, N, Okada, Y,
Yoshida, M, Sobue, G (2003) alpha-synuclein-positive structures in
association with diffuse neurofibrillary tangles with calcification.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 29: 280-287
Hitomi,
J, Katayama, T, Eguchi, Y, Kudo, T, Taniguchi, M, Koyama, Y, Manabe, T,
Yamagishi, S, Bando, Y, Imaizumi, K, Tsujimoto, Y, Tohyama, M (2004)
Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A
beta-induced cell death. JOURNAL OF CELL BIOLOGY 165: 347-356
Hock, C, Konietzko, U,
Papassotiropoulos, A, Wollmer, A, Streffer, J, von Rotz, RC, Davey, G, Moritz,
E, Nitsch, RM (2002) Generation of antibodies specific for beta-amyloid by
vaccination of patients with Alzheimer disease
Hoerndli,
FJ, Toigo, M, Schild, A, Gotz, J, Day, PJ (2004)
Reference genes identified in SH-SY5Y cells using custom-made gene arrays with
validation by quantitative polymerase chain reaction. ANALYTICAL BIOCHEMISTRY
335: 30-41
Hof_PR. (1997) Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease. EUROPEAN NEUROLOGY, 1997, Vol.37, No.2, pp.71-81
Hof,
PR, Morrison, JH (2004)
The aging brain: morphomolecular senescence of cortical circuits. TRENDS IN
NEUROSCIENCES 27: 607-613
Hogan, DB, Patterson, C (2002)
Progress in clinical neurosciences: Treatment of
Alzheimer's disease and other dementias - Review and comparison of the
cholinesterase inhibitors
Hol, EM, Roelofs, RF, Moraal, E, Sonnemans, MAF, Sluijs,
JA, Proper, EA, de Graan, PNE, Fischer, DF, van Leeuwen, FW (2003)
Neuronal expression of GFAP in patients with Alzheimer pathology and
identification of novel GFAP splice forms. MOLECULAR PSYCHIATRY 8: 786-796
Hol, EM, van Dijk, R, Gerez, L, Sluijs, JA, Hobo, B,
Tonk, MT, de Haan, A, Kamphorst, W, Fischer, DF, Benne, R, van Leeuwen, FW
(2003) Frameshifted beta-amyloid precursor protein (APP(+1)) is a secretory
protein, and the level of APP(+1) in cerebrospinal fluid is linked to Alzheimer
pathology. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 39637-39643
Holmberg, B, Johnels, B, Blennow, K, Rosengren, L
(2003) Cerebrospinal fluid a beta 42 is reduced in multiple system atrophy but
normal in Parkinson's disease and progressive supranuclear palsy. MOVEMENT
DISORDERS 18: 186-190
Holtzmam, A and Simon, EW (2000) Body temperature as a risk factor for Alzheimer's disease. MEDICAL HYPOTHESES 55: 440-444
Holtzman, DM (2001) Role of apoE/A beta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. JOURNAL OF MOLECULAR NEUROSCIENCE 17: 147-155
Holzer, M, Gartner, U, Stobe, A, Hartig, W, Gruschka,
H, Bruckner, MK, Arendt, T (2002) Inverse association of Pin1 and tau accumulation
in Alzheimer's disease hippocampus. ACTA NEUROPATHOLOGICA 104: 471-481
Holzer M, Holzapfel HP, Krohn K, Gertz HJ, Arendt T. (1999) Alterations in content and phosphorylation state of cytoskeletal proteins in the sciatic nerve during ageing and in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION 106: (7-8) 743-755 1999
Holzer, M, Rodel, L, Seeger, G, Gartner, U, Narz, F, Janke, C, Heumann, R, Arendt, T (2001) Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology. NEUROSCIENCE 105: 1041-1054
Hong,
JW, Ryu, MS, Lim, IK (2005)
Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1
binding in cytoplasm and cell death. JOURNAL OF BIOLOGICAL CHEMISTRY 280:
21256-21263
Honig, LS, Tang, MX, Albert, S, Costa, R, Luchsinger,
J, Manly, J, Stern, Y, Mayeux, R (2003)
Stroke and the risk of Alzheimer disease. ARCHIVES OF NEUROLOGY 60: 1707-1712
Hoozemans, JJM, Bruckner, MK, Rozemuller, AJM, Veerhuis, R, Eikelenboom, P, Arendt, T (2002) Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 678-688
Hope, AD, de Silva, R, Fischer, DF, Hol, EM, van
Leeuwen, FW, Lees, AJ (2003) Alzheimer's associated variant ubiquitin causes
inhibition of the 26S proteasome and chaperone expression. JOURNAL OF
NEUROCHEMISTRY 86: 394-404
Horiguchi,
T, Uryu, K, Giasson, BI, Ischiropoulos, H, LightFoot, R, Bellmann, C, Richter-Landsberg,
C, Lee, VMY, Trojanowski, JQ (2003)
Nitration of tau protein is linked to neurodegeneration in tauopathies. AMERICAN
JOURNAL OF PATHOLOGY 163: 1021-1031
Horsburgh, K, McCulloch, J, Nilsen, M, Roses, AD and Nicoll, JAR (2000) Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. EUROPEAN JOURNAL OF NEUROSCIENCE 12: 4309-4317
Hoshi, M, Sato, M, Matsumoto, S, Noguchi, A, Yasutake,
K, Yoshida, N, Sato, K (2003) Spherical aggregates of beta-amyloid (amylospheroid)
show high neurotoxicity and activate tau protein kinase I/glycogen synthase
kinase-3 beta. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED
STATES OF AMERICA 100: 6370-6375
HOSOI_T, UCHIYAMA_M, OKUMURA_E, SAITO_T, ISHIGURO_K, UCHIDA_T, OKUYAMA_A, KISHIMOTO_T, HISANAGA_S. (1995) EVIDENCE FOR CDK5 AS A MAJOR ACTIVITY PHOSPHORYLATING TAU-PROTEIN IN PORCINE BRAIN EXTRACT. JOURNAL OF BIOCHEMISTRY, 1995, Vol.117, No.4, pp.741-749
Houlden, H, Baker, M, McGowan, E, Lewis, P, Hutton, M, Crook, R, Wood, NW, Kumar-Singh, S, Geddes, J, Swash, M, Scaravilli, F, Holton, JL, Lashley, T, Tomita, T, Hashimoto, T, Verkkoniemi, A, Kalimo, H, Somer, M, Paetau, A, Martin, JJ, Van Broeckhoven, C, Golde, T, Hardy, J, Haltia, M and Revesz, T (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. ANNALS OF NEUROLOGY 48: 806-808
Houlden, H, Baker, M, Morris, HR, MacDonald, N, Pickering-Brown, S, Adamson, J, Lees, AJ, Rossor, MN, Quinn, NP, Kertesz, A, Khan, MN, Hardy, J, Lantos, PL, George-Hyslop, PS, Munoz, DG, Mann, D, Lang, AE, Bergeron, C, Bigio, EH, Litvan, I, Bhatia, KP, Dickson, D, Wood, NW, Hutton, M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. NEUROLOGY 56: 1702-1706
Houlden, H, Crook, R, Dolan, RJ, McLaughlin, J, Revesz, T, Hardy, J (2001) A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies. NEUROSCIENCE LETTERS 313: 93-95
Howlett, DR, Simmons, DL, Dingwall, C and Christie, G (2000) In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase. TRENDS IN NEUROSCIENCES 23: 565-570
Hsu, JJ, Chiang, CH, Hsieh, CC, Hsieh, TT (2003)
Elevated second-trimester maternal serum inhibin a levels in Asian pregnancies
with fetal down syndrome and other chromosomal abnormalities. FETAL DIAGNOSIS
AND THERAPY 18: 105-110
Hsu, LJ, Sagara, Y, Arroyo, A, Rockenstein, E, Sisk, A, Mallory, M, Wong, J, Takenouchi, T, Hashimoto, M and Masliah, E (2000) alpha-synuclein promotes mitochondrial deficit and oxidative stress AMERICAN JOURNAL OF PATHOLOGY 157: 401-410
Hsu T, McRackan D, Vincent TS and H. Gert de Couet (2001) Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nature Cell Biology 3: 538 - 543
Hu, CJ, Sung, SM, Liu, HC, Hsu, WC, Lee, LS, Lee, CC, Tsai, CH and Chang, JG (2000) Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan. JOURNAL OF THE NEUROLOGICAL SCIENCES 181: 127-131
Hu,
H, Columbus, J, Zhang, Y, Wu, DY, Lian, LB, Yang, S, Goodwin, J, Luczak, C,
Carter, M, Chen, L, James, M, Davis, R, Sudol, M, Rodwell, J, Herrero, JJ (2004)
A map of WW domain family interactions. PROTEOMICS 4: 643-655
Hu, YY, He, SS, Wang, XC, Duan, QH, Grundke-Iqbal, I, Iqbal, K, Wang, JZ (2002) Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients – An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay. AMERICAN JOURNAL OF PATHOLOGY 160: 1269-1278
Hu, YY, He, SS, Wang, XC, Duan, QH, Khatoon, S, Iqbal, K, Grundke-Iqbal, I, Wang, JZ (2002) Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. NEUROSCIENCE LETTERS 320: 156-160
Huang, HK, Forsburg, SL, John, UP, O'Connell, MJ, Hunter, T (2001) Isolation and characterization of the Pin1/Ess1p homologue in Schizosaccharomyces pombe. JOURNAL OF CELL SCIENCE 114: 3779-3788
Huang, N, Marie, SK, Livramento, JA, Chammas, R,
Nitrini, R (2003) 14-3-3 protein in the CSF of patients with rapidly
progressive dementia. NEUROLOGY 61: 354-357
Huang, THJ, Yang, DS, Fraser, PE and Chakrabartty, A (2000) Alternate aggregation pathways of the Alzheimer beta-amyloid peptide - An in vitro model of preamyloid. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 36436-36440
Huang_Y, Herman_MM, Liu_J, Katsetos_CD, Wills_MR, Savory_J. (1997) Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha(1)-antichymotrypsin and ubiquitin-protein conjugates. BRAIN RESEARCH, 1997, Vol.771, No.2, pp.213-220
Huang, YD, Liu, XQ, Wyss-Coray, T, Brecht, WJ, Sanan, DA and Mahley, RW (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 8838-8843
Huang, YD, Weisgraber, KH, Mucke, L, Mahley, RW (2004) Apolipoprotein E. JOURNAL OF MOLECULAR NEUROSCIENCE 23: 189-204
Huber, G, Marz, W, Martin, JR, Malherbe, P, Richards, JG, Sueoka, N, Ohm, T and Hoffmann, MM (2000) Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R). NEUROSCIENCE 101: 211-218
Huc_C, Escurat_M, Djabali_K, Derer_M, Landon_F, Gros_F, Portier_MM. (1989) Phosphorylation Of Peripherin, An Intermediate Filament Protein, In Mouse Neuro-Blastoma Nie-115 Cell-Line And In Sympathetic Neurons. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, Vol.160, No.2, pp.772-779
Hugon, J., Sindou, P., Lesort, M., Couratier, P., Esclaire, F. and Yardin, C. (1995) Modifications of phosphorylated tau immunoreactivity linked to excitotoxicity in neuronal cultures. pp. 172-179 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.
Huse, JT and Doms, RW (2001) Closing in on the amyloid cascade recent insights into the cell biology of Alzheimer's disease. MOLECULAR NEUROBIOLOGY 22: 81-98
Huse, JT, Liu, KN, Pijak, DS, Carlin, D, Lee, VMY, Doms, RW (2002)
beta-secretase processing in the trans-Golgi network preferentially
generates truncated amyloid species that accumulate in Alzheimer's
disease brain. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 16278-16284
Huse, JT, Pijak, DS, Leslie, GJ, Lee, VMY and Doms, RW (2000) Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme - The Alzheimer's disease beta-secretase. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 33729-33737
Hussain, I, Powell, DJ, Howlett, DR, Chapman, GA, Gilmour, L, Murdock, PR, Tew, DG, Meek, TD, Chapman, C, Schneider, K, Ratcliffe, SJ, Tattersall, D, Testa, TT, Southan, C, Ryan, DM, Simmons, DL, Walsh, FS, Dingwall, C and Christie, G (2000) ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. MOLECULAR AND CELLULAR NEUROSCIENCE 16: 609-619
Husseman, JW, Hallows, JL, Bregman, DB, Leverenz, JB, Nochlin, D, Jin, LW, Vincent, I (2001) Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 1219-1232
Husseman, JW, Nochlin, D and Vincent, I (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. NEUROBIOLOGY OF AGING 21: 815-828
Hutchins,
JRA, Clarke, PR (2004)
Many fingers on the mitotic trigger - Post-translational regulation of the
Cdc25C phosphatase. CELL CYCLE 3: 41-45
Hutton, M (2000) Molecular genetics of chromosome 17 tauopathies. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 63-73
Hutton, M (2001) Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. NEUROLOGY 56: S21-S25
Hutton, M.; Lendon, C. L.; Rizzu, P.; Baker, M.; Froelich, S.; Houlden, H.; Pickering-Brown, S.; Chakraverty, S.; Isaacs, A.; Grover, A.; Hackett, J.; Adamson, J.; and 39 others: (1998) Association of missense and 5-prime-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705
Hwang_SR, Steineckert_B, Kohn_A, Palkovits_M, Hook_VYH (1999) Molecular studies define the primary structure of alpha(1)-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brains - Comparison of ACT in hippocampus and liver JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, Vol.274, No.3, pp.1821-1827
Hyde, LA, Frisone, DF and Crnic, LS (2001) Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. BEHAVIOURAL BRAIN RESEARCH 118: 53-60
Hyman,
BT, Augustinack, JC, Ingelsson, M (2005)
Transcriptional and conformational changes of the tau molecule in Alzheimer's
disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 150-157
Hyman BT; Strickland D; Rebeck GW.(2000) Role of the low-density
lipoprotein receptor-related protein in beta-amyloid metabolism
and Alzheimer disease. Arch Neurol, 2000 May, 57:5, 646-50
| I |
Ihara, Y, Hayabara, T, Sasaki, K, Kawada, R, Nakashima, Y and Kuroda, S (2000) Relationship between oxidative stress and apoE phenotype in Alzheimer's disease. ACTA NEUROLOGICA SCANDINAVICA 102: 346-349
Iida, T, Furuta, A, Nakabeppu, Y, Iwaki, T (2004) Defense mechanism to oxidative DNA damage in glial cells. NEUROPATHOLOGY 24: 125-130
Iivonen,
S, Corder, E, Lehtovirta, M, Helisalmi, S, Mannermaa, A, Vepsalainen, S,
Hanninen, T, Soininen, H, Hiltunen, M (2004)
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease.
NEUROLOGY 62: 1170-1176
Ikeda, E, Shiba, K, Mori, H, Ichikawa, A, Sumiya, H, Kuji, I and Tonami, N (2000) Reduction of vesicular acetylcholine transporter in beta-amyloid protein-infused rats with memory impairment. NUCLEAR MEDICINE COMMUNICATIONS 21: 933-937
Ikeda, K, Akiyama, H, Arai, T, Tsuchiya, K (2002) Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease. ACTA NEUROPATHOLOGICA 103: 115-118
Ikeda, K, Akiyama, H, Arai, T, Ueno, H, Tsuchiya, K, Kosaka, K (2002) Morphometrical reappraisal of motor neuron system of Pick's disease and amyotrophic lateral sclerosis with dementia. ACTA NEUROPATHOLOGICA 104: 21-28
Ikeda,
M, Shoji, M, Kawarai, T, Kawarabayashi, T, Matsubara, E, Murakami, T, Sasaki, A,
Tomidokoro, Y, Ikarashi, Y, Kuribara, H, Ishiguro, K, Hasegawa, M, Yen, SH,
Chishti, MA, Harigaya, Y, Abe, K, Okamoto, K, George-Hyslop, PS, Westaway, D
(2005)
Accumulation of filamentous tau in the cerebral cortex of human tau R406W
transgenic mice. AMERICAN JOURNAL OF PATHOLOGY 166: 521-531
Ikeda S; Yanagisawa N; Allsop D; Glenner GG. (1990) Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol, 1990 Dec, 21:12, 1221-6
Ikeuchi, T, Sisodia, SS (2003)
The notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent
"gamma-secretase" cleavage. JOURNAL OF BIOLOGICAL CHEMISTRY 278:
7751-7754
Illenberger, S, Zheng-Fischhofer, QY, Preuss, U, Stamer, K, Baumann, K, Trinczek, B, Biernat, J, Godemann, R, Mandelkow, EM and Mandelkow, E (1998) The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's disease. MOLECULAR BIOLOGY OF THE CELL 9: 1495-1512
Imahori, K and Uchida, T (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. JOURNAL OF BIOCHEMISTRY (Tokyo) 121: 179-188
Inestrosa, NC, Alvarez, A, Godoy, J, Reyes, A and De Ferrari, GV (2000) Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in A beta neurotoxicity. ACTA NEUROLOGICA SCANDINAVICA 102: 53-59
Ingelson, M, Fabre, SF, Lilius, L, Andersen, C, Viitanen, M, Almkvist, O, Wahlund, LO and Lannfelt, L (2001) Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon 4. NEUROREPORT 12: 905-909
Ingelsson, M, Fukumoto, H, Newell, KL, Growdon, JH, Hedley-Whyte, ET, Frosch, MP, Albert, MS, Hyman, BT, Irizarry, MC (2004) Early A beta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. NEUROLOGY 62: 925-931
Ingelson_M, Vanmechelen_E, Lannfelt_L (1996) Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation NEUROSCIENCE LETTERS, 1996, Vol.220, No.1, pp.9-12
Ingram, DK (2001) Vaccine development for Alzheimer's disease: a shot of good news. TRENDS IN NEUROSCIENCES 24: 305-307
Ingram, EM, Spillantini, MG (2002)
Tau gene mutations: dissecting the pathogenesis of
FTDP-17
Iqbal, K, Alonso, AD, El-Akkad, E, Gong, CX, Haque, N, Khatoon, S, Tsujio, I, Grundke-Iqbal, I (2002) Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration
Iqbal,
K, Alonso, ADC, Chen, S, Chohan, MO, El-Akkad, E, Gong, CX, Khatoon, S, Li, B,
Liu, F, Rahman, A, Tanimukai, H, Grundke-Iqbal, I (2005)
Tau pathology in Alzheimer disease and other tauopathies. BIOCHIMICA ET
BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 198-210
Iqbal K, Alonso ADC, Gong, C-X, Khatoon PJ-J, Wang JZ, Grundke-Iqbal I (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm Suppl 53: 169-180
Iqbal K, Alonso ADC, Smith AJ, George L, Tung Y-C, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci 86: 5646-5650
Iqbal,
K, Grundke-Iqbal, I (2004)
Inhibition of neurofibrillary degeneration: A promising approach to Alzheimer's
disease and other tauopathies. CURRENT DRUG TARGETS 5: 495-502
Iseki_E, Odawara_T, Li_F, Kosaka_K, Nishimura_T, Akiyama_H, Ikeda_K. (1996) Age-related ubiquitin-positive granular structures in non-demented subjects and neurodegenerative disorders. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, Vol.142, No.1-2, pp.25-29
Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K (1992) Tau protein kinase-I converts normal tau protein into a68-like component of paired helical filaments. J Biol Chem 267: 10897-10901
Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee V. M.-Y (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24: 751-762
Ishihara, T, Zhang, B, Higuchi, M, Yoshiyama, Y, Trojanowski, JQ and Lee, VMY (2001) Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. AMERICAN JOURNAL OF PATHOLOGY 158: 555-562
Ishimaru, D, Andrade, LR, Teixeira, LSP, Quesado, PA,
Maiolino, LM, Lopez, PM, Cordeiro, Y, Costa, LT, Heckl, WM, Weissmuller, G,
Foguel, D, Silva, JL (2003) Fibrillar aggregates of the tumor suppressor p53
core domain. BIOCHEMISTRY 42: 9022-9027
Ishizawa, K, Dickson, DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 647-657
Ishizawa, T, Ko, LW, Cookson, N,
Davies, P, Espinoza, M, Dickson, DW (2002) Selective neurofibrillary degeneration of the
hippocampal CA2 sector is associated with four-repeat tauopathies
Ishizawa, T, Mattila, P, Davies, P, Wang, DS, Dickson,
DW (2003) Colocalization of tau and alpha-synuclein epitopes in
Lewy bodies. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 62: 389-397
Ishizawa,
T, Sahara, N, Ishiguro, K, Kersh, J, McGowan, E, Lewis, J, Hutton, M, Dickson,
DW, Yen, SH (2003)
Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and
granulovacuolar degeneration in transgenic mice. AMERICAN JOURNAL OF PATHOLOGY
163: 1057-1067
Israely,
I, Costa, RM, Xie, CW, Silva, AJ, Kosik, KS, Liu, X (2004)
Deletion of the neuron-specific protein delta-catenin leads to severe cognitive
and synaptic dysfunction. CURRENT BIOLOGY 14: 1657-1663
Itzhaki,
RE, Wozniak, MA, Appelt, DM, Balin, B (2004)
Infiltration of the brain by pathogens causes Alzheimer's disease. NEUROBIOLOGY
OF AGING 25: 619-627
Iwai, A (2000) Properties of NACP/alpha-synuclein and its role in Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1502: 95-109
Iwai, A, Masliah, E, Yoshimoto, M, Ge, NF, Flanagan, L, Desilva, HAR, Kittel, A and Saitoh, T (2000) The precursor protein of non-a-beta component of alzheimers-disease amyloid is a presynaptic protein of the central-nervous-system. NEURON 14: 467-475
Izumiyama N; Asami E; Itoh Y; Ohtsubo K. (1990) Alzheimer's neurofibrillary
tangles and paired helical filaments in the pheochromocytoma
cells of the adrenal medulla--electron microscopic and
immunoelectron microscopic observations. Acta Neuropathol
(Berl), 1990, 81:2, 213-6
| J |
Jack, C, Berezovska, O, Wolfe, MS and Hyman, BT (2001) Effect of PS1 deficiency and an APP gamma-secretase inhibitor on Notch1 signaling in primary mammalian neurons. MOLECULAR BRAIN RESEARCH 87: 166-174
Jackson, GR, Wiedau-Pazos, M, Sang, TK, Wagle, N, Brown, CA, Massachi, S, Geschwind, DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. NEURON 34: 509-519
Jackson,
MW, Agarwal, MK, Agarwal, ML, Agarwal, A, Stanhope-Baker, P, Williams, BRG,
Stark, GR (2004)
Limited role of N-terminal phosphoserine residues in the activation of
transcription by p53. ONCOGENE 23: 4477-4487
Jacobs, DM, Saxena, K, Grimme, S, Vogtherr, M, Pescatore, B, Langer, T, Elshorst, B, Fiebig, KM (2002) Letter to the editor: H-1, C-13 and N-15 backbone resonance assignment of the peptidyl-prolyl cis-trans isomerase Pin1. JOURNAL OF BIOMOLECULAR NMR 23: 163-164
Jacobs, DM, Saxena, K, Vogtherr, M, Bernado, P, Pons,
M, Fiebig, KM (2003) Peptide binding induces large scale changes in
inter-domain mobility in human Pin1. JOURNAL OF BIOLOGICAL CHEMISTRY 278:
26174-26182
Jaffar, S, Counts, SE, Ma, SY, Dadko, E, Gordon, MN, Morgan, D and Mufson, EJ (2001) Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: Alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. EXPERIMENTAL NEUROLOGY 170: 227-243
James_ND, Davis_DR, Sindon_J, Hanger_DP, Brion_JP, Miller_CCJ, Rosenberg_MP, Anderton_BH, Propst_F. (1996) Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine threonine kinase Mos. NEUROBIOLOGY OF AGING, 1996, Vol.17, No.2, pp.235-241
James,
VJ, Richardson, JC, Robertson, TA, Papadimitriou, JM, Dutton, NS, Maley, MAL,
Berstein, LM, Lantseva, OE, Martins, RN (2005) Fibre
diffraction of hair can provide a screening test for Alzheimer's Disease: a
human and animal model study. MEDICAL SCIENCE MONITOR 11: CR53-CR57
Jamsa,
A, Hasslund, K, Cowburn, RF, Backstrom, A, Vasange, M (2004)
The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y
cell line as a model for Alzheimer's disease-like tau phosphorylation.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319: 993-1000
Jang, JH, Surh, YJ (2002)
beta-amyloid induces oxidative DNA damage and cell
death through activation of c-Jun N terminal kinase
Janicki_SM, Monteiro_MJ. (1999) Presenilin overexpression arrests cells in the G1 phase of the cell cycle - Arrest potentiated by the Alzheimer's disease PS2(N141I) mutant. AMERICAN JOURNAL OF PATHOLOGY, 1999, Vol.155, No.1, pp.135-144
Janicki, SM, Stabler, SM and Monteiro, MJ (2000) Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. NEUROBIOLOGY OF AGING 21: 829-836
Jankowsky,
JL, Slunt, HH, Gonzales, V, Jenkins, NA, Copeland, NG, Borchelt, DR (2004) APP
processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
NEUROBIOLOGY OF AGING 25: 885-892
Jantzen, PT, Connor, KE, DiCarlo, G, Wenk, GL, Wallace, JL, Rojiani,
AM, Coppola, D, Morgan, D, Gordon, MN (2002) Microglial
activation and beta-amyloid deposit reduction caused by a nitric
oxide-releasing nonsteroidal anti-inflammatory drug in amyloid
precursor protein plus presenilin-1 transgenic mice. JOURNAL OF
NEUROSCIENCE 22: 2246-2254
Janus, C, Chishti, MA and Westaway, D (2000) Transgenic mouse models of Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1502: 63-75
Janus, C, Pearson, J, McLaurin, J, Mathews, PM, Jiang, Y, Schmidt, SD, Chishti, MA, Horne, P, Heslin, D, French, J, Mount, HTJ, Nixon, RA, Mercken, M, Bergeron, C, Fraser, PE, St George-Hyslop, P and Westaway, D (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. NATURE 408: 979-982
Janus, C, Westaway, D (2001) Transgenic mouse models of Alzheimer's disease. PHYSIOLOGY & BEHAVIOR 73: 873-886
Jellinger, KA (2001) Cell death mechanisms in neurodegeneration. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 5: 1-17
Jeong, SJ, Kim, HS, Chang, KA, Geum, DH, Park, CH, Seo, JH, Rah, JC, Lee, JH, Choi, SH, Lee, SG, Kim, K and Suh, YH (2000) Subcellular localization of presenilins during mouse preimplantation development. FASEB JOURNAL 14: 2171-2176
Jhoo, JH, Kim, KW, Lee, DY, Lee, KU, Lee, JH, Kim, SY, Youn, JY, Youn, JC and Woo, JI (2001) Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. JOURNAL OF THE NEUROLOGICAL SCIENCES 184: 21-25
Ji, SR, Wu, Y, Sui, SF (2002) Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 6273-6279
Jiang, ZH, Tang, H, Havlioglu, N, Zhang, XC, Stamm, S,
Yan, RQ, Wu, JY (2003) Mutations in tau gene exon 10 associated with
FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2
beta. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 18997-19007
Jimenez JL, Tennent G, Pepys M and Saibil HR (2001) Structural Diversity of ex vivo Amyloid Fibrils Studied by Cryo-electron Microscopy . Journal of Molecular Biology 311: 241-247
Jin,
KL, Peel, AL, Mao, XO, Xie, L, Cottrell, BA, Henshall, DC, Greenberg, DA (2004)
Increased hippocampal neurogenesis in Alzheimer's disease. PROCEEDINGS OF THE
NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101: 343-347
Jo, DG, Chang, JW, Hong, HS, Mook-Jung, I, Jung, YK
(2003) Contribution of presenilin/gamma-secretase to calsenilin-mediated
apoptosis. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 305: 62-66
Joachim, C. L.; Mori, H.; Selkoe, D. J. (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341: 226-230
Johansson, A, Hampel, H, Faltraco, F, Buerger, K,
Minthon, L, Bogdanovic, N, Sjogren, M, Zetterberg, H, Forsell, L, Lilius, L,
Wahlund, LO, Rymo, L, Prince, JA, Blennow, K (2003)
Increased frequency of a new polymorphism in the cycle 2 (cdc2) gene in patients
with Alzheimer's disease frontotemporal dementia. NEUROSCIENCE LETTERS 340:
69-73
Johnson,
GVW, Stoothoff, WH (2004) Tau
phosphorylation in neuronal cell function and dysfunction. JOURNAL OF CELL
SCIENCE 117: 5721-5729
Johnson, VJ, Sharma, RP (2003)
Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary
brain rotation-mediated aggregate cultures: Possible role in neurodegeneration.
NEUROTOXICOLOGY 24: 261-268
Johnstone_M, Goold_RG, Fischer_I, GordonWeeks_PR. (1997) The neurofilament antibody RT97 recognises a developmentally regulated phosphorylation epitope on microtubule-associated protein 1B. JOURNAL OF ANATOMY, 1997, Vol.191, No.Pt2, pp.229-244
Jones_KR, Oorschot_DE. (1998) Do aluminium and/or glutamate induce Alz-50 reactivity? A light microscopic immunohistochemical study. JOURNAL OF NEUROCYTOLOGY, 1998, Vol.27, No.1, pp.45-57
Jones_KR, Black_MJ, Oorschot_DE. (1998) Do aluminium and/or glutamate induce Alzheimer PHF-like formation? An electron microscopic study. J Neurocytol 27: 59-68 (1998)
Jonnala, RR, Terry, AV, Buccafusco, JJ (2002) Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. LIFE SCIENCES 70: 1543-1554
Jope,
RS, Johnson, GVW (2004)
The glamour and gloom of glycogen synthase kinase-3. TRENDS IN BIOCHEMICAL
SCIENCES 29: 95-102
Jordan,
J, Cena, V, Prehn, JHM (2003)
Mitochondrial control of neuron death and its role in neurodegenerative
disorders. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY 59: 129-141
Joseph,
JD, Daigle, SN, Means, AR (2004)
PINA is essential for growth and positively influences NIMA function in
Aspergillus nidulans. JOURNAL OF BIOLOGICAL CHEMISTRY 279: 32373-32384
Josephs, KA, Holton, JL, Rossor, MN, Braendgaard, H, Ozawa, T, Fox, NC, Petersen, RC, Pearl, GS, Ganguly, M, Rosa, P, Laursen, H, Parisi, JE, Waldemar, G, Quinn, NP, Dickson, DW, Revesz, T (2003) Neurofilament inclusion body disease: a new proteinopathy? BRAIN 126: 2291-2303
Josephs, KA, Ishizawa, T, Tsuboi,
Y, Cookson, N, Dickson, DW (2002) A clinicopathological study of vascular progressive
supranuclear palsy - A multi-infarct disorder presenting as progressive
supranuclear palsy
Jordan-Sciutto, KL, Malaiyandi, LM, Bowser, R (2002) Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 358-367
Judkins, AR, Forman, MS, Uryu, K, Hinkle, DA, Asbury, AK, Lee, VMY,
Trojanowski, JQ (2002) Co-occurrence of Parkinson's disease with
progressive supranuclear palsy. ACTA NEUROPATHOLOGICA 103: 526-530
Julien JP; Mushynski WE. (1998) Neurofilaments in health and disease.Prog Nucleic Acid Res Mol Biol, 1998, 61:, 1-23
Jung C; Yabe JT; Shea TB (2000) C-terminal phosphorylation of the
high molecular weight neurofilament subunit correlates
with decreased neurofilament axonal transport velocity. Brain
Res 856:12-19
| K |
Kaether, C, Lammich, S, Edbauer, D, Ertl, M, Rietdorf, J, Capell, A,
Steiner, H, Haass, C (2002) Presenilin-1 affects trafficking and processing
of beta APP and is targeted in a complex with nicastrin to the plasma membrane.
JOURNAL OF CELL BIOLOGY 158: 551-561
Kajkowski, EM, Lo, CF, Ning, XP, Walker, S, Sofia, HJ, Wang,
W, Edris, W, Chanda, P, Wagner, E, Vile, S, Ryan, K, McHendry-Rinde,
B, Smith, SC, Wood, A, Rhodes, KJ, Kennedy, JD, Bard, J, Jacobsen,
JS and Ozenberger, BA (2001) beta-amyloid peptide-induced apoptosis
regulated by a novel protein containing a G protein activation
module. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 18748-18756
Kakimura, J, Kitamura, Y, Takata,
K, Tsuchiya, D, Taniguchi, T, Gebicke-Haerter, PJ, Smith, MA, Perry, G,
Shimohama, S (2002) Possible involvement of ER chaperone Grp78 on reduced
formation of amyloid-beta deposits
Kakimura, J, Kitamura, Y, Takata, K, Umeki, M, Suzuki, S, Shibagaki,
K, Taniguchi, T, Nomura, Y, Gebicke-Haerter, PJ, Smith, MA,
Perry, G, Shimohama, S (2002)
Microglial activation and amyloid-beta clearance
induced by exogenous heat-shock proteins. FASEB JOURNAL 16:
U31-U54
Kakimura, J, Kitamura, Y, Taniguchi, T, Shimohama, S and Gebicke-Haerter, PJ (2001) BiP/GRP78-induced production of cytokines and uptake of amyloid-beta(1-42) peptide in microglia. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 281: 6-10
Kokubo,
H, Kayed, R, Glabe, CG, Yamaguchi, H (2005)
Soluble A beta oligomers ultrastructurally localize to cell processes and might
be related to synaptic dysfunction in Alzheimer's disease brain. BRAIN RESEARCH
1031: 222-228
Kalback, W, Watson, MD, Kokjohn, TA, Kuo, YM, Weiss, N, Luehrs, DC, Lopez, J, Brune, D, Sisodia, SS, Staufenbiel, M, Emmerling, M, Roher, AE (2002) APP transgenic mice Tg2576 accumulate A beta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. BIOCHEMISTRY 41: 922-928
Kamal, A, Almenar-Queralt, A, LeBlanc, JF, Roberts, EA, Goldstein, LSB (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. NATURE 414: 643-648
Kamal, A, Stokin, GB, Yang, ZH, Xia, CH and Goldstein, LSB (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. NEURON 28: 449-459
Kamenetz, F, Tomita, T, Hsieh, H, Seabrook, G, Borchelt,
D, Iwatsubo, T, Sisodia, S, Malinow, R (2003) APP processing and synaptic function. NEURON 37:
925-937
Kamimoto, T, Zama, T, Aoki, R, Muro, Y, Hagiwara, M (2001) Identification of a novel kinesin-related protein, KRMP1, as a target for mitotic peptidyl-prolyl isomerase Pin1. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 37520-37528
Kampers, T, Pangalos, M, Geerts, H, Wiech, H and Mandelkow, E (1999) Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS LETTERS 451: 39-44
Kanayama_G, Takeda_M, Niigawa_H, Ikura_Y, Tamii_H, Taniguchi_N, Kudo_T, Miyamae_Y, Morihara_T, Nishimura_T. (1996) The effects of repetitive mild brain injury on cytoskeletal protein and behavior. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1996, Vol.18, No.2, pp.105-115
Kanelis V, Farrow NA, Kay LE, Rotin D, FormanKay JD (1998) NMR studies of tandem WW domains of Nedd4 in complex with a PY motif-containing region of the epithelial sodium channel. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire 76: 341-350
Kang, CK, Jayasinha, V, Martin, PT (2003) Identification
of peptides that specifically bind A beta(1-40) amyloid in vitro and amyloid
plaques in Alzheimer's disease brain using phage display. NEUROBIOLOGY OF
DISEASE 14: 146-156
Kang DE, Soriano S, Frosch MP, Collins T, Naruse S, Sisodia SS, Leibowitz G, Levine F, Koo EH (1999) Presenilin 1 Facilitates the Constitutive Turnover of -Catenin: Differential Activity of Alzheimer's Disease-Linked PS1 Mutants in the -Catenin-Signaling Pathway. J. Neurosci. 19: 4229-4237
Kang,
HJ, Yoon, WJ, Moon, GJ, Kim, DY, Sohn, S, Kwon, HJ, Gwag, BJ (2005) Caspase-3-mediated
cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and
oxidative stress: an implication to Alzheimer's disease. NEUROBIOLOGY OF DISEASE
18: 450-458
Kang, J.; Lemaire, H.-G.; Unterbeck, A.; Salbaum, J. M.; Masters, C. L.; Grzeschik, K.-H.; Multhaup, G.; Beyreuther, K.; Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
Kanninen,
K, Goldsteins, G, Auriola, S, Alafuzoff, I, Koistinaho, J (2004) Glycosylation
changes in Alzheimer's disease as revealed by a proteomic approach. NEUROSCIENCE
LETTERS 367: 235-240
Kaplan, B, Ratner, V, Haas, E (2003)
alpha-Synuclein - Its biological function and role in neurodegenerative
diseases. JOURNAL OF MOLECULAR NEUROSCIENCE 20: 83-92
Kar, S, Fan, J, Smith, MJ, Goedert, M, Amos, LA (2003)
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol.
EMBO JOURNAL 22: 70-77
KARLSSON_JE, ROSENGREN_LE, HAGLID_KG. (1989) POLYCLONAL ANTISERA TO THE INDIVIDUAL NEUROFILAMENT TRIPLET PROTEINS - A CHARACTERIZATION USING ELISA AND IMMUNOBLOTTING. JOURNAL OF NEUROCHEMISTRY, 1989, Vol.53, No.3, pp.759-765
Kasashima, S, Oda, Y (2003)
Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of
progressive supranuclear palsy and corticobasal degeneration. ACTA
NEUROPATHOLOGICA 105: 117-124
Katayama,
H, Sasai, K, Kawai, H, Yuan, ZM, Bondaruk, J, Suzuki, F, Fujii, S, Arlinghaus,
RB, Czerniak, BA, Sen, S (2004)
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and
inhibition of p53. NATURE GENETICS 36: 55-62
Kato, N, Arai, K, Hattori, T (2003)
Study of the rostral midbrain atrophy in progressive supranuclear palsy. JOURNAL
OF THE NEUROLOGICAL SCIENCES 210: 57-60
Kato,
S, Han, SY, Liu, W, Otsuka, K, Shibata, H, Kanamaru, R, Ishioka, C (2003)
Understanding the function-structure and function-mutation relationships of p53
tumor suppressor protein by high-resolution missense mutation analysis.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
100: 8424-8429
Kato, Y, Ito, M, Kawai, K, Nagata, K, Tanokura, M (2002) Determinants of ligand specificity in Groups I and IV WW domains as studied by surface plasmon resonance and model building. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 10173-10177
Katsuse,
O, Iseki, E, Arai, T, Akiyama, H, Togo, T, Uchikado, H, Kato, M, de Silva, R,
Lees, A, Kosaka, K (2003)
4-repeat tauopathy sharing pathological and biochemical features of corticobasal
degeneration and progressive supranuclear palsy. ACTA NEUROPATHOLOGICA 106:
251-260
Katsuragi S; Miyakawa T; Ouchi K; Kuramoto R. (1991) Ultrastructure of neurofibrillary tangles in Alzheimer's disease by means of tilt-stage electron microscopy. Jpn J Psychiatry Neurol, 1991 Mar, 45:1, 91-4
Kaul, R, Angeles, AR, Jager, M, Powers, ET and Kelly, JW (2001) Incorporating beta-turns and a turn mimetic out of context in loop 1 of the WW domain affords cooperatively folded beta-sheets. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 123: 5206-5212
Kawahara, M, Kato, M and Kuroda, Y (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. BRAIN RESEARCH BULLETIN 55: 211-217
Kawahara, M and Kuroda, Y (2000) Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: Channel formation and disruption of calcium homeostasis. BRAIN RESEARCH BULLETIN 53: 389-397
Kawarabayashi, T, Younkin, LH, Saido, TC, Shoji, M, Ashe, KH and Younkin, SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid beta protein in the Tg2576 transgenic mouse model of Alzheimer's disease. JOURNAL OF NEUROSCIENCE 21: 372-381
Kawashima_M, Suzuki_SO, Dohura_K, Iwaki_T. (2000) alpha-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation. ACTA NEUROPATHOLOGICA, 2000, Vol.99, No.2, pp.154-160
Kayed, R, Head, E, Thompson, JL, McIntire, TM, Milton, SC, Cotman, CW, Glabe, CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. SCIENCE 300: 486-489
Kaytor, MD, Orr, HT (2002) The GSK3 beta signaling cascade and neurodegenerative disease. CURRENT OPINION IN NEUROBIOLOGY 12: 275-278
Kayyali_US, Zhang_W, Yee_AG, Seidman_JG, Potter_H. (1997) Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. JOURNAL OF NEUROCHEMISTRY, 1997, Vol.68, No.4, pp.1668-1678
Keck,
S, Nitsch, R, Grune, T, Ullrich, O (2003)
Proteasome inhibition by paired helical filament-tau in brains of patients with
Alzheimer's disease. JOURNAL OF NEUROCHEMISTRY 85: 115-122
Keefer, EW, Norton, SJ, Boyle, NAJ, Talesa, V and Gross, GW (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. NEUROTOXICOLOGY 22: 3-12
Kehoe, PG, Katzov, H, Feuk, L, Bennet, AM, Johansson,
B, Wiman, B, de Faire, U, Cairns, NJ, Wilcock, GK, Brookes, AJ, Blennow, K,
Prince, JA (2003) Haplotypes extending across ACE are associated with
Alzheimer's disease. HUMAN MOLECULAR GENETICS 12: 859-867
Kellersmann, J, Schmitz, B (2002) Alzheimer's disease: possible causes and promoting factors. ERNAHRUNGS-UMSCHAU 48: 312-318
Kemppainen, N, Roytta, M, Collan, Y, Ma, SY, Hinkka, S, Rinne, JO (2002) Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease. ACTA NEUROPATHOLOGICA 103: 43-47
Kerokoski, P, Soininen, H and Pirttila, T (2001) beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality. NEUROCHEMISTRY INTERNATIONAL 38: 127-134
Kerokoski, P, Suuronen, T, Salminen, A, Soininen, H and Pirttilä, T (2001) The Levels of cdk5 and p35 Proteins and Tau Phosphorylation Are Reduced during Neuronal Apoptosis. Biochem. Biophys. Res. Comm. 280: 998-1002
Kerokoski, P, Suuronen, T, Salminen,
A, Soininen, H, Pirttila, T (2002) Cleavage of the cyclin-dependent kinase 5 activator p35
to p25 does not induce tau hyperphosphorylation
Kerokoski, P, Suuronen, T, Salminen,
A, Soininen, H, Pirttila, T (2002) Influence of phosphorylation of p35, an activator of
cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35
Kertesz, A (2003)
Pick complex: An integrative approach to frontotemporal dementia - Primary
progressive aphasia, corticobasal degeneration, and progressive supranuclear
palsy. NEUROLOGIST 9: 311-317
Kertesz, A, Munoz, DG (2002) Frontotemporal dementia. MEDICAL CLINICS OF NORTH AMERICA 86: 501-520
Kertesz, A, Munoz, DG (2003) Primary progressive
aphasia and Pick complex. JOURNAL OF THE NEUROLOGICAL SCIENCES 206: 97-107
Kesavapany S,
Patel V, Zheng YL, Pareek TK, Bjelogrlic M, Albers W, Amin N, Jaffe H, Gutkind
JS, Strong MJ, Grant P, Pant HC (2007) Inhibition of Pin1 Reduces
Glutamate-induced Perikaryal Accumulation of Phosphorylated Neurofilament-H in
Neurons.
Mol Biol Cell.
Kesavapany, S, Lau, KF, Ackerley, S, Banner, SJ,
Shemilt, SJA, Cooper, JD, Leigh, PN, Shaw, CE, McLoughlin, DM, Miller, CCJ
(2003) Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent
kinase 5/p35-regulated kinase. JOURNAL OF NEUROSCIENCE 23: 4975
Kesavapany, S, Li, BS, Amin, N, Zheng, YL, Grant, P, Pant, HC (2004) Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 1697: 143-153
Kesavapany,
S, Li, BS, Pant, HC (2003)
Cyclin-dependent kinase 5 in neurofilament function and regulation. NEUROSIGNALS
12: 252-264
Kheterpal, I, Williams, A, Murphy, C, Bledsoe, B, Wetzel, R (2001) Structural features of the A beta amyloid fibril elucidated by limited proteolysis. BIOCHEMISTRY 40: 11757-11767
Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB (2006) TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model. Current Biology 16: 230–241
Ki, CS, Na, DL, Kim, DK, Kim, HJ, Kim, JW (2002) Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease. NEUROSCIENCE LETTERS 319: 75-78
Ki, CS, Na, DL, Kim, HJ and Kim, JW (2001) Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. NEUROSCIENCE LETTERS 302: 69-72
Kida, E, Choimiura, NH And Wisniewski, KE (1995) Deposition of apolipoprotein-e and apolipoprotein-j in senile plaques is topographically determined in both alzheimers-disease and downs-syndrome brain. BRAIN RESEARCH 685: 211-216
Kienlen-Campard, P, Miolet, S, Tasiaux, B, Octave, JN (2002) Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 15666-15670
Kienlen-Campard, P, Tasiaux, B and Octave, JN (2000) The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models. EXPERIMENTAL GERONTOLOGY 35: 843-850
Kikuchi,
K, Arawaka, S, Koyama, S, Kimura, H, Ren, CH, Wada, M, Kawanami, T, Kurita, K,
Daimon, M, Kawakatsu, S, Kadoya, T, Goto, K, Kato, T (2003)
An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide
precursor) is associated with tau inclusions in Pick's disease. BIOCHEMICAL AND
BIOPHYSICAL RESEARCH COMMUNICATIONS 308: 646-654
Kikuchi, S, Shinpo, K, Takeuchi, M, Yamagishi, S,
Makita, Z, Sasaki, N, Tashiro, K (2003)
Glycation - a sweet tempter for neuronal death. BRAIN RESEARCH REVIEWS 41:
306-323
Kim, DH, Koh, WK, Kim, JU, Lee, JH and Hong, HN (2001) Okadaic acid-induced upregulation of nitrotyrosine and heme oxygenase-1 in rat cortical neuron cultures. NEUROSCIENCE LETTERS 297: 33-36
Kim, HC, Kim, DK, Choi, IJ, Kang, KH, Yi, SD, Park, J and Park, YN (2001) Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population. PSYCHIATRY AND CLINICAL NEUROSCIENCES 55: 115-120
Kim, HJ, Lee, WH, Yoon, CH, Jeong, JC, Nam, KS, Kim, HM, Choo, YK, Lee, MC and Kim, CH (2001) Bombycis corpus extract prevents amyloid-beta-induced cytotoxicity and protects superoxide dismutase activity in cultured rat astrocytes. PHARMACOLOGICAL RESEARCH 43: 11-16
Kim, HS, Kim, EM, Lee, JP, Park, CH, Kim, S, Seo, JH,
Chang, KA, Yu, E, Jeong, SJ, Chong, YH, Suh, YH (2003)
C-terminal fragments of amyloid precursor protein exert neurotoxicity by
inducing glycogen synthase kinase-3 beta expression. FASEB JOURNAL 17: U253-U280
Kim, HS, Lee, JH, Lee, JP, Kim, EM,
Chang, KA, Park, CH, Jeong, SJ, Wittendorp, MC, Seo, JH,
Choi, SH, Suh, YH (2002) Amyloid beta peptide induces cytochrome c release from
isolated mitochondria
Kim, JH, Anwyl, R, Suh, YH, Djamgoz, MBA and Rowan, MJ (2001) Use-dependent effects of amyloidogenic fragments of beta-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. JOURNAL OF NEUROSCIENCE 21: 1327-1333
Kim, JM, Lee, KH, Choi, YL, Choe,
GY, Jeon, BS (2002) Levodopa-induced dyskinesia in an autopsy-proven case
of progressive supranuclear palsy
Kim, KW, Jhoo, JH, Lee, JH, Lee, DY, Lee, KU, Youn, JY and Woo, JI (2001) Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans. NEUROSCIENCE LETTERS 308: 45-48
Kim,
SH, Smith, CJ, Van Eldik, LJ (2004)
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta
production. NEUROBIOLOGY OF AGING 25: 431-439
Kim, SH, Vlkolinsky, R, Cairns, N and Lubec, G (2000) Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. CELLULAR AND MOLECULAR LIFE SCIENCES 57: 1810-1816
Kim,
SI, Voshol, H, van Oostrum, J, Hastings, TG, Cascio, M, Glucksman, MJ (2004)
Neuroproteomics: Expression profiling of the brain's proteomes in health and
disease. NEUROCHEMICAL RESEARCH 29: 1317-1331
Kimberly, WT, LaVoie, MJ, Ostaszewski, BL, Ye, WJ,
Wolfe, MS, Selkoe, DJ (2003) gamma-secretase is a membrane protein complex
comprised of presenilin, nicastrin, aph-1, and pen-2. PROCEEDINGS OF THE
NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100: 6382-6387
Kimchi, EY, Kajdasz, S, Bacskai, BJ and Hyman, BT (2001) Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 274-279
Kimura, M, Matsushita, S, Arai, H, Matsui, T, Yuzuriha, T and Higuchi, S (2000) No evidence of association between apolipoprotein E gene regulatory region polymorphism and Alzheimer's disease in Japanese. JOURNAL OF NEURAL TRANSMISSION 107: 1449-1456
Kimura, N, Tanemura, K, Nakamura, S, Takashima, A, Ono,
F, Sakakibara, I, Ishii, Y, Kyuwa, S, Yoshikawa, Y (2003)
Age-related changes of Alzheimer's disease-associated proteins in cynomolgus
monkey brains. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 310: 303-311
King,
ME (2005)
Can tau filaments be both physiologically beneficial and toxic? BIOCHIMICA ET
BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 260-267
King, ME, Ghoshal, N, Wall, JS, Binder, LI and Ksiezak-Reding, H (2001) Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments. AMERICAN JOURNAL OF PATHOLOGY 158: 1481-1490
Kingham, PJ and Pocock, JM (2001) Microglial secreted cathepsin B induces neuronal apoptosis. JOURNAL OF NEUROCHEMISTRY 76: 1475-1484
Kinoshita, A, Whelan, CM, Berezovska, O, Hyman, BT (2002) The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 28530-28536
Kirschenbaum, F, Hsu, SC, Cordell, B and McCarthy, JV (2001) Substitution of a glycogen synthase kinase-3 beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 7366-7375
Kirschenbaum, F, Hsu, SC, Cordell, B and McCarthy, JV (2001) Glycogen synthase kinase-3 beta regulates presenilin 1 C-terminal fragment levels. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 30701-30707
Kitaguchi, N.; Takahashi, Y.; Tokushima, Y.; Shiojiri, S.; Ito, H.(1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331: 530-532
Kitazawa,
M, Yamasaki, TR, LaFerla, FM (2004)
Microglia as a potential bridge between the amyloid beta-peptide and tau.
PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES 1035: 85-103
Kiuchi, Y, Isobe, Y, Fukushima, K (2002) Type IV collagen prevents amyloid beta-protein fibril formation. LIFE SCIENCES 70: 1555-1564
Klein, WL, Krafft, GA and Finch, CE (2001) Targeting small A beta oligomers: the solution to an Alzheimer's disease conundrum? TRENDS IN NEUROSCIENCES 24: 219-224
Kleiner-Fisman, G, Black, SE, Lang, AE (2003)
Neurodegenerative disease and the evolution of art: The effects of presumed
corticobasal degeneration in a professional artist. MOVEMENT DISORDERS 18:
294-302
Knockaert, M, Greengard, P, Meijer, L (2002) Pharmacological inhibitors of cyclin-dependent kinases. TRENDS IN PHARMACOLOGICAL SCIENCES 23: 417-425
Knowles_RB, GomezIsla_T, Hyman_BT. (1998) A beta associated neuropil changes: Correlation with neuronal loss and dementia. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, Vol.57, No.12, pp.1122-1130
Ko,
LW, DeTure, M, Sahara, N, Chihab, R, Vega, IE, Yen, SH (2005)
Recent advances in experimental modeling of the assembly of tau filaments.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 125-139
Ko, LW, DeTure, M, Sahara, N, Chihab, R, Yen, SH (2002) Cellular models for tau filament assembly. JOURNAL OF MOLECULAR
NEUROSCIENCE 19: 311-316
Ko LW, Liu WK, Georgieff S, and Yen SHC (1996) Modulated induction of tau proteins in cultured human neuroblastoma cells. BRAIN RESEARCH 707: 256-265
Ko,
LW, Rush, T, Sahara, N, Kersh, JS, Easson, C, DeTure, M, Lin, WL, Connor, YD,
Yen, SHC (2004) Assembly
of filamentous tau aggregates in human neuronal cells. JOURNAL OF ALZHEIMERS
DISEASE 6: 605-622
Kobayashi, K, Nakano, H, Hayashi, M, Shimazaki, M,
Fukutani, Y, Sasaki, K, Sugimori, K, Koshino, Y (2003)
Association of phosphorylation site of tau protein with neuronal apoptosis in
Alzheimer's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES 208: 17-24
Kobayashi, M, Ishiguro, K, Katoh-Fukui, Y, Yokoyama, M, Fujita, SC (2003) Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice. NEUROREPORT 14: 699-702
Kobayashi, T, Mori, H, Okuma, Y, Dickson, DW, Cookson, N, Tsuboi, Y,
Motoi, Y, Tanaka, R, Miyashita, N, Anno, M, Narabayashi, H, Mizuno,
Y (2002) Contrasting genotypes of the tau gene in two phenotypically
distinct patients with P301L mutation of frontotemporal dementia and
parkinsonism linked to chromosome 17. JOURNAL OF NEUROLOGY 249: 669-675
Kobayashi,
T, Ota, S, Tanaka, K, Ito, Y, Hasegawa, M, Umeda, Y, Motoi, Y, Takanashi, M,
Yasuhara, M, Anno, M, Mizuno, Y, Mori, H (2003) A novel L266V mutation of the tau gene causes
frontotemporal dementia with a unique tau pathology.
ANNALS OF NEUROLOGY 53: 133-137
Koh, JY (2001) Zinc and disease of the brain. MOLECULAR NEUROBIOLOGY 24: 99-106
Kohn,
KW, Pommier, Y (2005)
Molecular interaction map of the p53 and Mdm2 logic elements, which control the
Off-On switch of p53 in response to DNA damage. BIOCHEMICAL AND BIOPHYSICAL
RESEARCH COMMUNICATIONS 331: 816-827
Kohnken, R, Buerger, K, Zinkowski, R, Miller, C,
Kerkman, D, DeBernardis, J, Shen, JF, Moller, HJ, Davies, P, Hampel, H (2000)
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of
Alzheimer's disease patients. NEUROSCIENCE LETTERS 287: 187-190
Koistinaho, M, Kettunen, MI, Goldsteins, G, Keinanen, R, Salminen, A, Ort, M, Bures, J, Liu, D, Kauppinen, RA, Higgins, LS, Koistinaho, J (200 2) beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99: 1610-1615
Koistinaho, M, Ort, M, Cimadevilla, JM, Vondrous, R, Cordell, B, Koistinaho, J, Bures, J, Higgins, LS (2001) Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98: 14675-14680
Kolasa, K and Harrell, LE (2000) Apoptotic protein expression and activation of caspases is changed following cholinergic denervation and hippocampal sympathetic ingrowth in rat hippocampus. NEUROSCIENCE 101: 541-546
Kolsch,
H, Lutjohann, D, Ludwig, M, Schulte, A, Ptok, U, Jessen, F, von Bergmann, K, Rao,
ML, Maier, W, Heun, R (2002)
Polymorphism in the cholesterol 24S-hydroxylase gene is
associated with Alzheimer's disease
MOLECULAR PSYCHIATRY 7: 899-902
Komuro A, Saeki N, Kato S (1999) Npw38, a novel nuclear protein possessing a WW domain capable of activating basal transcription. Nucleic Acids research 27: 1957-1965
Kondratick, CM and Vandre, DD (1996) Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. JOURNAL OF NEUROCHEMISTRY 67: 2405-2416
Kong J and Xu Z (2000) Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci Lett 281: 72-4
Konno,
T, Morii, T, Hirata, A, Sato, SI, Oiki, S, Ikura, K (2005) Covalent
blocking of fibril formation and aggregation of intracellular amyloidgenic
proteins by transglutaminase-catalyzed intramolecular cross-linking.
BIOCHEMISTRY 44: 2072-2079
Konsman, JP, Blond, D and Vigues, S (2000) Neurobiology of interleukin-1 receptors: getting the message. EUROPEAN CYTOKINE NETWORK 11: 699-702
Kontush, A (2001) Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins. CELLULAR AND MOLECULAR NEUROBIOLOGY 21: 299-315
Kontush, A, Berndt, C, Weber, W, Akopyan, V, Arlt, S, Schippling, S and Beisiegel, U (2001) Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. FREE RADICAL BIOLOGY AND MEDICINE 30: 119-128
Kopan, R and Goate, A (2000) A common enzyme connects Notch signaling and Alzheimer's disease. GENES & DEVELOPMENT 14: 2799-2806
Kops, O, Zhou, XZ, Lu, KP (2002) Pin1 modulates the dephosphorylation of the RNA polymerase IIC-terminal domain by yeast Fcp1. FEBS LETTERS 513: 305-311
Kosik, KS, Ahn, J, Stein, R, Yeh,
LA (2002) Discovery of compounds that will prevent tau pathology
Kosik KS, Ferreira A, Knowles R, Leclerc N and Greenberg SM (1995) Linking amyloid precursor protein processing and tau-related pathology in Alzheimer's disease. pp. 230-240 In: Alzheimer's Disease: Lessons from Cell Biology. Eds. K.S. Kosik, Y. Christen and D.J. Selkoe. Springer-Verlag.
Kosik,
KS, Shimura, H (2005)
Phosphorylated tau and the neurodegenerative foldopathies. BIOCHIMICA ET
BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1739: 298-310
Kostyszyn, B, Cowburn, RF, Seiger, A, Kjaeldgaard, A and Sundstrom, E (2001) Expression of presenilin-1 and notch-1 receptor in human embryonic CNS. NEUROSCIENCE 103: 885-898
Kotilinek, LA, Bacskai, B, Westerman, M, Kawarabayashi, T, Younkin, L, Hyman, BT, Younkin, S, Ashe, KH (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. JOURNAL OF NEUROSCIENCE 22: 6331-6335
Kotzbauer, PT, Trojanowski, JQ, Lee, VMY (2001) Lewy body pathology in Alzheimer's disease. JOURNAL OF MOLECULAR NEUROSCIENCE 17: 225-232
Koudinov,
AR, Berezov, TT (2004)
Alzheimer's amyloid-beta (A beta) is an essential synaptic protein, not
neurotoxic junk. ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64: 71-79
Kovacs_T, Cairns_NJ and Lantos_PL (1999) beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 25: 481-491
Kovacs, T, Cairns, NJ and Lantos, PL (2001) Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. NEUROREPORT 12: 285-288
Kovacs,
GG, Laszlo, L, Kovacs, J, Jensen, PH, Lindersson, E, Botond, G, Molnar, T,
Perczel, A, Hudecz, F, Mezo, G, Erdei, A, Tirian, L, Lehotzky, A, Gelpi, E,
Budka, H, Ovadi, J (2004)
Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common
marker of alpha-synucleinopathies. NEUROBIOLOGY OF DISEASE 17: 155-162
Kowalik-Jankowska, T, Ruta-Dolejsz,
M, Wisniewska, K, Lankiewicz, L, Kozlowski, H (2002) Possible involvement of copper(II) in Alzheimer disease
Kowalska, A (2002) Molecular genetics of frontotemporal dementia and
parkinsonism linked to chromosome 17 (FTDP-17)
Kowalska, A (2003)
Amyloid precursor protein gene mutations responsible for early-onset autosomal
dominant Alzheimer's disease. FOLIA NEUROPATHOLOGICA 41: 35-40
Kowalska, A, Takahashi, K, Kozubski, W, Tabira, T
(2003) Microtubule associated protein (Tau) gene variability in patients with
frontotemporal dementia. FOLIA NEUROPATHOLOGICA 40: 1-5
Kowalski, JA, Liu, K, Kelly, JW (2002) NMR solution structure of the isolated Apo Pin1 WW domain: Comparison to the X-ray crystal structures of Pin1. BIOPOLYMERS 63: 111-121
Kraemer, BC, Zhang, B, Leverenz, JB, Thomas, JH,
Trojanowski, JQ, Schellenberg, GD (2003)
Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans
model of tauopathy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE
UNITED STATES OF AMERICA 100: 9980-9985
Krapfenbauer, K, Engidawork, E, Cairns, N, Fountoulakis,
M, Lubec, G (2003) Aberrant expression of peroxiredoxin subtypes in
neurodegenerative disorders. BRAIN RESEARCH 967: 152-160
Krapfenbauer, K, Yoo, BC, Kim, SH., Cairns, N, Lubec, G (2001) Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome. LIFE SCIENCES 68: 2169-2179
Kril, JJ, Patel, S, Harding, AJ, Halliday, GM (2002) Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. ACTA NEUROPATHOLOGICA 103: 370-376
Kroemer, G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Medicine 3: 614-620
Kruman, II, Kumaravel, TS, Lohani, A, Pedersen, WA, Cutler, RG, Kruman, Y, Haughey, N, Lee, J, Evans, M, Mattson, MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons. JOURNAL OF NEUROSCIENCE 22: 1752-1762
Ksiezak-Reding, H, He, DK, Gordon-Krajcer, W, Kress, Y, Lee, S and Dickson, DW (2000) Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes. CELL MOTILITY AND THE CYTOSKELETON 47: 236-252
Ksiezak-Reding, H, Pyo, HK, Feinstein, B, Pasinetti, GM
(2003) Akt/PKB kinase phosphorylates separately Thr212 and
Ser214 of tau protein in vitro. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF
DISEASE 1639: 159-168
Ksiezak-Reding H, Yen SH. (1987) Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins. J Neurochem, 1987 Feb, 48:2, 455-62
Kuazi,
AD, Kito, K, Abe, Y, Shin, RW, Kamitani, T, Ueda, N (2003) NEDD8 protein is involved in ubiquitinated inclusion
bodies. JOURNAL OF PATHOLOGY 199: 259-266
Kudo, T, Katayama, T, Imaizumi, K,
Yasuda, Y, Yatera, M, Okochi, M, Tohyama, M, Takeda, M (2002) The unfolded protein response is involved in the
pathology of Alzheimer's disease
Kuhlewein,
A, Voll, G, Alvarez, BH, Kessler, H, Fischer, G, Rahfeld, JU, Gemmecker, G
(2004) Solution
structure of Escherichia coli Par10: The prototypic member of the Parvulin
family of peptidyl-prolyl cis/trans isomerases. PROTEIN SCIENCE 13: 2378-2387
Kumar, A (2000) Alzheimer's disease: amyloid beta-peptide antibody vaccine as plaque remover. JOURNAL OF BIOSCIENCES 25: 315-316
Kumar, VB, Farr, SA, Flood, JF, Kamlesh, V, Franko, M, Banks, WA and Morley, JE (2000) Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. PEPTIDES 21: 1769-1775
Kumar, VB, Vyas, K, Franko, M, Choudhary, V, Buddhiraju, C, Alvarez, J and Morley, JE (2001) Molecular cloning, expression, and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8). BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE 79: 57-67
Kumar-Singh, S, De Jonghe, C, Cruts, M, Kleinert, R, Wang, R, Mercken, M, De Strooper, B, Vanderstichele, H, Lofgren, A, Vanderhoeven, I, Backhovens, H, Vanmechelen, E, Kroisel, PM and Van Broeckhoven, C (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N- truncated A beta(42) in Alzheimer's disease. HUMAN MOLECULAR GENETICS 9: 2589-2598
Kumar-Singh, S, Dewachter, I, Moechars, D, Lubke, U, De Jonghe, C, Ceuterick, C, Checler, F, Naidu, A, Cordell, B, Cras, P, Van Broeckhoven, C and Van Leuven, F (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. NEUROBIOLOGY OF DISEASE 7: 9-22
Kunugi, H, Ueki, A, Otsuka, M, Isse, K, Hirasawa, H, Kato, N, Nabika, T, Kobayashi, S and Nanko, S (2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. MOLECULAR PSYCHIATRY 6: 83-86
Kuo, YM, Kokjohn, TA, Beach, TG, Sue, LI, Brune, D, Lopez, JC, Kalback, WM, Abramowski, D, Sturchler-Pierrat, C, Staufenbiel, M and Roher, AE (2001) Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 12991-12998
Kuperstein, F, Reiss, N, Koudinova, N and Yavin, E (2001) Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures. JOURNAL OF NEUROCHEMISTRY 76: 758-767
Kuperstein, F, Yavin, E (2002) ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures. EUROPEAN JOURNAL OF NEUROSCIENCE 16: 44-54
Kuperstein, F, Yavin, E (2003)
Pro-apoptotic signaling in neuronal cells following iron and amyloid beta
peptide neurotoxicity. JOURNAL OF NEUROCHEMISTRY 86: 114-125
Kurganov,
B, Doh, M, Arispe, N (2004)
Aggregation of liposomes induced by the toxic peptides Alzheimer's A beta s,
human amylin and prion (106-126): facilitation by membrane-bound G(M1)
ganglioside. PEPTIDES 25: 217-232
Kurosinski, P, Guggisberg, M, Gotz, J (2002) Alzheimer's and Parkinson's disease - overlapping or synergistic pathologies?. TRENDS IN MOLECULAR MEDICINE 8: 3-5
Kurt MA; Davies DC; Kidd M. (1999) beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. Exp Neurol, 1999 Jul, 158:1, 221-8
Kurt, MA, Davies, DC, Kidd, M, Duff, K, Howlett, DR
(2003) Hyperphosphorylated tau and paired helical filament-like structures in
the brains of mice carrying mutant amyloid precursor protein and mutant
presenilin-1 transgenes. NEUROBIOLOGY OF DISEASE 14: 89-97
Kuzuhara,
T, Horikoshi, M (2004)
A nuclear FK506-binding protein is a histone chaperone regulating rDNA
silencing. NATURE STRUCTURAL & MOLECULAR BIOLOGY 11: 275-283
Kvetnoy, IM, Hernandez-Yago, J, Kvetnaia, TV, Khavinson, VK, Malinin, VV, Yarilin, AA, Sharova, NI, Blesa, JR, Anisimov, VN, Lenskaia, LV, Sluchevskaia, SF, Chekalina, SI, Tokarev, OY and Yuzhakov, V (2000) Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for life-time diagnosis of Alzheimer's disease. NEUROENDOCRINOLOGY LETTERS 21: 313-318
Kwon, JM. Chakraverty, S, Martinez, M, Morris, JC and Goate, AM (2000) The association between low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease is modified by apolipoprotein E and alpha-2 macroglobulin. AMERICAN JOURNAL OF HUMAN GENETICS 67: 1206